Common use of Additional Definitions Clause in Contracts

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(ii) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 Closing Section 3.3 Closing Date Section 3.3 COBRA Section 4.11(d) Company Preamble Company Common Stock Recitals Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(g) Company License-Out Agreements Section 4.16(h) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a) Company Securities Section 4.2(a) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company D&O Insurance Section 7.8(c) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b) Exchange Fund Section 3.8(b) Expiration Time Section 2.1(d)(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b) Recitals Recitals Indemnified Persons Section 7.8(a) Inventions Section 1.1 Material Contract Section 4.18(a) Maximum Annual Premium Section 7.8(c) Merger Recitals Merger Consideration Section 3.7(a)(i) Minimum Condition Section 2.1(a)(i) Multiemployer Plan Section 4.11(c)

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(iiAntitrust Approval Annex A Appointment Time 2.3(a) Antiboycott Rules Section 4.22(aAssets 4.14 Assumed Option 3.7(e) Board Recommendation Section 2.2(bAssumed RSU 3.7(d) Cancelled Company Shares Section 3.7(a)(iiCapitalization Date 4.6(a) Certificates 3.8(c) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 Closing Section 3.3 Closing Date Section 3.3 COBRA Section 4.11(dCollective Bargaining Agreements 4.18(a) Company Preamble Company Common Stock Recitals Board Recommendation 6.3(a) Company Board Recommendation Change 6.3(b) Company Compensation Committee 4.18(k) Company Disclosure Letter Article Art. IV Preamble Company License-In Intellectual Property Agreements Section 4.16(g4.15(b) Company License-Out Agreements Section 4.16(hPlans 7.2(c) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a4.8 Company Securities 4.6(c) Company Securities Section 4.2(aStockholder Meeting 6.4(a) Company Shares Recitals Comparable Plans 7.2(c) Confidentiality Agreement Section 10.4 Current Company 8.8 Consent 4.5 Continuing Directors 2.3(a) Conversion RSUs 3.7(d)(ii) Covered Securityholders 4.18(k) D&O Insurance Section 7.8(c7.1(c) Customs Laws Section 4.22(aDeemed Cashout Value 3.7(e)(ii) Debt Financing Dispute Section 10.9(a) Delaware Secretary of State 3.2 DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a3.7(c) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(bEmployee Plans 4.18(a) Employment Compensation Arrangements 4.18(k) ERISA Affiliate 4.18(a) Exchange Fund Section 3.8(b) Expiration Time Section 2.1(d)(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b) Recitals Recitals Indemnified Persons Section 7.8(a7.1(a) Inventions Section 1.1 Material Contract Section International Employee Plans 4.18(a) Leased Real Property 4.13(b) Leases 4.13(b) (a) Maximum Annual Premium Section 7.8(c7.1(c) Merger Recitals 3.1 Merger Consideration Section 3.7(a)(i3.7(a) Minimum Condition Section 2.1(a)(i2.1(a) Multiemployer Plan Section 4.11(cNew Plans 7.2(d) Offer Recitals Offer Price Recitals Offer to Purchase 2.1(a) Offer Documents 2.1(g) Old Plans 7.2(d) Option Consideration 3.7(e) Parent Preamble Payment Agent 3.8(a) Permits 4.19 Proxy Statement 4.28(c) Recommendation Change Notice 6.3(b) Representatives 6.2(b) Requisite Stockholder Approval 4.3 Schedule TO 2.1(g) Schedule 14D-9 2.2(b) Stockholders Recitals Subsidiary Securities 4.7(c) Superior Proposal Notice 10.1(e) Surviving Corporation 3.1 (a) Tax Returns 4.16 (a) Tender and Voting Agreement Recitals Termination Date 10.1(b) Top-Up Notice 2.4(a) Top-Up Option 2.4(a) Top-Up Option Shares 2.4(a) Uncertificated Shares 3.8(c)

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto given to them in the respective sections Sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iAdditional Approval Condition 3.4(b) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii5.4(a) Antiboycott Rules Section 4.22(aAnti-Bribery Laws 3.22(c) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(ii) Certificate Articles of Merger Section 3.2 2.4(a) Certificates Section 3.8(c2.9(c)(i) Changes Section 1.1 Charter Amendment Effective Time 2.3 Closing Section 3.3 2.5 Closing Date Section 3.3 COBRA Section 4.11(d) 2.5 Company Preamble Company Common Stock Recitals Charter Amendment Certificate 2.1 Company Disclosure Letter Article IV 1.4 Company License-In Agreements Section 4.16(gIntellectual Property 3.17(b) Company License-Out Agreements Section 4.16(hLeased Real Property 3.15(b) Company Financial Advisor Section 4.10 Option 2.8(c)(i) Company Owned Real Property 3.15(a) Company PSU 2.10(c)(i) Company Recommendation 3.3(a) Company Recommendation Change 5.4(c)(i) Company RSU 2.10(a)(i) Company SEC Reports Section 4.7(a3.8(d) Company Securities Section 4.2(a3.7(b) Company Shares Special Committee Recitals Confidentiality Agreement Section 10.4 Current Company D&O Insurance Section 7.8(cStockholder Meeting 6.4(a) Customs Laws Section 4.22(aConverted PSU Award 2.10(c)(ii) Debt Financing Dispute Section 10.9(aConverted Restricted Share Award 2.10(b) DGCL Recitals Dissenting Company Shares Section 3.7(c)(iConverted RSU Award 2.10(a)(ii) EAR Section 4.22(aCopyrights 1.1(kkk) Covenant Exceptions 5.1(a) Data Privacy/Security Requirements 3.17(g) Effect 1.1(x) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b2.4(b) Electronic Delivery 9.13 Enforcement Expenses 8.3(d) Ex-Im Laws 3.22(c) Exchange Fund Section 3.8(b2.9(b) Expiration Time Section 2.1(d)(iExcluded Arrangements 6.10(a) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bFHWA 3.21(b) Recitals Recitals Financing 6.5(a) FMCSA 3.21(b) Indemnified Party Proceeding 6.9(b) Indemnified Persons Section 7.8(a6.9(a) Inventions Section 1.1 Material Contract Section 4.18(aLabor Agreements 3.20(a) Leased Real Property Leases 3.15(b) Marks 1.1(kkk) Maximum Annual Premium Section 7.8(c6.9(b) Merger Recitals Merger Consideration Section 3.7(a)(iSub Preamble Merger Sub Stockholder Approval 6.16 Net Debt 5.2(h)(i) Minimum Condition Section 2.1(a)(iNew Plans 6.9(a) Multiemployer Plan Section 4.11(cNotice Period 5.4(d)(ii)(3) Old Plans 6.9(a) Owned Company Shares 2.9(a)(ii) Parent Preamble Party or Parties Preamble Patents 1.1(kkk) Payment Agent 2.9(a) Per Share Price 2.9(a)(iii) Proxy Holder Recitals Proxy Statement 6.3(a) Required Permits 3.20(c) Restraint 7.1(b) Rollover Agreement Recitals Rollover Shares Recitals Statutory Charter Amendment Stockholder Approvals 3.4(a) Statutory Merger Stockholder Approval 3.4(a) Statutory Stockholder Approvals 3.4(a) Support Agreement Recitals Surviving Corporation Recitals Tail Policy 6.9(b) Termination Date 8.1(b) Trade Secrets 1.1(kkk) Transaction Matters 9.11(a) Uncertificated Shares 2.9(c)(ii) Union 3.20(a) Vested Company PSU 2.10(c)(i) Vested Company RSU 2.10(a)(i)

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii401(k) Acquisition Proposal Section 6.2(e)(iTermination Date 7.11(d) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iAcceptance Time 2.3(a) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(iiAppointment Time 2.3(a) Antiboycott Rules Section 4.22(aAssets 4.19 Book-Entry Shares 3.9(c) Board Recommendation Section 2.2(bCapitalization Date 4.4(a) Cancelled Company Shares Section 3.7(a)(ii) Capitalization Representation Annex A Certificate of Merger Section 3.2 Certificates Section 3.8(c3.9(c) Changes Section 1.1 Claims Annex A Closing Section 3.3 Closing Date Section 3.3 COBRA Section 4.11(dCollective Bargaining Agreements 4.17(a) Company Preamble Company Common Stock Recitals Board Recommendation 2.2(a)(iv) Company Board Recommendation Change 7.2(b) Company Disclosure Letter Schedule Article IV Company License-In Agreements Section 4.16(gRegistered Intellectual Property 4.20(b) Company License-Out Agreements Section 4.16(h) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(aRepresentatives 7.1(b) Company Securities Section 4.2(a4.4(c) Company Shares Recitals Stockholders 2.1(f)(ii) Company Stockholders’ Meeting 7.3(a) Compensation Committee 4.3(c) Confidentiality Agreement Section 10.4 Current Company 7.9 Consent 4.5(b) Continuing Directors 2.3(a) Continuing Employees 7.11(a) D&O Insurance Section 7.8(c7.12(b) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a) DGCL Recitals Delaware Secretary of State 3.2 Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(bEmployee Plans 4.16(a) Employment Agreement Recitals ESPP 3.8(c) eScription Transition Condition Annex A Exchange Fund Section 3.8(b3.9(b) Expiration Time Section 2.1(d)(iFinal Exercise Date 3.8(c) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bForeign Employees 4.16(k) Recitals Recitals Funded International Employee Plan 4.16(b) Government Conditions 7.5(f) Indemnified Persons Section 7.8(aParties 7.12(a) Inventions Section 1.1 International Employee Plans 4.16(a) IP Contracts 4.20(h) Lazard 4.26 Leased Real Property 4.18(b) Leases 4.18(b) Material Contract Section 4.18(a4.11(a) Material Customer 4.23(a) Material Supplier 4.23(b) Maximum Annual Premium Section 7.8(c7.12(b) Merger Recitals 3.1 Merger Consideration Section 3.7(a)(i) Merger Sub Preamble Minimum Condition Section 2.1(a)(i) Multiemployer Plan Section 4.11(c)

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto given to them in the respective sections Sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iiiAdverse Effect on Financing 7.18(d) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iAdvisor 4.3(b) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii6.3(b) Antiboycott Rules Section 4.22(aBuyer Parties Preamble Bylaws 4.1 Capitalization Date 4.6(a) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(ii) Cash Offer Price Recitals Certificate of Merger Section 3.2 Certificates Section 3.8(c3.9(c) Changes Section 1.1 Charter 3.5(a) Chosen Courts 10.10 Closing Section 3.3 Closing Date Section 3.3 COBRA Section 4.11(dCollective Bargaining Agreement 4.18(a) Company Preamble Company Common Stock 401(k) Plan 7.8(e) Company Board Recommendation Recitals Company Board Recommendation Change 6.3(d)(i) Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(gEquity Award Schedule 4.6(b) Company License-Out Agreements Section 4.16(hOwned Software 4.15(h) Company Financial Advisor Section 4.10 PSU Consideration 3.8(b) Company Registered IP 4.15(a) Company RSA Consideration 3.8(a) Company SEC Reports Section 4.7(a4.8 Company Securities 4.6(c) Company Securities Section 4.2(aTermination Fee 9.3(b)(i) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company Consent 4.5 Copyrights 1.1(zz) Cut-Off Time 6.3(b) D&O Insurance Section 7.8(c7.7(c) Customs Data Protection Laws Section 4.22(a1.1(bb) Debt Financing Dispute Section 10.9(aDepository Agent 3.9(a) DGCL Recitals Discharge 7.16 Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a▇▇▇▇▇ 4.8 Effect 1.1(u) Effective Time Section 3.2 Electronic Delivery 10.13 Employee Plans 4.17(a) Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(bLimitations 4.2 ERISA Affiliate 4.17(c) Event Notice Period 6.3(e)(i)(2) Exchange Fund Section 3.8(b3.9(b) Expiration Time Section 2.1(d)(iDate 2.1(c) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bExtension Deadline 2.1(c) Recitals Recitals Form S-4 2.1(e) Government Closure 7.2(a) Indemnified Persons Section 7.8(a7.7(a) Inventions Section 1.1 Lease 4.13(b) Leased Real Property 4.13(b) Marks 1.1(zz) Material Contract Section 4.18(a4.12(a) Maximum Annual Premium Section 7.8(c7.7(c) Merger Recitals Merger Consideration Section 3.7(a)(iFractional Share Payout 3.7(d) Minimum Condition Section 2.1(a)(i) Merger Sub Preamble Multiemployer Plan Section 4.11(c4.17(d) New Plan 7.8(d) Offer Recitals Offer Acceptance Time 2.1(h) Offer Commencement Date 2.1(c) Offer Conditions 2.1(b)

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality A&R Partnership Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Recitals Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) Agreement Preamble Alternative Acquisition Financing Section 6.19(a) BAM Letter Agreement Section 6.2(c)(ii) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Recitals Cancelled Company Shares Section 3.7(a)(ii2.07(a)(ii) Capitalization Date Section 3.06(a) Cash Electing Share Section 2.03(d)(1) Cash Election Section 2.03(d)(1) Certificate of Merger Section 3.2 2.02 Certificates Section 3.8(c2.09(c) Changes Section 1.1 Charter Closing Section 3.3 2.03(a) Charter Closing Date Section 3.3 COBRA 2.03(a) Charter Effective Time Section 4.11(d2.03(a) Citigroup Section 3.25 Class B Exchange Recitals Class B Exchange Agreement Section 2.03(b) Class B Exchange Closing Section 2.03(b) Class B Exchange Effective Time Section 2.03(b) Collective Bargaining Agreement Section 3.19(a) Committed Financing Section 4.29 Company Preamble Company Common Stock Benefit Plans Section 3.18(a) Company Board Recitals Company Board Recommendation Section 3.02 Company Board Recommendation Change Section 5.03(c) Company Board Recommendation Notice Section 5.03(f) Company Budget Section 5.01(a) Company Charter Recitals Company Disclosure Letter Article IV III Company License-In Agreements Related Parties Section 4.16(g8.03(d) Company License-Out Agreements Section 4.16(h) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a) 3.08 Company Securities Section 4.2(a3.06(c) Company Shares Special Distribution Section 5.01(a) Company Stockholder Meeting Section 3.02 Company Stockholders Recitals Competing Acquisition Transaction Section 8.03(b)(ii) Competing Proposal Section 5.03(b) Confidentiality Agreement Section 10.4 Current Company D&O Insurance 9.04 Consent Section 7.8(c3.05 Continuing Employees Section 6.08(a) Customs Laws Converted Option Section 4.22(a2.07(d)(ii) Debt Financing Dispute Converted Restricted Stock Section 10.9(a2.07(e)(i) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i2.07(c)(i) EAR Election Deadline Section 4.22(a2.08(b) Effective Time Election Form Section 3.2 2.08(a) Election Form Record Date Section 2.08(a) Enforceability Exceptions Limitations Section 4.4 Environmental Permits 3.02 Escrow Account Section 4.15(b2.09(a) Escrow Agent Section 2.09(a) Escrow Agreement Section 2.09(a) Exchange Fund Section 3.8(b2.09(b) Expiration Time Expenses Section 2.1(d)(i8.03(a) Financial Statements Incipio Incipio Merger Agreement Fee Letter Section 4.7(b4.29 Final Offering Section 2.07(g) Recitals Recitals Financing Commitment Section 4.29 Financing Commitment Papers Section 4.29 Form F-4 Section 4.23 Form S-4 Section 3.28 Fraud and Bribery Laws Section 3.21(b) ▇▇▇▇▇▇▇ ▇▇▇▇▇ Section 3.25 Indemnified Persons Parties Section 7.8(a6.07(a) Inventions Mailing Date Section 1.1 2.08(a) Material Contract Section 4.18(a) Maximum Annual Premium Section 7.8(c3.12(a) Merger Recitals Merger Closing Section 2.03(e) Merger Closing Date. Section 2.03(e) Merger Consideration Section 3.7(a)(i2.07(a)(i) Minimum Condition Merger Effective Time Section 2.1(a)(i2.02 New Plans Section 6.08(b) Multiemployer Plan Non-Electing Shares Section 4.11(c2.08(b) Notice Period Section 5.03(g) Old Plans Section 6.08(b) Operating Partnership Recitals Owned Real Property Section 3.13(a) Parent Preamble Parent Capitalization Date Section 4.06 Parent Common Units Election Section 2.08(b) Parent Common Units Election Share Section 2.08(b) Parent Common Units Exchange Section 2.03(f) Parent Disclosure Letter Article IV Parent Material Contract Section 4.12(a) Parent Related Parties Section 8.03(d) Parent SEC Reports Section 4.08 Parent Securities Section 4.06(c) Parent Subsidiary Securities Section 4.07(c) Parent Unitholder Consent Section 4.04 Parent Unitholder Meeting Section 6.16 Partnership Agreement Amendment and Restatement Recitals Payment Agent Section 2.09(a) Per Restricted Share Cash Consideration Section 2.07(e)(i) Permits Section 3.20 Pre-Closing Dividend Section 2.03(d) Prorated Per Share Cash Dividend Section 2.03(d)(1) Prorated Per Share Stock Dividend Section 2.03(d)(2) Proxy Statement Section 3.28 PTP Qualifying Income Section 8.03(b)(iv)(1) Qualifying Income Section 8.03(c)(i) Qualifying Income Section 8.03(b)(iv)(3) REIT Affiliate Section 8.03(b)(iv)(3) REIT Subsidiary Section 3.17(f) Representatives Section 5.03(a) Requested Transactions Section 6.14 Requested Transactions Closing Section 2.03(c) Requested Transactions Effective Time Section 2.03(c) Requisite Stockholder Approval Section 3.03 Retention Program Section 6.08(d) Rev. Proc. 93-27 Section 3.06(b) Reverse Termination Fee Section 8.03(c) Rights Agreement Recitals Schedule 13E3 Section 4.23 Shelf Registration Statement(s) Section 7.03(e) Short Taxable Year Section 7.02(d) Special Committee Recitals Specified JV Agreements Section 6.19(c) Specified JV Consent Section 6.19(c) Specified JV Party Section 6.19(c) Stock Electing Share Section 2.03(d)(2) Stock Election Section 2.03(d)(2) Subsidiary Interests Section 6.14 Subsidiary Securities Section 3.07(c) Surviving Corporation Section 2.01 Surviving Debt Section 6.19(b) Surviving Debt Consent Section 6.19(b) Surviving Debt Party Section 6.19(b) Tail Period Section 8.03(b)(ii) Tail Policy Section 6.07(b) Tax Protection Agreement Section 3.17(j) Tax Sharing Agreement Section 3.17(j) Termination Date Section 8.01(a)(ii) Termination Fee Section 8.03(b)(i) Uncertificated Shares Section 2.09(c) Voting Agreement Recitals Voting Parties Recitals WARN Section 3.19(c)

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii401(k) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iPlan 7.11(a) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(iiAmended Offer Documents 2.1(a)(i) Antiboycott Rules Section 4.22(aAnnual Meeting 7.6(b) Board Recommendation Section 2.2(bAssets 4.19 Assumed Option 3.8(a) Cancelled Company Assumed Restricted Stock Unit 3.8(b) Book-Entry Shares Section 3.7(a)(ii3.9(b)(i) Capitalization Date 4.4(a) Certificate 3.9(b)(i) Certificate of Merger Section 3.3(a) Closing 3.2 Certificates Section 3.8(c) Changes Section 1.1 Closing Section 3.3 Closing Date Section 3.3 COBRA Section 4.11(d3.2 Collective Bargaining Agreements 4.16(a) Company Preamble Company Common Stock Recitals Board Recommendation 7.7(a) Company Board Recommendation Change 7.7(a) Company Capitalization Representation Annex A Company Disclosure Letter Schedule Article IV Company LicenseForm 10-In Agreements Section 4.16(gK 4.1(b) Company License-Out Agreements Section 4.16(hInsiders 7.14 Company Products 4.20(a) Company Financial Advisor Section 4.10 Restricted Stock 3.8(c) Company SEC Reports Section 4.7(a4.6(a) Company Securities Section 4.2(a4.4(c) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company Stockholder Meeting 7.6(a) Confidential Materials 7.9(a) Continuing Directors 2.4(b) Consent 4.3(b) D&O Insurance Section 7.8(c7.12(b) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(aDelaware Secretary of State 3.3(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i3.7(b)(vi) EAR Section 4.22(aEffect 1.1(pp) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b3.3(a) (a) Exchange Agent 3.9(a)(i) Exchange Fund Section 3.8(b3.9(a)(ii) Expiration Time Section 2.1(d)(iDate Annex A Foreign Employees 4.15(j) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bIn-Licenses 4.20(d) Recitals Recitals Indemnified Persons Section 7.8(aParties 7.12(a) Inventions Section 1.1 Independent Directors 2.4(c) Leased Real Property 4.17 Leases 4.17 Material Contract Section 4.18(a4.13(a) Maximum Annual Premium Section 7.8(c7.12(b) Merger Recitals Merger Agreement Annex A Merger Consideration Section 3.7(a)(i3.7(b)(i) Merger Proposal 7.6(a) Minimum Tender Condition Section 2.1(a)(i) Multiemployer Plan Section 4.11(cAnnex A NetApp Merger Agreement Recitals Notes 7.9(a)

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto given to them in the respective sections Sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii5.3(a) Antiboycott Rules Section 4.22(aCertificates 2.12(c)(i) Board Recommendation Section 2.2(bCFIUS Filing 6.2(c) Cancelled Company Shares Section 3.7(a)(iiChosen Courts 9.12(a) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 Closing Section 3.3 2.6 Closing Date Section 3.3 COBRA Section 4.11(d2.6 Collective Bargaining Agreement 3.19(a) Company Preamble Company Common Stock Recitals Benefit Plan Expiration Date 6.11(b) Company Board Recommendation 3.3(a) Company Board Recommendation Change 5.3(c)(i) Company Breach Notice Period 8.1(g) Company Disclosure Letter Article IV 1.4 Company License-In Agreements Section 4.16(gPlans 6.11(c) Company License-Out Agreements Section 4.16(hRelated Parties 8.3(e) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a3.8 Company Securities 3.6(c) Company Securities Section 4.2(aSoftware 3.15(j) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Stock-Based Award Consideration 2.11(a) Company D&O Insurance Section 7.8(cTrade Secrets 3.15(i) Customs Laws Section 4.22(aComparable Plans 6.11(c) Debt Financing Dispute Section 10.9(aContributor 3.15(h) DGCL Recitals Copyrights 1.1(eee) Dissenting Company Shares Section 3.7(c)(i2.10(c)(i) EAR Section 4.22(aDissenting Shareholder Statute 2.10(c)(i) Draft CFIUS Filing 6.2(c) DTC Payment 2.12(d) ▇▇▇▇▇ 3.8 Effect 1.1(x) Effective Time Section 2.5 Electronic Delivery 9.14 Enforceability Limitations 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(bEvent Notice Period 5.3(d)(i)(1) Exchange Fund Section 3.8(b2.12(b) Excluded Benefits 6.11(c) Expiration Date 2.1(c) Expiration Time Section 2.1(d)(iAnnex I Extension Deadline 2.1(d)(ii) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b) Recitals Recitals Indemnified Persons Section 7.8(a6.10(a) Inventions Section 1.1 Material Contract Section 4.18(aInitial Expiration Date 2.1(c) International Company Benefit Plans 3.18(a) Joinder 9.7 Lease 3.13(b) Leased Real Property 3.13(b) Marks 1.1(eee) Maximum Annual Premium Section 7.8(c6.10(c) Merger Recitals Merger Consideration Section 3.7(a)(i) Sub Recitals Minimum Condition Section 2.1(a)(iAnnex I New Plans 6.11(d) Multiemployer Plan Section 4.11(cOffer Recitals Offer Acceptance Consideration 2.2(a)(iii) Offer Acceptance Time 2.2(a)(iii) Offer Commencement Date 2.1(f)(i) Offer Conditions 2.1(b)(i) Offer Documents 2.1(f)(i)

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iAccepted Company Shares 2.7(a)(ii) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(iiAnti-Bribery/AML Laws 3.19(a) Antiboycott Rules Section 4.22(aBorrower 4.7(a) Board Recommendation Section 2.2(b) Cancelled Canceled Company Shares Section 3.7(a)(ii2.7(a)(ii) Capitalization Date 3.4(a) Certificate of Merger Section 3.2 2.2 Certificates Section 3.8(c2.8(c) Changes Section 1.1 Change of Control Payment 3.15(a)(xii) Closing Section 3.3 2.3 Closing Date Section 3.3 COBRA Section 4.11(d) 2.3 Company Preamble Company Common Stock Recitals Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(gBoard Recommendation 6.1(a) Company License-Out Agreements Section 4.16(hBoard Recommendation Change 6.1(b) Company ESPP Rights 2.7(e) Company Financial Advisor Section 4.10 Advisors 3.21 Company Financial Statements 3.5(b) Company Plans 6.9(c) Company Related Parties 8.4(c) Company SEC Reports Section 4.7(a3.5(a) Company Securities Section 4.2(a3.4(a) Company Shares Recitals Confidentiality Agreement Section 10.4 Company Termination Fee 8.4(a) Competing Acquisition Transaction 8.4(a)(i) Current Company D&O Insurance Section 7.8(c6.4(c) Customs Laws Section 4.22(aDebt Commitment Letter 4.7(a) Debt Financing Dispute Section 10.9(a4.7(a) DGCL Recitals Disclosure Schedule Article III Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a2.7(b)(i) Effective Time Section 3.2 2.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b) 3.2 Exchange Fund Section 3.8(b2.8(b) Expiration Time Section 2.1(d)(i1.1(c)(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bFinal Exercise Date 2.7(e) Recitals Recitals Financing Agreements 6.16(d) Financing Sources 8.5 In-bound License 3.14(b) In-the-money Option 2.7(c) Indemnified Persons Section 7.8(a6.4(a) Indemnified Proceeding 6.4(b) Inventions Section 1.1 Article X Know-How Article X Labor Agreements 3.15(a)(xvii) Labor Organizations 3.16(i) Material Contract Section 4.18(a3.15(a) Maximum Annual Premium Section 7.8(c6.4(c) Merger Recitals Term Section Reference Merger Consideration Section 3.7(a)(i2.7(a)(i) Merger Sub Preamble Minimum Condition Section 2.1(a)(i1.1(a)(i) Multiemployer Plan Section 4.11(c)3.16(c) New Plans 6.9(c) Notice of Intended Recommendation Change 6.1(c) Offer Recitals Offer Commencement Date 1.1(a) Offer Conditions Annex A Offer Documents 1.1(e)(i) Offer Price Recitals Offer to Purchase 1.1(a) Old Plans 6.9(c) Option Consideration 2.7(c) Out-bound License 3.14(b) Parent Preamble Payment Agent 2.8(a) Payoff Amount 2.7(f) Payoff Letter 2.7(f) Plans 3.16(a) Principal Stockholders Recitals Real Property Leases 3.13(b) Representatives 5.3 Restraint 7.1(b) Regulatory Authorities 3.17(b) Regulatory Permits 3.17(b) Required Information 6.16(a)(iv) Restricted Benefits 3.19(b) RSU Consideration 2.7(d) Schedule 14D-9 1.2(a) Schedule TO 1.1(e)(i) Software Article X Stockholder List Date 1.2(b) Surviving Corporation 2.1 Termination Date 8.1(b) Termination Fee 8.4(a)(i) Trademarks Article X Uncertificated Shares 2.8(c) Works of Authorship Article X

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto given to them in the respective sections Sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iEffect on Financing 7.18 Advisor 4.3(b) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii6.3(b) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(iiBuyer Parties Preamble Bylaws 4.1 Capitalization Date 4.6(a) Certificate of Merger Section 3.2 Certificates Section 3.8(c3.9(c) Changes Section 1.1 Charter 3.5(a) Chosen Courts 10.10 Closing Section 3.3 Closing Date Section 3.3 COBRA Section 4.11(dCollective Bargaining Agreement 4.18(a) Company Preamble Company Common Stock 401(k) Plan 7.8(e) Company Board Recommendation Recitals Company Board Recommendation Change 6.3(d)(i) Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(gEquity Award Schedule 4.6(b) Company License-Out Agreements Section 4.16(hOwned Software 4.15(h) Company Financial Advisor Section 4.10 PSU Consideration 3.8(b) Company Registered IP 4.15(a) Company RSA Consideration 3.8(a) Company SEC Reports Section 4.7(a4.8 Company Securities 4.6(c) Company Securities Section 4.2(aTermination Fee 9.3(b)(i) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company Consent 4.5 Copyrights 1.1(zz) Cut-Off Time 6.3(b) D&O Insurance Section 7.8(c7.7(c) Customs Data Protection Laws Section 4.22(a1.1(bb) Debt Financing Dispute Section 10.9(aDepository Agent 3.9(a) DGCL Recitals Discharge 7.16 Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(aE▇▇▇▇ 4.8 Effect 1.1(t) Effective Time Section 3.2 Electronic Delivery 10.13 Employee Plans 4.17(a) Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(bLimitations 4.2 ERISA Affiliate 4.17(c)6.3(e)(i) Event Notice Period 6.3(e)(i) Exchange Fund Section 3.8(b3.9(b) Expiration Time Section 2.1(d)(iDate 2.1(c) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bExtension Deadline 2.1(c) Recitals Recitals Go-Shop Period 6.3(a) Government Closure 7.2(a) Indemnified Persons Section 7.8(a7.7(a) Inventions Section 1.1 Material Contract Section 4.18(aLease 4.13(b) Leased Real Property 4.13(b) Marks 1.1(zz) (a) Maximum Annual Premium Section 7.8(c7.7(c) Merger Recitals Merger Consideration Section 3.7(a)(i) Minimum Condition Section 2.1(a)(i) Sub Preamble Multiemployer Plan Section 4.11(c4.17(d) New Plan 7.8(d) No-Shop Period Start Date 6.3(a) Offer Recitals Offer Acceptance Time 2.1(h) Offer Commencement Date 2.1(c) Offer Conditions 2.1(b)

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(iiBook-Entry Shares 2.8(c)(ii) Antiboycott Rules Section 4.22(aBurdensome Condition 6.2(a) Board Recommendation Section 2.2(bCanceled Shares 2.7(a)(ii) Cancelled Company Shares Section 3.7(a)(iiCapitalization Date 3.2(a) Certificate of Merger Section 3.2 2.2 Certificates Section 3.8(c2.8(c)(i) Changes Section 1.1 Change of Recommendation Notice 5.3(b) Closing Section 3.3 2.3 Closing Date Section 3.3 2.3 COBRA Section 4.11(d3.13(d) Company Preamble Company Common Stock Board Recitals Company Board Recommendation 3.5 Company Board Recommendation Change 5.3(a) Company Disclosure Letter Article IV Company License-In Agreements III Term Section 4.16(g) Company License-Out Agreements Section 4.16(h) Reference Company Financial Advisor Section 4.10 3.12 Company SEC Reports Section 4.7(a3.8(a) Company Securities Section 4.2(a3.2(c) Company Shares Recitals Termination Fee 8.3(c) Confidentiality Agreement Section 10.4 Current Company 9.4 D&O Insurance Section 7.8(c) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a6.8(c) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i2.7(c)(i) EAR Section 4.22(a) Domain Names 1.1 Effect 1.1 Effective Time Section 3.2 2.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b) 3.4 Exchange Fund Section 3.8(b2.8(b) Expiration Time Section 2.1(d)(iFDA Permits 3.22(b) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bFinal Exercise Date 2.7(f) Recitals Recitals Final Offering Periods 2.7(f) Foreign Antitrust Laws 3.7 Indemnified Persons Section 7.8(a6.8(a) Indemnified Proceeding 6.8(b) Intercompany Indebtedness 1.1 Inventions Section 1.1 Letter of Transmittal 2.8(c)(i) Material Contract Section 4.18(a) Maximum Annual Premium Section 7.8(c) 3.21 Merger Recitals Merger Consideration Section 3.7(a)(i2.7(a)(i) Minimum Condition Section 2.1(a)(iMerger Sub Preamble New Plans 6.9(c) Multiemployer Plan Section 4.11(cOld Plans 6.9(c) Option Consideration 2.7(d) Parent Preamble Parent Termination Fee 8.3(d) Paying Agent 2.8(a) Payor 2.8(e) Plans 3.13(a) Proxy Statement 6.1(a) Real Property Leases 3.20(b) RSU Consideration 2.7(e) Solvent 4.10 Stockholder Approval 3.6 Stockholders Meeting 6.1(c) Surviving Corporation 2.1 Termination Date 8.1(b)(i)

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto given to them in the respective sections Sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iAdditional Stockholder Approvals 3.4(b) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii5.4(a) Antiboycott Rules Section 4.22(aAnti-Bribery Laws 3.22(c) Board Recommendation Section 2.2(bCARES Act 3.18(h) Cancelled Company Shares Section 3.7(a)(iiCertificates 2.9(c)(i) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 Closing Section 3.3 2.3 Closing Date Section 3.3 COBRA Section 4.11(d2.3 Commitment Letters 4.10(a) Company Preamble Company Common Stock Recitals Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(g1.3(u) Company License-Out Agreements Section 4.16(hIntellectual Property 3.17(b) Company Financial Advisor Section 4.10 Option 2.8(c)(i) Company Privacy Policy 3.17(m) Company PSU 2.8(b)(i) Company Recommendation 3.3(a) Company Recommendation Change 5.4(c)(i) Company RSU 2.8(a)(i) Company SEC Reports Section 4.7(a3.8(d) Company Securities Section 4.2(a3.7(b) Company Shares Special Committee Recitals Confidentiality Agreement Section 10.4 Current Company D&O Insurance Section 7.8(cStockholder Meeting 6.4(a) Customs Laws Section 4.22(aContinuing Employees 6.11(b) Converted Cash Award 2.8(a)(ii) Copyrights 1.1(hhh) Covenant Exceptions 5.1(a) Debt Commitment Letter 4.10(a) Debt Fee Letter 6.6(b)(ii) Debt Financing Dispute Section 10.9(a4.10(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a2.7(d)(i) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b2.2 Electronic Delivery 9.14 Elephant Recitals Enforcement Expenses 8.3(e) Equity Commitment Letters 4.10(a) Equity Financing 4.10(a) Exchange Fund Section 3.8(b2.9(b) Expiration Time Section 2.1(d)(iExcluded Arrangements 6.11(b) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bFinancing 4.10(a) Founder Recitals Guarantees Recitals Guarantors Recitals Indemnified Party Proceeding 6.10(b) Indemnified Persons Section 7.8(a6.10(a) Inventions Section 1.1 Material Contract Section 4.18(aInternational Employee Plans 3.19(a) IP Contracts 3.17(d) KKR Recitals Labor Agreements 3.20(a) Lease 3.15(b) Leased Real Property 3.15(b) Marks 1.1(hhh) Maximum Annual Premium Section 7.8(c6.10(b) Merger Recitals Merger Sub Preamble Merger Sub Stockholder Approval 6.19 New Plans 6.11(a) Notice Period 5.4(d)(ii)(2) Old Plans 6.11(a) Other Required Company Filing 6.3(e) Other Required Parent Filing 6.3(f) Owned Company Shares 2.7(a)(ii) Parent Preamble Parent Divesture Obligations 6.2(b) Party or Parties Preamble Patents 1.1(hhh) Payment Agent 2.9(a) Per Share Price 2.7(a)(iii) Promissory Note 6.22 Proxy Statement 6.3(a) Reimbursement Obligations 6.6(h) Reinvestment Shareholders Recitals Required Amount 4.10(a) Required Permits 3.20(c) Restraint 7.1(b) Rollover Shares Recitals Statutory Stockholder Approval 3.4(a) Support Agreements Recitals Surviving Corporation Recitals Tail Policy 6.10(b) Technical Deficiencies 3.17(l) Termination Date 8.1(b) Trade Controls 3.22(b) Trade Secrets 1.1(hhh) Transaction Matters 9.12(a) Uncertificated Shares 2.9(c)(ii) Unvested Company Option 2.8(c)(ii) Unvested Company PSU 2.8(b)(i) Unvested Company RSU 2.8(a)(ii) Vested Company Option 2.8(c)(i) Vested Company Option Consideration Section 3.7(a)(i2.8(c)(i) Minimum Condition Section 2.1(a)(iVested Company PSU 2.8(b)(i) Multiemployer Plan Section 4.11(c)Vested Company PSU Consideration 2.8(b)(i) Vested Company RSU 2.8(a)(i) Vested Company RSU Consideration 2.8(a)(i) Vista Recitals

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto given to them in the respective sections Sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) Agreement Preamble Alternate Debt Financing 6.5(d) Alternative Acquisition Agreement Section 6.2(c)(ii5.3(b) Antiboycott Rules Section 4.22(aASU 1.1(zz) Board Recommendation Section 2.2(bCertificates 2.9(c)(i) Cancelled Company Shares Section 3.7(a)(ii) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 Closing Section 3.3 2.3 Closing Date Section 3.3 COBRA Section 4.11(d) 2.3 Company Preamble Company Common Stock Recitals Board Recommendation 3.3(a) Company Board Recommendation Change 5.3(d)(i) Company Disclosure Letter Article IV 1.4 Company License-In Agreements Section 4.16(gPrivacy Policy 3.16(h) Company License-Out Agreements Section 4.16(hPlans 6.11(b) Company Financial Advisor Section 4.10 Related Parties 8.3(f)(ii) Company SEC Reports Section 4.7(a3.9 Company Securities 3.7(c) Company Securities Section 4.2(aStock-Based Award Consideration 2.8(a)(i) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company D&O Insurance Section 7.8(cStockholder Meeting 6.4(a) Customs Laws Section 4.22(aComparable Plans 6.11(b) Converted Stock-Based Award 2.8(a)(ii) Copyrights 1.1(aaa) Debt Commitment Letters 4.10(a) Debt Financing Dispute Section 10.9(a4.10(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i2.7(c)(i) EAR Section 4.22(aDPA 4.13(a) DTC Payment 2.9(d) Effect 1.1(t) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b2.2 Electronic Delivery 9.14 Equity Commitment Letter 4.10(a) Equity Financing 4.10(a) Exchange Fund Section 3.8(b2.9(b) Expiration Time Section 2.1(d)(iExcluded Benefits 6.11(b) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bFee Letters 4.10(a) Financing 4.10(a) Financing Letters 4.10(a) Guarantee Recitals Guarantor Recitals Indemnified Persons Section 7.8(a6.10(a) Inventions Section 1.1 Material Contract Section 4.18(aInternational Employee Plans 3.18(a) IP Contracts 3.16(e) Lease 3.14(b) Leased Real Property 3.14(b) Lookback Date Article III Marks 1.1(aaa) Maximum Annual Premium Section 7.8(c6.10(c) Merger Recitals Merger Sub Preamble New Debt Commitment Letters 6.5(d) New Plans 6.11(c) No-Shop Period Start Date 5.3(a) Notice Period 5.3(e)(ii)(3) Old Plans 6.11(c) Option Consideration Section 3.7(a)(i2.8(b) Minimum Condition Section 2.1(a)(iOther Required Company Filing 6.3(e) Multiemployer Plan Section 4.11(cOther Required Parent Filing 6.3(f) Owned Company Shares 2.7(a)(ii) Parent Preamble Parent Related Parties 8.3(f)(i) Party Preamble Patents 1.1(aaa) Payment Agent 2.9(a) Payoff Letter 6.18 Per Share Price 2.7(a)(iii) Proxy Statement 6.3(a) SEC Reports Article III Reimbursement Obligations 6.6(f) Required Financing Information 6.6(a)(v) Requisite Stockholder Approval 3.4 Surviving Corporation 2.1 Tail Policy 6.10(c)

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii2023 Bonus Plan 7.9(b) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iAccepted Company Shares 3.7(a)(ii) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii) Antiboycott Rules Section Anti-Bribery Laws 4.22(a) Board Recommendation Section 2.2(bAntitrust Clearance Condition Annex A Balance Sheet Date 1.1 Burdensome Condition 7.2(a) Cancelled Canceled Company Shares Section 3.7(a)(ii) Capitalization Date 4.2(a) Cash Amount Recitals Certificate of Merger Section 3.2 Certificates Section 3.8(c3.8(c)(i) Changes Section 1.1 Change of Recommendation/Termination Notice 6.3(c) Closing Section 3.3 Closing Date Section Date. 3.3 COBRA Section 4.11(dCollaboration Agreement 4.19(a)(v) Company Preamble Company Common Stock Recitals Board Recommendation 6.3(a) Company Board Recommendation Change 6.3(b) Company Compensation Committee 4.23 Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(gEquity Award Schedule 4.2(b) Company License-Out Agreements Section 4.16(h) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a) Company Securities Section 4.2(a4.2(c) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company Covered Entity 4.20(j) CVR Recitals CVR Agreement Recitals D&O Insurance Section 7.8(cIndemnified Party 7.8(a) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(aData 1.1 Depository Agent 3.8(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a) Effect 1.1 Effective Time Section 3.2 Employment Compensation Arrangement 4.23 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b) 4.16 Exchange Fund Section 3.8(b) Existing Payment Period 3.7(h) Expiration Time Section 2.1(d)(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bFDCA 4.20(a) Recitals Recitals Indemnified Persons Section 7.8(aForeign Antitrust Laws 4.6 French Tax Code 10.14 GDPR 1.1 Internet Properties 1.1 Inventions 1.1 Leased Real Property 4.18(b) Inventions Section 1.1 Material Contract Section 4.18(a4.19(a) Maximum Annual Premium Section 7.8(cMedical Device 4.20(a) Merger Recitals Merger Consideration Section 3.7(a)(i) Merger Sub Preamble Milestone Option Amount 3.7(d)(ii) Minimum Condition Section 2.1(a)(i) Multiemployer Plan Section 4.11(c)Money Laundering Laws 4.22(b) New Plans 7.9(c) No Antitrust Proceedings Condition Annex A No Legal Restraint Condition Annex A Offer Recitals Offer Documents 2.1(f)(i) Offer Price Recitals Offer to Purchase 2.1(a) Old Plans 7.9(c) Option Consideration 3.7(d) Owned Real Property 4.18(a) Parent Preamble Paying Agent 3.8(a) Proprietary Information 1.1 PSU Consideration 3.7(f) Real Property 4.18(a) Real Property Leases 4.18(b) Regulatory Permits 4.20(i) Remedy Action 7.2(a) Rights Agent Recitals RSU Consideration 3.7(e) Schedule TO 2.1(f)(i) Schedule 14D-9 2.2(a) Social Security Act 4.20(e) Subsidiary Securities 4.2(e) Surviving Corporation. 3.1 Termination Condition Annex A Termination Date 9.1(b)(i) Termination Fee 9.3(b) Trademarks 1.1 Uncertificated Shares 3.8(c)(ii) Works of Authorship 1.1

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Agreement Preamble Ancillary Scheme Documentation Section Reference Acceptable Confidentiality Agreement 4.1(a) Anti-Takeover Laws Section 6.2(e)(iii5.30 Bidco Preamble Burdensome Condition Section 8.2(a) Acquisition Proposal Closing Section 6.2(e)(i2.2 Closing Date Section 2.2 Company Preamble Company 401(k) Acquisition Sub Preamble Adverse Plan Section 8.8(c) Company Board Recitals Company Board Recommendation Section 5.5 Company Board Recommendation Change Section 6.2(c)(i7.3(a) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(ii) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 Closing Section 3.3 Closing Date Section 3.3 COBRA Section 4.11(d) Company Preamble Company Common Stock Recitals Company Disclosure Letter Article IV V Company License-In Agreements Equity Award Consideration Section 4.16(g3.2(a)(iii) Company License-Out Agreements Option Consideration Section 4.16(h3.2(a)(i) Company Financial Advisor Permits ‎Section 5.24‎(e) Company PRSU Consideration Section 4.10 3.2(a)(iv) Company Related Parties Section 6.12 Company RSU Consideration Section 3.2(a)(iii) Company SEC Reports Section 4.7(a5.9(a) Company Securities Section 4.2(a5.2(d) Company Shares Recitals Confidentiality Agreement Section 10.4 11.6 Consideration Section 3.1(a) Court Documentation ‎Section 4.1‎(g) Current Company Employee ‎Section 8.8‎(a) D&O Insurance Section 7.8(c8.7(c) Customs Laws EBT Cash Amounts Section 4.22(a3.2(b) Debt Financing Dispute EBT Settled Company Equity Awards Section 10.9(a3.2(a)(i) DGCL Recitals Dissenting Company Shares EBT Trustee Section 3.7(c)(i) EAR Section 4.22(a3.2(a)(i) Effective Time Section 3.2 2.2 End Date Section 10.1(b)(i) Enforceability Exceptions Section 4.4 Environmental Permits 5.4 Equity Securities Section 4.15(b5.2(d) Exchange Fund Forms of Proxy Section 3.8(b4.1(a) Expiration Time In the Money Company Option Section 2.1(d)(i3.2(a)(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b) Recitals Recitals Indemnified Persons Section 7.8(a8.7(b) Inventions Indemnified Proceeding Section 1.1 8.7(b) Interim Time Section 3.2(a)(i) Leased Real Property ‎Section 5.22‎(b) Match Right Notice Section 7.3(b) Material Contract ‎Section 5.23‎(a) Other Required SEC Filing Section 4.18(a4.1(a) Maximum Annual Premium Parent Preamble Parent 401(k) Plan Section 7.8(c8.8(c) Merger Parent Board Recitals Merger Parent Related Parties Section 6.12 Parties Preamble Paying Agent Section 3.1(b) Payment Fund Section 3.1(b) Per ADS Consideration Section 3.7(a)(i3.1(a) Minimum Condition Proxy Statement Section 2.1(a)(i4.1(a) Multiemployer Plan Real Property Leases ‎Section 5.22‎(b) Remedial Action Section 4.11(c)8.2(a) Scheme Document Annex Section 4.1(a) Transaction Recitals Transaction Documentation ‎Section 4.1‎(d) Transfer Taxes Section 10.3(b) Voting and Support Agreement Recitals

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii401(k) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iPlan 7.11(a) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(iiAssumed Company Option 3.8(a) Antiboycott Rules Section 4.22(aAssumed Company Restricted Stock 3.8(c) Board Recommendation Section 2.2(bAssumed Company RSU 3.8(d) Cancelled Assumed Company Stock Awards 3.8(d) Amended Offer Documents 2.1(a)(i) Assets 4.14 Book-Entry Shares Section 3.7(a)(ii3.9(b)(i) Capitalization Date 4.4(a) Certificate 3.9(b)(i) Certificate of Merger Section 3.3(a) Closing 3.2 Certificates Section 3.8(c) Changes Section 1.1 Closing Section 3.3 Closing Date Section 3.3 COBRA Section 4.11(d) 3.2 Company Preamble Company Common Stock Recitals Board Recommendation 7.7(a) Company Board Recommendation Change 7.7(a) Company Capitalization Representation Annex A Company Disclosure Letter Schedule Article IV Company LicenseForm 10-In Agreements Section 4.16(gK 4.1(b) Company License-Out Agreements Section 4.16(hInsiders 7.14 Company Restricted Stock 3.8(c) Company Financial Advisor Section 4.10 Rights 4.16 Company SEC Reports Section 4.7(a4.6 Company Securities 4.4(c) Company Securities Section 4.2(aSeverance Arrangements 7.11(c) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company Stockholder Meeting 7.5(a) Continuing Directors 2.4(b) Continuing Employee 3.8(a) Consent 4.3(b) D&O Insurance Section 7.8(c7.12(b) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(aDelaware Secretary of State 3.3(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i3.7(b)(iv) EAR Section 4.22(aEffect 1.1(kk) (a) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(bExchange Agent 3.9(a)(i) Exchange Fund Section 3.8(b3.9(a)(ii) Expiration Time Section 2.1(d)(iDate Annex A Indemnified Parties 7.12(a) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bIndependent Directors 2.4(c) Recitals Recitals Indemnified Persons Section 7.8(a) Inventions Section 1.1 Material Contract Section 4.18(a4.13(a) Maximum Annual Premium Section 7.8(c7.12(b) Merger Recitals Merger Agreement Annex A Merger Consideration Section 3.7(a)(i3.7(b)(i) Merger Proposal 7.5(a) Minimum Tender Condition Section 2.1(a)(i) Multiemployer Plan Section 4.11(cAnnex A Non-Continuing Employee 3.8(b)

Additional Definitions. The Each of the following capitalized terms shall have has the respective meanings ascribed thereto meaning specified in the respective sections Section of this Agreement set forth opposite each of the capitalized terms belowsuch term: Term Section Reference Acceptable Confidentiality Agreement Adjusted Option Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i3.2(a) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(ii) Certificate Articles of Merger Section 3.2 Certificates 2.2 Bank Merger Recitals Bank Merger Surviving Bank Section 3.8(c2.6 Burdensome Condition Section 6.3(c) Changes Cash Consideration Section 1.1 3.1(a)(1) Closing Section 3.3 2.2 Closing Date Section 3.3 COBRA Section 4.11(d) 2.2 Code Recitals Company Preamble Company Common Stock 401(k) Plan Section 6.12(b)(1) Company Articles Section 2.5 Company Bank Sub Recitals Company Disclosure Letter Article IV Company License-In Agreements FA Section 4.16(g) Company License-Out Agreements Section 4.16(h5.2(i) Company Financial Advisor Statements Section 4.10 Company SEC Reports Section 4.7(a5.2(j)(1) Company Securities Indemnified Parties Section 4.2(a6.11(b) Company Shares Meeting Section 6.2(a) Term Section Company Restricted Stock Award Section 3.1(a)(1) Company Shareholder Matters Section 5.2(e) Company Stock Option Section 3.2(a) Company Voting Agreements Recitals Confidentiality Agreement Conversion Project Manager Section 10.4 Current Company D&O Insurance 6.13 Covered Employees Section 7.8(c6.12(b) Customs Laws Determination Date Section 4.22(a8.1(h) Debt Financing Dispute Disclosure Schedule Section 10.9(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a) 5.1 Effective Time Section 3.2 Enforceability Exceptions 2.2 Environmental Condition Section 4.4 6.15(a) Environmental Permits Survey Section 4.15(b6.15(a) Equity Award Exchange Ratio Section 3.2(a) Exchange Agent Section 3.3(a) Exchange Fund Section 3.8(b3.3(a) Expiration Time Exchange Ratio Section 2.1(d)(i3.1 FDICIA Reporting Requirements Section 5.2(j)(2) Financial Statements Incipio Incipio Merger Agreement Fee Section 4.7(b8.3(a) Fee Triggering Event Section 8.3(a) Final Parent Market Price Section 8.1(h) Final Index Price Section 8.1(h) Index Section 8.1(h) Index Ratio Section 8.1(h) Initial Index Price Section 8.1(h) Initial Parent Market Price Section 8.1(h) Intended Tax Treatment Recitals Recitals Indemnified Persons Interest Rate Instruments Section 7.8(a5.2(aa) Inventions Joint Proxy Statement Section 1.1 6.5(a) Loans Section 5.2(z)(1) Material Contract Contracts Section 4.18(a) Maximum Annual Premium Section 7.8(c5.2(v)(1) Merger Recitals Merger Sub Preamble New Certificates Section 3.3(a) Old Certificates Section 3.3(a) OREO Section 6.14(a) Outside Date Section 8.1(e) Parent Preamble Parent 401(k) Plan Section 6.12(b)(3) Parent Audited Financial Statements Section 5.3(i)(1) Parent Bank Sub Recitals Parent Closing Price Section 3.2(a) Parent Common Stock Issuance Section 5.3(e) Parent Determination Stock Price Section 8.1(g) Parent Meeting Section 6.2(b) Term Section Parent Merger Recitals Parent Merger Surviving Company Section 2.6 Parent SEC Filings Section 5.3(i)(1) Pension Plan Section 5.3(r), Section 5.2(t)(2) Per Common Share Consideration Section 3.7(a)(i3.1(a)(1) Minimum Condition Phase II Survey Section 2.1(a)(i6.15(b) Multiemployer Plan Real Property Section 4.11(c5.2(u)(2) Registration Statement Section 6.5(a) Required Third Party Consents Section 6.3(a) Requisite Regulatory Approvals Section 6.3(a) Scheduled Intellectual Property Section 5.2(p)(1) Subsequent Mergers Recitals Supplemental Disclosure Schedule Section 6.1(c) Survey Section 6.14(a) Surviving Corporation Recitals Tail Coverage Period Section 6.11(a)(2) Tail Policy Section 6.11(a)(1) Takeover Laws Section 5.2(h) Title Commitment Section 6.14(a) Title Company Section 6.14(a) Title Notice Section 6.14(b) Title Review Period Section 6.14(b) Trust or Agency Accounts Section 5.2(y)(1) Trust or Agency Agreements Section 5.2(y)(1) Trust or Agency Records Section 5.2(y)(6) ▇▇▇▇▇▇ Section 7.3(c)

Additional Definitions. The For purposes of this Agreement, the following capitalized terms terms, when used in this Agreement, shall have the respective meanings ascribed thereto assigned to them in the respective sections of this Agreement set forth opposite each of the capitalized terms belowidentified Section: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i6.3(c) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(iiAggregate Merger Consideration 3.1(c) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(iiAntitrust Condition 8.1(b)(i) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 2.3 Closing Section 3.3 2.2 Closing Date Section 3.3 COBRA Section 4.11(d2.2 Code 3.2(g) Collective Bargaining Agreement 4.9 Company Preamble Company Closing Price 3.3(a)(ii) Company Common Stock Recitals Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(gContracts 4.12(a) Company License-Out Agreements Section 4.16(hIndemnitees 6.7(a) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(aLeases 4.4(b) Company Securities Section 4.2(aMultiemployer Plans 4.10(a)(ii) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Stockholder Approval 4.2(a)(ii) Company D&O Insurance Section 7.8(cStockholders Meeting 6.4(a) Customs Laws Section 4.22(aCompany Tenant Lease 4.4(b) Company Title IV Plan 4.10(d) Consent Solicitation 6.11(a) Continuing Employees 6.14(a) Debt Financing Dispute Section 10.9(aTender Offer 6.11(a) DGCL Recitals Dissenting Company 2.1 Discharge 6.11(b) Dissent Shares Section 3.7(c)(i3.1(d) EAR Section 4.22(aDissenters’ Rights Statute 3.1(d) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b2.3 ERISA 1.1 Exchange Agent 3.2(a) Exchange Fund Section 3.8(bExtension Termination Fee 8.2(f) Expiration Time Section 2.1(d)(iFinancing 6.5(a) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bFinancing Commitments 5.17 Form S-4 6.10(a) Recitals Recitals Indemnified Persons Section 7.8(aIndenture 6.11(a) Inventions Section 1.1 Material Contract Section 4.18(aIRS 4.10(a)(iii) Maximum Annual Premium Section 7.8(cJoint Proxy Statement 6.10(a) Merger Recitals Merger Sub Preamble MGCL 4.20 Nine-Month Termination Fee 8.2(d) Notice of Adverse Change 6.3(c) One-Year Termination Fee 8.2(e) Option Exchange Ratio 3.3(a)(iii) Outside Date 8.1(b)(i) Owned Real Property 4.4(a) Parent Preamble Parent Multiemployer Plans 5.10(b) Parent Stockholder Approval 5.2(a) Parent Stockholders Meeting 6.4(b) Parent Title IV Plan 5.10(c) PBGC 4.10(d) Per Share Cash Consideration Section 3.7(a)(i3.1(c) Minimum Condition Section 2.1(a)(iPer Share Merger Consideration 3.1(c) Multiemployer Plan Section 4.11(cPer Share Stock Consideration 3.1(c) Permanent Restraint 8.1(b)(iv) Pre-Amendment Option 3.3(a)(iii) Real Property 4.4(c) Required Information 6.5(b)(v) Restraints 7.1(c) Share Issuance 5.2(a) Stock Option 3.3(a)(i) Surviving Corporation 2.1 Voting Debt 4.3(a)

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Accel Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iRecitals Accel Breakup Fee 1.1(ss) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii5.3(e)(ii) Antiboycott Rules Section 4.22(aAssets 3.14 Bylaws 2.5(b) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(iiCapitalization Date 3.7(a) Certificate of Merger Section 3.2 2.2 Certificates Section 3.8(c2.8(c) Changes Section 1.1 Charter 2.5(a) Closing Section 3.3 2.3 Closing Date Section 3.3 COBRA Section 4.11(d2.3 Collective Bargaining Agreement 3.19(a) Commitment Letter 4.10(a) Company Preamble Company Common Stock Recitals Board Recommendation 3.3(a) Company Board Recommendation Change 6.5(a) Company Disclosure Letter Article IV III Company License-In Intellectual Property Agreements Section 4.16(g3.16(c) Company License-Out Agreements Section 4.16(hProducts 3.16(b) Company Financial Advisor Section 4.10 Registered Intellectual Property 3.16(a) Company SEC Reports Section 4.7(a3.9 Company Securities 3.7(d) Company Securities Section 4.2(aStock-Based Award Consideration 2.7(d) Company Shares Recitals Stockholder Meeting 6.4 Confidentiality Agreement Section 10.4 Current 9.4 Consent 3.6 Continuing Discussion Period 5.3(c) Dissenting Company Shares 2.7(c)(i) D&O Insurance Section 7.8(c) Customs Laws Section 4.22(a6.10(c) Debt Financing Dispute Section 10.9(a) 6.6 DGCL Recitals Dissenting Company Shares Section 3.7(c)(i2.7(c) EAR Section 4.22(aEffect 1.1(m) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b2.2 Employee Plans 3.18(a) ERISA Affiliate 3.18(a) ESPP 2.7(g) Exchange Fund Section 3.8(b2.8(b) Expiration Time Section 2.1(d)(iFinal Offering 2.7.(g) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b) Guarantee Recitals Guarantor Recitals Indemnified Persons Section 7.8(a6.10(a) Inventions Section 1.1 In-Licenses 3.16(c) International Employee Plans 3.18(a) Investor 4.10(a) Leased Real Property 3.15(b) Lease 3.15(b) Material Contract Section 4.18(a3.13(a) Material Customer Agreements 3.13(a)(iii) Maximum Annual Premium Section 7.8(c6.10(c) Merger Recitals Merger Sub Preamble Newco Preamble Newco Expenses 8.3 Newco Representatives 5.3(f) No-Shop Period Start Date 5.3(a) Notice Period 5.3(f) Option Consideration Section 3.7(a)(i2.7(e) Minimum Condition Section 2.1(a)(iOther Required Company Filing or Other Required Company Filings 3.27(a) Multiemployer Plan Section 4.11(c)Other Required Newco Filing or Other Required Newco Filings 4.6(b) Out-Licenses 3.16(c) Owned Company Shares 2.7(a)(iii) Payment Agent 2.8(a) Proxy Statement 3.27(a) Recent SEC Reports Article III Representatives 5.3(a) Requisite Stockholder Approval 3.4 Sublease 3.15(c) Subsidiary Securities 3.8(c) Surviving Corporation 2.1 (a) Termination Date 8.1

Additional Definitions. The Each of the following capitalized terms shall have the respective meanings ascribed thereto definitions is set forth in the respective sections section of this Agreement set forth opposite each of the capitalized terms indicated below: DEFINITION SECTION 35 U.S.C. § 102(c) Patent Section 10.7 Academic Essential Provisions Section 8.6(b)(iii) Accounting Standards Master Agreement Acquirer Program Section 8.6(b)(v)(D) Additional Study Section 3.4 Additional Study Approval Section 3.4(c) Affiliate Master Agreement Agreement Preamble Allocable Overhead Exhibit D Allowable Expenses Exhibit D Allowed Indication Section 8.6(b)(viii) Antitrust Law Master Agreement Audit Team Section 9.9(a) Audit Rights Holder Section 9.9(e) Auditee Section 9.9(e) Bankruptcy Code Section 8.8 Barred Indication Section 8.6(b)(vii) Business Day Master Agreement CCB Program MTA Master Agreement Celgene Preamble Celgene Indemnified Parties Section 13.1(b) Celgene Independent Product Master Agreement Challenge Section 14.2(d) Challenging Party Section 14.2(d) Change of Control Master Agreement Clinically Develop Section 8.6(a) Co-Co Buy-In Section 3.5 DEFINITION SECTION Combination Product Section 1.39 Commercialization/Commercialize Master Agreement Commercially Reasonable Efforts Master Agreement Competitive Infringement Section 10.3(b) Competitive Program Section 8.6(b)(iv) Competitive Program Party Section 8.6(b)(iv) Control/Controlled Master Agreement Cooperating Party Section 11.3(b)(iii) Costs of Goods Sold or COGs Exhibit D Cover/Covering/Covered Master Agreement CPI Section 1.29 Cure Period Section 14.2(b)(i) Damages Master Agreement Deemed Buy-In Section 3.4(c) Develop/Development Master Agreement Development Budget Section 3.2(a)(i) Development Cost Share Section 9.1(a) Directed Master Agreement Disclosing Party Section 11.1 Dispute Section 15.1 [Distinct Product Master Agreement] [Distinct Product Catch-Up Payments Section 9.2(a)(iv)] Distribution Costs Exhibit D Earlier Patent Section 10.7 Electronic Delivery Section 15.16 Enabling Manufacturing Section 8.6(a) Execution Date Preamble FDA Master Agreement FDCA Master Agreement Finance Working Group Section 2.2(f) force majeure event Section 15.7 Functional Phenotypic Assay Similarity Criteria Master Agreement Global Safety Database Section 5.3 Gross Profit Exhibit D Incentive Compensation Section 6.5(b)(v) IND Master Agreement Indemnified Party Section 13.3 Indemnitor Section 13.3 Indirect Taxes Section 9.10(b)(i) Indication Master Agreement Information Request Section 6.5(b)(vii) Joint Inventions Section 10.1(c) Joint Patents Section 10.1(c) Know-How Master Agreement Law Master Agreement DEFINITION SECTION Licensed Branding Section 6.6(c) Licensing Party Section 8.5(c) Lump Sum Section 3.4(c) Manufacture/Manufacturing Master Agreement Manufacturing Costs Exhibit D Marketing Costs Exhibit D Master Agreement Introduction Material Breach Section 14.2(b)(i) Operating Profits or Losses Exhibit D Opt-In Right Master Agreement Other Operating Income/Expense Exhibit D Party or Parties Preamble Patent Officers Master Agreement Patent Prosecution Expenses Section 10.2(c) Patent Master Agreement Payee Party Section 9.10(b)(i) Paying Party Section 9.10(b)(i) Permitted Indication Section 8.6(b)(vii) Person Master Agreement Pharmacovigilance Agreement Section 5.3 Pharmacovigilance Expenses Exhibit D Phase I Study Master Agreement Phase II Study Master Agreement Phase III Study Master Agreement Pivotal Clinical Trial Master Agreement Product Recall Expenses Exhibit D Product Trademarks Section 6.6(a) Profit & Loss Share Section 9.6(a) Program Assets Section 12.4(a) Program Compound Master Agreement Program Product Master Agreement Program Target Master Agreement Prosecuting Party Section 10.2(d)(ii) Prosecution/Prosecute Master Agreement Publication Master Agreement Pursuing Party Section 14.2(d) Receiving Party Section 11.1 Redacted Version Section 11.3(b)(i) Regulatory Approval Master Agreement Regulatory Authority Master Agreement Regulatory Interactions Section 5.1(b) Regulatory Expenses Exhibit D Report Exhibit D Requesting Party Section 11.3(b)(iii) ROW Development Costs Section 9.1(a) DEFINITION SECTION Royalty Term Section Reference Acceptable Confidentiality 9.3(b) Sales Costs Exhibit D Sales Milestone Condition Section 9.2(b) SEC Section 11.3(b)(i) Selected Target Master Agreement Selling Party Section 1.39 Separate Program Master Agreement Separate Program Product Section 8.6(b)(vii) Sublicense Revenues Exhibit D Subsequent Third Party Agreement Section 6.2(e)(iii9.7(b) Acquisition Proposal Term Section 6.2(e)(i14.1(a) Acquisition Sub Third Party Contractors Section 8.2(a)(ii) Third Party Infringement Section 10.3(a) Third Party Infringement Action Section 10.4 Third Party Products Liability Action Section 13.5(a) U.S. Commercialization Budget Section 6.2(c) U.S. Commercialization Costs Section 6.5(c) U.S. Commercialization Plan Section 6.2(a) Vividion Preamble Adverse Recommendation Change Vividion Indemnified Parties Section 6.2(c)(i13.1(a) Agreement Preamble Alternative Acquisition Agreement Vividion Opt-Out Notice Section 6.2(c)(ii2.3(a) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(ii) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 Closing Section 3.3 Closing Vividion Opt-Out Date Section 3.3 COBRA 2.3(b) Worldwide Development Costs Section 4.11(d) Company Preamble Company Common Stock Recitals Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(g) Company License-Out Agreements Section 4.16(h) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a) Company Securities Section 4.2(a) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company D&O Insurance Section 7.8(c) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b) Exchange Fund Section 3.8(b) Expiration Time Section 2.1(d)(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b) Recitals Recitals Indemnified Persons Section 7.8(a) Inventions Section 1.1 Material Contract Section 4.18(a) Maximum Annual Premium Section 7.8(c) Merger Recitals Merger Consideration Section 3.7(a)(i) Minimum Condition Section 2.1(a)(i) Multiemployer Plan Section 4.11(c9.1(a)

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(iiArrangements 4.17(m) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Assets 4.14 Cancelled Company Shares Section 3.7(a)(ii) Capitalization Date 4.6(a) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 Change of Recommendation Notice 7.4(b)(ii) Closing Section 3.3 Closing Date Section 3.3 COBRA Section 4.11(dCollective Bargaining Agreement 4.18(a) Company Preamble Company Board Recommendation 7.4(a) Company Board Recommendation Change 7.4(b) Company Common Stock Recitals Company Compensation Committee 4.17(m) Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(gFinancial Advisors 4.25 Company IP Contract 4.15(b) Company License-Out Agreements Section 4.16(hPlans 7.10(c) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a) Company Securities Section 4.2(a4.8(a) Company Shares Recitals Competing Acquisition Transaction 9.3(b)(iii) Competing Party 9.3(b)(iii) Confidentiality Agreement Section 10.4 Consent 4.5 Current Company D&O Insurance Section 7.8(c) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a7.9(c) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a) Effective Time Section 3.2 Employee Plan 4.17(a) Employee Plans 4.17(a) Employment Compensation Arrangement 4.17(m) Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b) Limitations 4.2 Exchange Fund Section 3.8(b) Expiration Time Section 2.1(d)(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bGrant Date 4.6(e) Recitals Recitals Indemnified Persons Section 7.8(a7.9(a) Inventions Section 1.1 Leased Real Property 4.13(b) Leases 4.13(b) LKQ Preamble Material Contract Section 4.18(a4.12(a) Maximum Annual Premium Section 7.8(c7.9(c) Merger Recitals Merger Consideration Section 3.7(a)(i) Minimum Condition Section 2.1(a)(i) Multiemployer Plan Section 4.11(cModified Terms 7.4(c) New Plans 7.10(c) Offer Recitals Offer Documents 2.1(g)(i) Offer Price Recitals Offer to Purchase 2.1(a) Old Plans 7.10(c) Option Consideration 3.7(d) Outside Date 9.1(b) Parent Preamble Payment Agent 3.8(a) Permits 4.19 Representatives 6.2(b) Restraint 8.1(b) Schedule 14D-9 2.2(b) Schedule TO 2.1(g)(i) Stockholder List Date 2.2(c) Subsidiary Securities 4.7(c) Support Agreement Recitals Surviving Corporation 3.1 Tax Returns 4.16(a) Termination Fee 9.3(b)(i) Uncertificated Shares 3.8(c) Union 4.18(a)

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto given to them in the respective sections Sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iAdvisor 3.3(c) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii5.3(c)(ii) Antiboycott Rules Section 4.22(aAlternative Financing 6.5(b) Board Recommendation Section 2.2(bAnti-Corruption Laws 3.26(b) Cancelled Company Shares Section 3.7(a)(iiBuyer Parties Preamble Capitalization Date 3.7(a) Certificate of Merger Section 3.2 2.2 Certificates Section 3.8(c2.10(c) Changes Section 1.1 Charter 2.5(a) Chosen Courts 9.12 Closing Section 3.3 2.3 Closing Date Section 3.3 COBRA Section 4.11(d2.3 Collective Bargaining Agreement 3.19(a) Commitment Letters 4.11(a) Company Preamble Company Common Stock Recitals Board Recommendation 3.3(b) Company Disclosure Letter Article IV III Company License-In Agreements Section 4.16(gOption Consideration 2.9(a) Company License-Out Agreements Section 4.16(hPBRSU Consideration 2.9(c) Company Financial Advisor Section 4.10 Related Parties 8.3(e) Company RSU Consideration 2.9(b) Company SEC Reports Section 4.7(a3.9 Company Securities 3.7(c) Company Securities Section 4.2(aStockholder Meeting 6.4(a) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company Agreements 9.6 Consent 3.6 Copyrights 1.1(bbb) D&O Insurance Section 7.8(c6.9(c) Customs Laws Section 4.22(aDebt Commitment Letters 4.11(a) Debt Financing Dispute Section 10.9(a4.11(a) Definitive Financing Agreements 6.5(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i2.7(d)(i) EAR Section 4.22(aDTC 2.10(d) DTC Payment 2.10(d) ▇▇▇▇▇ 1.3(q) Effect 1.1(s) Effective Time Section 2.2 Electronic Delivery 9.15 Employee Plan 3.18(a) Enforceability Limitations 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(bEquity Commitment Letter 4.11(a) Equity Financing 4.11(a) ERISA Affiliate 3.18(b) Exchange Fund Section 3.8(b2.10(b) Expiration Time Section 2.1(d)(iFairness Opinions 3.3(c) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bFee Letter 4.11(a) Fee Letters 6.5(a) Financing 4.11(a) Guarantee Recitals Holdings Recitals Holdings Subsidiary Recitals Indemnified Persons Section 7.8(a6.9(a) Inventions Section 1.1 Material Contract Section 4.18(aInternational Employee Plans 3.18(a) IP Contracts 3.16(f) Lease 3.14(b) Leased Real Property 3.14(b) Marks 1.1(bbb) Maximum Annual Premium Section 7.8(c6.9(c) Maximum Company Liability Amount 8.3(e) Maximum Parent Liability Amount 8.3(a) Merger Recitals Merger Consideration Section 3.7(a)(iSub Preamble New Plan 6.10(c) Minimum Condition Section 2.1(a)(iNon-Recourse Party 9.18 Other Required Company Filing 6.3(b) Multiemployer Plan Section Other Required Parent Filing 6.3(c) Owned Company Share 2.7(a)(ii) Owned Real Property 3.14(a) Parent Preamble Parent Disclosure Letter Article IV Parent Related Parties 8.3(a) Parties Preamble Party Preamble Patents 1.1(bbb) Payment Agent 2.10(a) Payoff Letters 6.19 Per Share Price 2.7(a)(iv) Permits 3.20 Proxy Statement 6.3(a) Recent SEC Reports Article III Recommendation Change 5.3(c)(i) Repaid Indebtedness 6.19 Required Amount 4.11(c) Requisite Stockholder Approval 3.4 Reverse Termination Fee 8.3(a) Rollover Agreements Recitals Rollover Shares 2.7(a)(ii) Rollover Stockholders Recitals SaaS 3.16(f) Schedule 13e-3 6.3(a) Special Committee Recitals Special Committee Recommendation 3.3(a) Sublease 3.14(c) Subsidiary Owned Share 2.7(a)(iii) Support Agreement Recitals Surviving Corporation 2.1 Tax Returns 3.17(a) Termination Date 8.1(c) Trade Control Laws 3.26(a) Uncertificated Shares 2.10(c) Written 1.3(r)

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(iiAnti-Corruption Law 3.18(b) Antiboycott Rules Section 4.22(aAntitrust Laws 7.2(a) Board Recommendation Section 2.2(bAssumed Option 2.7(d) Assumed Unit 2.7(d)(ii) Barclays 3.26 Book-Entry Shares 2.8(b)(i) Cancelled Company Shares Section 3.7(a)(ii2.7(b)(iv) Cash Consideration 2.7(b)(i) Certificate 2.8(b)(i) Certificate of Merger Section 3.2 Certificates Section 3.8(c2.3(a) Changes Section 1.1 Closing Section 3.3 2.2 Closing Date Section 3.3 COBRA Section 4.11(d) 2.2 Code Recitals Company Preamble Company Common Stock Recitals 2001 Plan 3.4(a) Company 2007 Director Plan 3.4(a) Company 2007 Plan 3.4(a) Company 2012 Inducement Plan 3.4(a) Company Board Recommendation 6.4(a) Company Board Recommendation Change 6.4(b) Company Capitalization Representations 8.2(a)(ii) Company Disclosure Letter Article IV III Company License-In Agreements Section 4.16(gExpense Reimbursement 9.3(c)(vi) Company License-Out Agreements Section 4.16(hFundamental Representations 8.2(a)(i) Company Financial Advisor Section 4.10 In Licenses 3.12(e) Company IP Licenses 3.12(f) Company Material Contract 3.13(a) Company Non-U.S. Employee Plans 3.15(i) Company Out Licenses 3.12(f) Company Permits 3.19 Company Qualified Plan 3.15(e) Company Real Property Leases 3.10 Company Registered Intellectual Property Rights 3.12(a) Company SEC Reports Section 4.7(a3.6 Company Stock Awards 3.4(c) Company Securities Section 4.2(aStock Option 2.7(d)(i) Company Shares Recitals Stock Plans 3.4(b) Company Stockholder Meeting 7.4(a) Company Subsidiary Documents 3.1(b) Company Terminating Plans 7.7(a) Company Voting Proposal 3.2(b) Confidentiality Agreement Section 10.4 Current Company 7.5(h) D&O Insurance Section 7.8(cPolicy 7.8(b) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(aDelaware Secretary of State 2.3(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i2.7(c) DLLCA Recitals ▇▇▇▇-▇▇▇▇▇ Act 3.6 EAR Section 4.22(a3.18(c)(i) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b) Exchange Fund Section 3.8(b) Expiration Time Section 2.1(d)(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b) Recitals Recitals Indemnified Persons Section 7.8(a) Inventions Section 1.1 Material Contract Section 4.18(a) Maximum Annual Premium Section 7.8(c) Merger Recitals Merger Consideration Section 3.7(a)(i) Minimum Condition Section 2.1(a)(i) Multiemployer Plan Section 4.11(cECCNs 3.18(c)(ii)

Additional Definitions. The For the purposes of this Agreement, the following capitalized terms shall have the respective meanings ascribed thereto meaning specified in the respective sections of this Agreement Section set forth opposite each of the capitalized terms belowto such term: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) Agreement Preamble Aggregate Merger Consideration 3.1 Alternative Acquisition Agreement Section 6.2(c)(ii7.2(d)(i)(D) Antiboycott Rules Section 4.22(aCompany Agreement Amendment 2.4 Applicable Date 5.5(a) Board Recommendation Section 2.2(bBankruptcy and Equity Exception 5.3(a) Cancelled Company Shares Section 3.7(a)(ii) Book-Entry Share 3.2 Certificate 3.2 Certificate of Merger Section 3.2 Certificates Section 3.8(c2.3 Change of Recommendation 7.2(d)(i)(D) Changes Section 1.1 Chosen Courts 10.4(b) Closing Section 3.3 2.2 Closing Date Section 3.3 COBRA Section 4.11(d) 2.2 Company Preamble Company Common Stock Approvals 5.4(a) Company Board Recitals Company Disclosure Letter Article IV ARTICLE V Company License-In Agreements Section 4.16(gMaterial Contracts 5.12(a) Company License-Out Agreements Section 4.16(hRecommendation Recitals Company Reports 5.5(a) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a) Company Securities Section 4.2(a) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company D&O Insurance Section 7.8(c) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a7.10(b) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a) DLLCA Recitals EECI Preamble Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b) 2.3 Eligible Shares 3.1 Encumber 5.11 Encumbrance 5.11 Exchange Agent 4.1 Exchange Fund Section 3.8(b4.1 Exchange Ratio 4.1 Indemnified Parties 7.10(a) Expiration Time Section 2.1(d)(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b) Recitals Recitals Indemnified Persons Section 7.8(a) Inventions Section 1.1 Material Contract Section 4.18(a) Maximum Annual Premium Section 7.8(cLetter of Transmittal 4.2(a) Merger Recitals Merger Consideration Section 3.7(a)(i3.1 Merger Sub Preamble Non-DTC Book-Entry Share 4.2(b) Minimum Condition Section 2.1(a)(iOriginal Date 7.4(b) Multiemployer Plan Section 4.11(cOutside Date 9.2(a) Parent Preamble Parent Approvals 6.4 Parent Board Recitals Parent Capital Stock 6.2(a) Parent Common Stock Recitals Parent Disclosure Letter ARTICLE VI Parent Material Contract 6.12(a) Parent Reports 6.5(a) Party/Parties Preamble Preference Shares 6.2(a) Proxy/Prospectus 7.3(a) Public Shareholders Recitals Registration Statement 7.3(a) Requisite Company Vote 5.3(a) Special Committee Recitals Surviving Entity 2.1 Tail Period 7.10(b) Transaction Litigation 7.13 Transactions Recitals Voting Shares 5.2(a)

Additional Definitions. The Each of the following capitalized terms shall have the respective meanings ascribed thereto definitions is set forth in the respective sections section of this Agreement set forth opposite each of the capitalized terms indicated below: DEFINITION SECTION 35 U.S.C. § 102(c) Patent Section 10.7 Academic Essential Provisions Section 8.6(b)(iii) Accounting Standards Master Agreement Acquirer Program Section 8.6(b)(v)(D) Additional Study Section 3.3 Additional Study Approval Section 3.3(c) Affiliate Master Agreement Agreement Preamble Allocable Overhead Exhibit D Allowable Expenses Exhibit D Allowed Indication Section 8.6(b)(viii) Antitrust Law Master Agreement Audit Team Section 9.7(a) Audit Rights Holder Section 9.7(e) Auditee Section 9.7(e) DEFINITION SECTION Bankruptcy Code Section 8.8 Barred Indication Section 8.6(b)(vii) Business Day Master Agreement CCB Program MTA Master Agreement Celgene Preamble Celgene Indemnified Parties Section 13.2 Celgene Independent Product Master Agreement Challenge Section 14.3(d) Challenging Party Section 14.3(d) Change of Control Master Agreement Clinically Develop Section 8.6(a) Co-Co Buy-In Section 3.4 Combination Product Section 1.41 Commercialization/Commercialize Master Agreement Commercialization Budget Section 6.2(c) Commercialization Costs Section 6.5(c) Commercialization Plan Section 6.2(a) Commercially Reasonable Efforts Master Agreement Competitive Infringement Section 10.3(b) Competitive Program Section 8.6(b)(iv) Competitive Program Party Section 8.6(b)(iv) Control/Controlled Master Agreement Cooperating Party Section 11.3(b)(iii) Costs of Goods Sold or COGS Exhibit D Cover/Covering/Covered Master Agreement CPI Section 1.29 Cure Period Section 14.3(b)(i) Damages Master Agreement Deemed Buy-In Section 3.3(c) Develop/Development Master Agreement Development Budget Section 3.1(a)(i) Directed Master Agreement Disclosing Party Section 11.1 Dispute Section 15.1 [Distinct Product Master Agreement] [Distinct Product Catch-Up Payments Section 9.2(a)(iii)] Distribution Costs Exhibit D Earlier Patent Section 10.7 Electronic Delivery Section 15.16 Enabling Manufacturing Section 8.6(a) Execution Date Preamble FDA Master Agreement FDCA Master Agreement Finance Working Group Section 2.2(f) force majeure event Section 15.7 DEFINITION SECTION Functional Phenotypic Assay Similarity Criteria Master Agreement Global Safety Database Section 5.3 Gross Profit Exhibit D Incentive Compensation Section 6.5(b)(v) IND Master Agreement Indemnified Party Section 13.3 Indemnitor Section 13.3 Indirect Taxes Section 9.8(b)(i) Indication Master Agreement Information Request Section 6.5(b)(vii) Initial Enforcement Party Section 10.3(b) Joint Inventions Section 10.1(c) Joint Patents Section 10.1(c) Know-How Master Agreement Law Master Agreement Licensed Branding Section 6.6(c) Licensing Party Section 8.5(c) Lump Sum Section 3.3(c) Manufacture/Manufacturing Master Agreement Manufacturing Costs Exhibit D Marketing Costs Exhibit D Master Agreement Introduction Material Breach Section 14.3(b)(i) Non-Proposing Party Section 3.3 Operating Profits or Losses Exhibit D Opt-In Right Master Agreement Other Operating Income/Expense Exhibit D Party or Parties Preamble Patent Officers Master Agreement Patent Prosecution Expenses Section 10.2(c) Patent Master Agreement Payee Party Section 9.8(b)(i) Paying Party Section 9.8(b)(i) Permitted Indication Section 8.6(b)(vii) Person Master Agreement Pharmacovigilance Agreement Section 5.3 Pharmacovigilance Expenses Exhibit D Phase I Study Master Agreement Phase II Study Master Agreement Phase III Study Master Agreement Pivotal Clinical Trial Master Agreement Product Recall Expenses Exhibit D Product Trademarks Section 6.6(a) Profit & Loss Share Section 9.3(a) Program Assets Section 12.4(a) DEFINITION SECTION DEFINITION SECTION Program Compound Master Agreement Program Product Master Agreement Program Target Master Agreement Proposing Party Section 3.3 Prosecuting Party Section 10.2(d)(ii) Prosecution/Prosecute Master Agreement Publication Master Agreement Pursuing Party Section 14.3(d) Receiving Party Section 11.1 Redacted Version Section 11.3(b)(i) Regulatory Approval Master Agreement Regulatory Authority Master Agreement Regulatory Expenses Exhibit D Regulatory Interactions Section 5.1(b) Report Exhibit D Requesting Party Section 11.3(b)(iii) Royalty Rate Section 9.4(a) Royalty Term Section Reference Acceptable Confidentiality 9.4(b) Sales Costs Exhibit D Sales Milestone Condition Section 9.2(b) SEC Section 11.3(b)(i) Selected Target Master Agreement Selling Party Section 1.41 Separate Program Master Agreement Separate Program Product Section 8.6(b)(vii) Step-In Enforcement Party Section 10.3(d) Sublicense Revenues Exhibit D Subsequent Third Party Agreement Section 6.2(e)(iii9.5(b) Acquisition Proposal Term Section 6.2(e)(i14.1 Third Party Contractors Section 8.2(a)(ii) Acquisition Sub Third Party Infringement Section 10.3(a) Third Party Infringement Action Section 10.4 Third Party Products Liability Action Section 13.5(a) Vividion Preamble Adverse Recommendation Change Vividion Indemnified Parties Section 6.2(c)(i13.1 Vividion Opt-Out Notice Section 2.3(a) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(ii) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 Closing Section 3.3 Closing Vividion Opt-Out Date Section 3.3 COBRA Section 4.11(d) Company Preamble Company Common Stock Recitals Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(g) Company License-Out Agreements Section 4.16(h) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a) Company Securities Section 4.2(a) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company D&O Insurance Section 7.8(c) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b) Exchange Fund Section 3.8(b) Expiration Time Section 2.1(d)(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b) Recitals Recitals Indemnified Persons Section 7.8(a) Inventions Section 1.1 Material Contract Section 4.18(a) Maximum Annual Premium Section 7.8(c) Merger Recitals Merger Consideration Section 3.7(a)(i) Minimum Condition Section 2.1(a)(i) Multiemployer Plan Section 4.11(c2.3(b)

Additional Definitions. The Each of the following capitalized terms shall have the respective meanings ascribed thereto definitions is set forth in the respective sections section of this Agreement set forth opposite each of the capitalized terms indicated below: DEFINITION SECTION 35 U.S.C. § 102(c) Patent Section 10.8 Academic Essential Provisions Section 8.6(b)(iii) Accounting Standards Master Agreement Acquirer Program Section 8.6(b)(v)(4) Affiliate Master Agreement Agreement Preamble Allowed Indication Section 8.6(b)(viii) Antitrust Law Master Agreement Audit Team Section 9.5(a) Bankruptcy Code Section 8.8 Business Day Master Agreement CCB Program Master Agreement Celgene Preamble Celgene Independent Product Master Agreement Celgene Indemnified Parties Section 13.2(a) Celgene Manufacturing Responsibilities Section 4.1(a) Challenge Section 14.3(d) Challenging Party Section 14.3(d) Clinically Develop Section 8.6(a) Combination Product Section 1.34 Commercialization/Commercialize Master Agreement Commercially Reasonable Efforts Master Agreement Competitive Infringement Section 10.3(b) DEFINITION SECTION Competitive Program Section 8.6(b)(iv) Competitive Program Party Section 8.6(b)(iv) Compound Master Agreement Control/Controlled Master Agreement Cooperating Party Section 11.3(b)(iii) Cover/Covering/Covered Master Agreement Cure Period Section 14.3(b)(i) Deal Target Master Agreement Deal Target Program Master Agreement Develop/Development Master Agreement Directed Master Agreement Disclosing Party Section 11.1 Dispute Section 15.1 Distinct Product Master Agreement Distinct Product Catch-Up Payments Section 9.1(a)(iv) Earlier Patent Section 10.8 Electronic Delivery Section 15.14 Enabling Manufacturing Section 8.6(a) Execution Date Preamble E3 Ligase Program Master Agreement FDA Master Agreement First Program Master Agreement force majeure event Section 15.5 Functional Phenotypic Assay Similarity Criteria Master Agreement Implementation Date Master Agreement IND Master Agreement Indication Master Agreement Indirect Taxes Section 9.6(a) Invalidity Claim Section 10.4(b) Joint Inventions Section 10.1(c) Joint Patents Section 10.1(c) Know-How Master Agreement Law Master Agreement Licensed Branding Section 6.2(c) Licensed Product Data Section 14.4(c) Licensed Program Introduction Manufacture/Manufacturing Master Agreement Master Agreement Introduction Material Breach Section 14.3(b)(i) Opt-In Right Master Agreement Party/Parties Preamble Patent Master Agreement Payee Party Section 9.6(a) Paying Party Section 9.6(a) Person Master Agreement DEFINITION SECTION Permitted Indication Section 8.6(b)(vii) Phase I Study Master Agreement Phase II Study Master Agreement Phase III Study Master Agreement Product Trademarks Section 6.2(a) Program Assets Section 12.4 Program Compound Master Agreement Prosecution/Prosecute Master Agreement Publication Master Agreement Publication Purpose Section 11.4(a) Pursuing Party Section 14.3(d) Receiving Party Section 11.1 Redacted Version Section 11.3(b)(i) Regulatory Approval Master Agreement Regulatory Authority Master Agreement Regulatory Interactions Section 5.2 Requesting Party Section 11.3(b)(iii) Royalty Term Section Reference Acceptable Confidentiality 9.2(b) SEC Section 11.3(b)(i) Separate Program Master Agreement Separate Program Product Section 6.2(e)(iii8.6(b)(vii) Acquisition Proposal Selling Party Section 6.2(e)(i1.34 Target Master Agreement Term Section 14.1 Third Party Master Agreement Third Party Contractors Section 8.2(b) Acquisition Sub Third Party Infringement Section 10.3(a) Third Party Infringement Action Section 10.4(a) Vividion Preamble Adverse Recommendation Change Vividion Cereblon Program Master Agreement Vividion Indemnified Parties Section 6.2(c)(i13.1(a) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(ii) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 Closing Section 3.3 Closing Date Section 3.3 COBRA Section 4.11(d) Company Preamble Company Common Stock Recitals Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(g) Company LicenseVividion Opt-Out Agreements Section 4.16(h) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a) Company Securities Section 4.2(a) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company D&O Insurance Section 7.8(c) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b) Exchange Fund Section 3.8(b) Expiration Time Section 2.1(d)(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b) Recitals Recitals Indemnified Persons Section 7.8(a) Inventions Section 1.1 Material Contract Section 4.18(a) Maximum Annual Premium Section 7.8(c) Merger Recitals Merger Consideration Section 3.7(a)(i) Minimum Condition Section 2.1(a)(i) Multiemployer Plan Section 4.11(c)Notice Master Agreement

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality 102 Amounts ‎Section 2.8(d)(i) Alternative Acquisition Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i‎Section 5.3(b) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(iiApplicable Vesting Period ‎Section 2.7(c)(ii) Antiboycott Rules Section 4.22(aApproval ‎Section 3.5 Assignee ‎Section 10.3 Assumed Consideration ‎Section 2.7(c)(ii) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(iiCapitalization Date ‎Section 3.6(a) Certificate of Merger Section 3.2 ‎Section 2.3 Certificates Section 3.8(c‎Section 2.8(c) Change ‎Section 1.1 Changes Section ‎Section 1.1 Charter Documents ‎Section 3.1 Closing Section 3.3 ‎Section 2.2 Closing Date Section 3.3 COBRA Section 4.11(d‎Section 2.2 Code ‎Section 2.8(f) Collective Bargaining Agreement ‎Section 3.18(a) Companies Registrar ‎Section 2.3 Company Preamble Company Common Stock Recitals Board Recommendation ‎Section 5.3(a) Company Board Recommendation Change ‎Section 5.3(b) Company Disclosure Letter Article IV ‎Article III Company License-In Agreements Section 4.16(gProducts ‎Section 3.15(b) Company License-Out Agreements Reports ‎Section 3.8 Term Section 4.16(hReference Company Securities ‎Section 3.6(d) Company Financial Advisor Section 4.10 Shareholder Approval ‎Section 3.2 Company SEC Reports Section 4.7(aShareholders Meeting ‎Section 7.3(a) Company Securities Section 4.2(a) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company ‎Section 7.8 D&O Insurance Section 7.8(c6.1(c) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a) Due Diligence Review ‎Section 4.13 Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b‎Section 2.3 Employee Plans ‎Section 3.17(a) Exchange Fund ‎Section 2.8(b) FCPA Section 3.8(b3.20(b) Expiration Time Section 2.1(d)(iFDA ‎Section 3.20(c) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b‎Section 3.9(a) Recitals Funded International Employee Plan ‎Section 3.17(i) Good Clinical Practices ‎Section 3.20(e) Good Laboratory Practices ‎Section 3.20(f) ICL Recitals Indemnified Persons Section 7.8(a‎Section 6.1(a) Information Agent ‎Section 2.8(a) Interim Option Tax Ruling ‎Section 7.9(a) Israeli Employees ‎Section 3.18(d) ITA ‎Section 2.8(f) Inventions Section ‎Section 1.1 Joint Venture Interests ‎Section 3.7(f) Leased Real Property ‎Section 3.13(b) Leases ‎Section 3.13(b) Letter of Transmittal ‎Section 2.8(c) Material Contract Section 4.18(a‎Section 3.12(a) Material Employee Plans ‎Section 3.17(a) Maximum Annual Premium Section 7.8(c) Merger Recitals Merger Consideration Section 3.7(a)(i) Minimum Condition Section 2.1(a)(i) Multiemployer Plan Section 4.11(c‎Section 6.1(c)

Additional Definitions. The In addition, each of the following capitalized terms definitions shall have the respective meanings ascribed thereto set forth in the respective sections section of this Agreement set forth opposite each of the capitalized terms indicated below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) Acquired Assets 2.3 Additional Withholding Taxes 5.9.2 Agreed Claims 9.5.6 Agreement Preamble Alternative Acquisition Assignment Consent 2.7.1 Assumed Liabilities 2.5 Buyer Preamble Buyer Change 5.9.2 Buyer Indemnified Parties 9.3 CDA Effective Date CDA definition [***] Merger Agreement Section 6.2(c)(ii) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(ii) 3.5.1 Claim Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 9.5.1 Claims 9.2 Clinical Trial Agreements 2.8.2 Closing Section 3.3 2.1 Closing Cash Consideration 5.1 Closing Date Section 3.3 COBRA Section 4.11(d) Company 2.1 Commercial Milestone Event 5.4 Commercial Milestone Payment 5.4 Confidential Information 7.2.1 Cooperation Period 2.7.1 Deductible 9.4.1 Excluded Assets 2.4 Excluded Liabilities 2.6 Factors Net Sales Definition FIRPTA Certificate 5.9.5 IFRS Net Sales Definition IND Transfer 2.9 Indemnifying Party 9.5.1 Indication 5.3 Licensed Patent 7.2.6 Losses 9.2 MHRA Regulatory Authority Definition Non-Assignable Asset 2.7.1 Ongoing Clinical Trials 2.8.1 Party/Parties Preamble Company Common Stock Recitals Company Purchase Price Allocation 5.9.7 Regulatory Milestone Event 5.3 Regulatory Milestone Payment 5.3 Report 3.3.1 Royalty Term 5.2.2 Seller Preamble Seller Disclosure Letter Article IV Company LicenseSchedule 6.1 Seller Indemnified Parties 9.2 Selling Party Net Sales Definition Term 8.1 Third-In Agreements Section 4.16(g) Company License-Out Agreements Section 4.16(h) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a) Company Securities Section 4.2(a) Company Shares Recitals Confidentiality Party Claim 9.5.1 Transfer Taxes 5.9.3 Transferred Agreement Section 10.4 Current Company D&O Insurance Section 7.8(c) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b) Exchange Fund Section 3.8(b) Expiration Time Section 2.1(d)(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b) Recitals Recitals Indemnified Persons Section 7.8(a) Inventions Section 1.1 Material Contract Section 4.18(a) Maximum Annual Premium Section 7.8(c) Merger Recitals Merger Consideration Section 3.7(a)(i) Minimum Condition Section 2.1(a)(i) Multiemployer Plan Section 4.11(c)Reimbursement Amount 5.1

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(iiAnti Bribery Laws 3.20(c) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(bArticles of Merger 2.2 Assets 3.14 Assumed Restricted Stock Unit Award 2.7(d)(ii) Cancelled Company Shares Section 3.7(a)(ii2.7(a)(ii) Capitalization Date 3.6(a) Cash Consideration 2.7(a)(i) Certificate of Merger Section 3.2 2.2 Certificates Section 3.8(c2.8(c) Changes Section 1.1 Closing Section 3.3 2.3 Closing Date Section 3.3 COBRA Section 4.11(d2.3 Collective Bargaining Agreement 3.18(a) Commitment Letter 4.28 Company Preamble Company Annual Report Article III Company Board Recommendation Recitals Company Board Recommendation Change 6.5(a) Company Common Stock Recitals Company Disclosure Letter Article IV III Company License-In Agreements Section 4.16(gEmployee Plans 3.17(a) Company License-Out Agreements Section 4.16(hERISA Affiliate 3.17(a) Company ESPP Rights 2.7(f) Company Financial Advisor Section 4.10 3.25 Company International Employee Plans 3.17(a) Company Material Contract 3.12(a) Company Material Customer 3.30(a) Company Material Supplier 3.30(b) Company Plans 6.12(a) Company Related Parties 8.3(b)(v) Company SEC Reports Section 4.7(a3.8 Company Securities 3.6(c) Company Securities Section 4.2(aSource Code 3.15(o) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Stockholder Approval 3.3 Company Stockholder Meeting 6.4(a) Company Subsidiary Securities 3.7(c) Consent 3.5 Contaminants 3.15(n) Copyrights 1.1 D&O Insurance Section 7.8(c) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a6.11(b) DGCL Recitals 2.1 Dissenting Company Shares Section 3.7(c)(i2.7(c)(i) EAR Section 4.22(aECCN 3.20(i) Effective Time Section 3.2 2.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(bLimitations 3.2(b) Exchange Agent 2.8(a) Exchange Fund Section 3.8(b2.8(b) Expiration Time Section 2.1(d)(iexport 3.20(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bFee Letter 4.27 Final Exercise Date 2.7(f) Recitals Recitals Financing 4.28(a) Financing Documents 4.28(a) Financing Failure Termination Fee 8.3(c)(iii) Form S-4 3.28 FSE List 3.20(i) Fractional Share Cash Amounts 2.11 FY2019 Plans 6.12(c) Government Officials 3.20(d) Grant Date 3.6(e) Indemnified Persons Section 7.8(a6.11(a) Inventions Section 1.1 Material Contract Section 4.18(aInitial Termination Date 8.1(b)(i) Joint Proxy Statement/Prospectus 3.28 Leased Real Property 3.13(b) Leases 3.13(b) Lenders 4.28 Maximum Annual Premium Section 7.8(c6.11(b) MBCA Recitals Merger Recitals Merger Consideration Section 3.7(a)(i2.7(a)(i) Minimum Condition Section 2.1(a)(iMerger Sub Preamble New Plans 6.12(b) Multiemployer Old Plans 6.12(b) Owned Real Property 3.13(a) Parent Preamble Parent Annual Report Article IV Parent Board Recommendation Recitals Parent Board Recommendation Change 6.6(a) Parent Capitalization Date 4.6(a) Parent Common Stock Recitals Parent Common Stock Issuance Recitals Parent Disclosure Letter Article IV Parent Financial Advisor 4.24 Parent Grant Date 4.6(e) Parent Related Parties 8.3(c)(iii) Parent SEC Reports 4.8 Parent Securities 4.6(c) Parent Stockholder Approval 4.3 Parent Stockholder Meeting 6.4(c) Parent Subsidiary Securities 4.7(c) Patents 1.1 Permits 3.19 Regulatory Filings 6.2(a) Repatriation Notice 6.20 Replacement Bonus Plan Section 4.11(c6.12(c) Representatives 5.3(a) Restricted Stock Unit Consideration 2.7(d)(i) Reverse Termination Fee 8.3(c)(i) SDN List 3.20(i)

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(iAcceptance Time 2.3(a) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(iiArrangements 4.17(n) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Assets 4.14 Cancelled Company Shares Section 3.7(a)(ii) Capitalization Date 4.6(a) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Change 1.1 Change of Recommendation Notice 7.5(b) Changes Section 1.1 Closing Section 3.3 Closing Date Section 3.3 COBRA Section 4.11(dCollective Bargaining Agreement 4.18(a) Company Preamble Company Board Recommendation 7.5(a) Company Board Recommendation Change 7.5(b) Company Common Stock Recitals Company Compensation Committee 4.17(n) Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(gIP Contract 4.15(b) Company License-Out Agreements Section 4.16(hPlans 7.11(c) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a) Company Securities Section 4.2(a) 4.8 Company Shares Recitals Company Stockholder Meeting 7.4(a) Competing Acquisition Transaction 9.4(b)(i) Confidential Information 1.1 Confidentiality Agreement Section 10.4 Consent 4.5 Continuing Directors 2.3(a) Copyright Rights 1.1 Covered Securityholders 4.17(n) Current Company D&O Insurance Section 7.8(c) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a7.10(c) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a▇▇▇▇▇ 4.8(a) Effective Time Section 3.2 Employee Plan / Employee Plans 4.17(a) Employment Compensation Arrangement 4.17(n) Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(bLimitations 4.2 ERISA Affiliate 4.17(a) Exchange Fund Section 3.8(b) Expiration Time Section 2.1(d)(iGrant Date 4.6(e) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b) Recitals Recitals Indemnified Persons Section 7.8(a7.10(a) Institutions 4.15(h) International Employee Plans 4.17(a) Inventions Section 1.1 Leased Real Property 4.13(b) Leases 4.13(b) Material Contract Section 4.18(a4.12(a) Maximum Annual Premium Section 7.8(c7.10(c) Merger Recitals Merger Consideration Section 3.7(a)(i) Minimum Condition Section 2.1(a)(i) Multiemployer Plan Section 4.11(cModified Terms 7.5(b) New Plans 7.11(c)

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto given to them in the respective sections Sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iiiAcquisition Transaction 1.1(c) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iAdvisor 3.3(b) Agreement Preamble Alternate Debt Financing 6.5(d) Alternative Acquisition Agreement Section 6.2(c)(ii5.3(b) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(iiBylaws 3.1 Capitalization Date 3.7(a) Certificate of Merger Section 3.2 2.2 Certificates Section 3.8(c2.9(c) Changes Section 1.1 Charter 2.5(a) Charter Amendment 6.20 Chosen Courts 9.10 Closing Section 3.3 2.3 Closing Date Section 3.3 COBRA Section 4.11(d2.3 Collective Bargaining Agreement 3.20(a) Company Preamble Company Common Stock 401(k) Plan 6.11(b) Company Board Recitals Company Board Recommendation 3.3(a) Company Board Recommendation Change 5.3(d)(i) Company Disclosure Letter Article IV III Company License-In Agreements Section 4.16(gPSU Consideration 2.8(b) Company License-Out Agreements Section 4.16(hRelated Parties 8.3(f)(ii) Company Financial Advisor Section 4.10 Restricted Stock Consideration 2.8(d) Company RSU Consideration 2.8(a) Company SEC Reports Section 4.7(a3.9 Company Securities 3.7(c) Company Securities Section 4.2(aSpecial Committee Recitals Company Stockholder Meeting 6.4(a) Comparable Plans 6.11(c) Confidentiality Agreement 9.4 Consent 3.6 Continuation Period 6.11(c) Converted Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company 2.7(a)(iv) Copyrights 1.1(oo) D&O Insurance Section 7.8(c6.10(c) Customs Laws Section 4.22(aDebt Commitment Letters 4.10(a) Debt Financing Dispute Section 10.9(a4.10(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i2.7(c)(i) EAR Section 4.22(aDTC 2.9(d) Effect 1.1(l) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b2.2 Electronic Delivery 9.14 Employee Plans 3.19(a) Exchange Fund Section 3.8(bEquity Commitment Letter 4.10(a) Expiration Time Section 2.1(d)(iEquity Financing 4.10(a) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bERISA Affiliate 3.19(b) Recitals Recitals Fee Letter 4.10(a) Financing 4.10(a) Financing Letters 4.10(a) Indemnified Persons Section 7.8(a6.10(a) Inventions Section 1.1 Investor 4.10(a) Lease 3.15 Leased Real Property 3.15 Legal Restraint 7.1(c) Marks 1.1(oo) Material Contract Section 4.18(a) Suppliers 3.14 Maximum Annual Premium Section 7.8(c6.10(c) Merger Recitals Merger Sub Preamble New Debt Commitment Letters 6.5(d) New Plans 6.11(d) No-Shop Period Start Date 5.3(a) Notice Period 5.3(e)(i)(3) Old Plans 6.11(d) Option Consideration Section 3.7(a)(i2.8(b) Minimum Condition Section 2.1(a)(iOther Required Company Filing 6.3(b) Multiemployer Plan Section 4.11(cOwned Company Shares 2.7(a)(iii) Parent Preamble Parent Disclosure Letter 4.12 Parent Liability Cap 8.3(f)(i) Parent Related Parties 8.3(f)(i) Parent Termination Fee 8.3(c) Party Preamble Patents 1.1(oo) Paying Agent 2.9(a) Payment Fund 2.9(b) Permits 3.21 Per Share Price 2.7(a)(ii) Proxy Statement 6.3(a) Recent SEC Reports Article III Reimbursement Obligations 6.6(f) Representatives 5.3(a) Required Amount 4.10(c) Requisite Stockholder Approval 3.4 Sublease 3.15 Surviving Corporation Article II Termination Date 8.1(c) Uncertificated Shares 2.9(c)

Additional Definitions. The Each of the following capitalized terms shall have has the respective meanings ascribed thereto meaning described in the respective sections corresponding section of this PD-1 License Agreement set forth opposite each of the capitalized terms indicated below: Additional Study 2.3.2 CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT WERE OMITTED AND REPLACED WITH “[***]”. A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECRETARY OF THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO AN APPLICATION REQUESTING CONFIDENTIAL TREATMENT PURSUANT TO RULE 406 PROMULGATED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. Additional Study Approval 2.3.2(c) Celgene Preamble Celgene Corp. Preamble Celgene PD-1 Patents 4.5.1 Celgene RIVOT Preamble Collaboration Combination Products 2.2.1 Combination Products 2.2.1 Competitive Infringement 4.5.1 Cure Period 6.3 [***] [***] Development Costs 2.3.5 Development Cost Report 2.3.5(b) Development Cost Share 2.3.5 Included Collaboration Candidates 2.1.3 Indemnification Claim 5.3 Indemnitee 5.3 Indemnitor 5.3 Indirect Taxes 3.2.3(b) Jounce Preamble Jounce Independent Product 4.5.2(b) Jounce License Material Transfer Agreement 2.7.1 Jounce License Material Transfer Agreement Effective Date Exhibit B Jounce Licensed Materials 2.7.1 Jounce Licensed Product Patents 4.5.2(a) Jounce Licensed Purpose 2.7.1 [***] [***] Jounce Reversion Products 6.7.1 JWG 2.3.1(a) Licensed Candidate 2.1.3; Exhibit A Licensed Diagnostic Products 2.2.1 Licensed Enforcement Proceeding 4.5.2(b) Licensed Materials Receiving Party 2.7.1 Licensed Products Recitals Licensed Program Assets 2.9 Licensed Step-In Proceeding 4.5.2(b) Licensed Target 2.1.2 License Transferring Party 2.7.1 Lump Sum 2.3.2(c) Master Collaboration Agreement Recitals Monotherapy Products 2.2.1 Non-Proposing Party 2.3.2 Party or Parties Preamble CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT WERE OMITTED AND REPLACED WITH “[***]”. A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECRETARY OF THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO AN APPLICATION REQUESTING CONFIDENTIAL TREATMENT PURSUANT TO RULE 406 PROMULGATED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. Payee Party 3.2.3 Paying Party 3.2.3 PD-1 Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) 6.1 PD-1 License Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(iiPD-1 Effective Date Preamble Proposing Party 2.3.2(b) Antiboycott Rules Section 4.22(aRegulatory Interactions 2.4.2 Revenue Split Product Exhibit E Third Party Agreements 3.2.1(a) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(ii) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 Closing Section 3.3 Closing Date Section 3.3 COBRA Section 4.11(d) Company Preamble Company Common Stock Recitals Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(g) Company License-Out Agreements Section 4.16(h) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a) Company Securities Section 4.2(a) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company D&O Insurance Section 7.8(c) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b) Exchange Fund Section 3.8(b) Expiration Time Section 2.1(d)(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b) Recitals Recitals Indemnified Persons Section 7.8(a) Inventions Section 1.1 Material Contract Section 4.18(a) Maximum Annual Premium Section 7.8(c) Merger Recitals Merger Consideration Section 3.7(a)(i) Minimum Condition Section 2.1(a)(i) Multiemployer Plan Section 4.11(c)Safety and CMC Data 2.4.4 Safety Reason 6.2.2

Additional Definitions. The In addition, each of the following capitalized terms shall have the respective meanings ascribed thereto meaning described in the respective sections corresponding section in the body of this Agreement set forth opposite each of or in the capitalized terms Financial Appendix referenced below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iiiIntroduction All Other Costs Exhibit 4.2E Asia-Pacific License 2.4(a) Acquisition Proposal Section 6.2(e)(iAsia-Pacific Licensee 2.4(b) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iAuditing Party 7.17(a) BioMarin CF Improvements 11.1(c) BioMarin CF Indemnitees 16.2 Capitalized Asset Financial Appendix Co-Chair 3.3 Collaboration Agreement Preamble Alternative Acquisition Financial Appendix Completion Notice 7.7 Confidential Information 10.1 Contingent Right 2.4(f) Controlled Affiliate 1.2 Cost Effective Price 9.1(a) Data Monitoring Board 7.6(a) Definitive Agreement Section 6.2(c)(ii2.4(c) Antiboycott Rules Section 4.22(aDevelopment Costs Financial Appendix Development Transition Period 14.4(a)(i) Board Recommendation Section 2.2(bDispute 17.2 Distribution Costs Financial Appendix Effective Date Introduction Eliminated Party 14.4(a)(i) Cancelled Company Shares Section 3.7(a)(iiEnforcement Action 11.3(b)(i) Certificate Equity Election Notice 7.5 Fault of Merger Section 3.2 Certificates Section 3.8(cBioMarin CF 16.4(b)(ii) Changes Section 1.1 Closing Section 3.3 Closing Date Section 3.3 COBRA Section 4.11(dFault of La Jolla 16.4(b)(i) Company Preamble Company Common Stock Recitals Company Disclosure Letter Article IV Company LicenseField-In Agreements Section 4.16(gBased FTEs 6.2(a)(i) Company LicenseFirst Commercial Sale Financial Appendix FTE Costs Financial Appendix Force Majeure Event 18.1 Forecast Exhibit 9.1A Futile Determination 7.6(b) GAAP Financial Appendix GMP 5.4 Gross Sales Financial Appendix IFRS Financial Appendix Indemnitee 16.3 Indemnitor 16.3 Infringement 11.3(a) Infringement Actions 11.4 Initial Operating Plan/Budget 4.2(b) Initial Product 4.3(a) Inspected Party 5.3 Interest Rate 7.14(b) IP Management Costs Financial Appendix JAMS 17.3(a) Joint Promotion Plan 6.2(c) Joint Steering Committee or JSC 3.1(a) JHU License Exhibit 1.15 La Jolla Improvements 11.1(c) La Jolla Indemnitees 16.1 Launch-1st Year Period Exhibit 4.2E Liabilities 16.1 Manufacturing Costs Financial Appendix Manufacturing Process Development 4.2(e)(ii) Marketing Costs Financial Appendix Maximum Regional Spend Exhibit 4.2E Multiple Product Sales Financial Appendix Negotiation Period 2.4(c) New Technology 11.6(c) Net Sales Financial Appendix Non-Out Agreements Section 4.16(hFutile Determination 7.6(b) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(aObjecting Party 17.2 Ongoing Trials 14.4(a)(i) Company Securities Section Operating Forecast 4.2(a) Company Shares Recitals Confidentiality Operating Plan/Budget 4.2(a) Other Operating Expense Financial Appendix Other Operating Income Financial Appendix Out-of-Pocket Expenses Financial Appendix Paying Party Financial Appendix Phase IV Studies Exhibit 4.2E Prior Agreement Section 10.6 Producing Party 9.4(a) Product Liability Claim 16.5(a) Product Promotional Materials 12.1 Profit/Loss Financial Appendix Promotional/Sales/Marketing or PSM Exhibit 4.2E Proposed Territory 2.4(a) Prosecution and Maintenance or Prosecute and Maintain 11.2(c) Publication 10.4 Current Company D&O Insurance Section 7.8(cPurchased Interests 14.2.2(a) Customs Laws Section 4.22(aPurchase Notice 14.2.2(b) Debt Financing Dispute Section 10.9(aPurchase Price 14.2.2(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(iPurchase Right 14.2.2(a) EAR Section 4.22(aP-Value Achievement 7.6(c) Effective Time Section Quarterly Measurement Exhibit 4.2E Q4, Q5 and Q6 Exhibit 9.1A Recall Costs 16.4(b) Region Exhibit 4.2E Remaining Party 14.4(a)(i) Renal Events Committee 7.6(d) Report Table Financial Appendix Responding Party 7.17(a) ROT Exhibit 4.2E Royalty Notice 6.3 R&D/LCM Exhibit 4.2E Sale Price 14.2.1 Sale Right 14.2.1 Sales Costs Financial Appendix Sales Force Deployment Option 6.2(a) Shared Costs Financial Appendix SEC Financial Appendix Secured Note 14.2.1 SLE Background Sold Interests 14.2.1 Third Party Claim 16.1 Wind-down Period 14.4(a)(ii) Working Group 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b) Exchange Fund Section 3.8(b) Expiration Time Section 2.1(d)(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b) Recitals Recitals Indemnified Persons Section 7.8(a) Inventions Section 1.1 Material Contract Section 4.18(a) Maximum Annual Premium Section 7.8(c) Merger Recitals Merger Consideration Section 3.7(a)(i) Minimum Condition Section 2.1(a)(i) Multiemployer Plan Section 4.11(c2nd Year of Sales Exhibit 4.2E 128 Flare Topline Data 7.6(e)

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(iiAnti-Bribery Laws 3.22(a) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Cancelled Balance Sheet Date 1.1 Canceled Company Shares Section 3.7(a)(ii2.7(a)(ii) Capitalization Date 3.2(a) Certificate of Merger Section 3.2 2.2 Certificates Section 3.8(c2.8(c) Changes Section 1.1 Change of Recommendation/Termination Notice 5.3(c) Closing Section 3.3 2.3 Closing Date Section 3.3 COBRA Section 4.11(d2.3 Collaboration Agreement 3.19(a)(v) Company Preamble Company Common Stock Recitals Board Recommendation 5.3(a) Company Board Recommendation Change 5.3(b) Company Disclosure Letter Article IV III Company License-In Agreements Section 4.16(g) Company License-Out Agreements Section 4.16(hEquity Award Schedule 3.2(b) Company Financial Advisor Section 4.10 3.11 Company Program Party 3.20(e) Company Program Requirements 3.20(d) Company Programs 3.20(d) Company SEC Reports Section 4.7(a3.7(a) Company Securities Section 4.2(a3.2(c) Company Shares Recitals Company Stockholders’ Meeting 6.12(b) Company Trade Secrets 3.17(i) Confidentiality Agreement Section 10.4 9.4 Current Company D&O Insurance Section 7.8(c6.8(b) Customs Laws Section 4.22(aD&O Tail Insurance 6.8(b) Debt Financing Dispute Section 10.9(a) Data 1.1 DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a2.7(c)(i) Effective Time Section 3.2 2.2 Effects 1.1 Enforceability Exceptions Section 4.4 3.4 Environmental Permits Section 4.15(b) 3.16 Exchange Fund Section 3.8(b2.8(b) Expiration Time Section 2.1(d)(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b) Recitals Recitals FFDCA 1.1 GDPR 1.1 Indemnified Persons Section 7.8(a6.7(a) Internet Properties 1.1 Inventions Section 1.1 IP Contracts 3.17(k) Leased Real Property 3.18(b) Material Contract Section 4.18(a3.19(a)(xix) Maximum Annual Premium Section 7.8(cAmount 6.7(b) Merger Recitals Merger Consideration Section 3.7(a)(i2.7(a)(i) Minimum Condition Section 2.1(a)(iMerger Sub Preamble Money Laundering Laws 3.22(b) Multiemployer Plan Section 4.11(c)New Plans 6.8(b) Old Plans 6.8(b) Option Consideration 2.7(d) Parent Preamble Parent Disclosure Letter 1.1 Paying Agent 2.8(a) Predecessor Registrant 3.7(a) Real Property Leases 3.18(b) Regulatory Agency 3.20(b) Regulatory Permits 3.20(b) Reorganization Date 3.7(c) RSU Consideration 2.7(e) Specified Governmental Authority 7.2 Subsidiary Securities 3.2(e) Surviving Corporation 2.1 Termination Date 8.1(b)(i) Termination Fee 8.3(b) Trade Secret 1.1 Trademarks 1.1 Uncertificated Shares 2.8(c) Works of Authorship 1.1

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii401(k) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iTermination Date 7.12(a) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(iiAppointment Time 2.3(a) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(iiAssets 4.21 Certificates 3.8(c) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 Closing Section 3.3 Closing Date Section 3.3 COBRA Section 4.11(dCollective Bargaining Agreements 4.19(a) Company Preamble Company Common Stock Recitals Acquisition Transaction 9.4(b) Company Board Recommendation 7.2(a) Company Board Recommendation Change 7.2(b) Company Disclosure Letter Schedule Article IV Preamble Company License-In IP Agreements Section 4.16(g4.22(e) Company License-Out Agreements Section 4.16(hProducts 4.22(a) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(aRestricted Stock 3.7(e) Company Securities Section 4.2(a4.4(c) Company Shares Recitals Company Stockholders 2.1(f) Company Stockholders’ Meeting 7.3(a) Confidentiality Agreement Section 10.4 Current Company 7.9 Consent 4.5(b) Continuing Directors 2.3(a) D&O Insurance Section 7.8(c7.13(b) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a) DGCL Recitals Delaware Secretary of State 3.2 Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a3.7(c) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(bEmployee Plans 4.18(a) ERISA Affiliate 4.18(a) Exchange Fund Section 3.8(b) Expiration Time Section 2.1(d)(iExchange Ratio 7.11(a) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bExtended Termination Date 9.1(c) Recitals Recitals Foreign Employees 4.18(l) Funded International Employee Plan 4.18(b) Indemnified Persons Section 7.8(aParties 7.13(a) Inventions Section 1.1 Initial Termination Date 9.1(c) International Employee Plans 4.18(a) Leased Real Property 4.20(b) Leases 4.20(b) Material Contract Section 4.18(a4.11(a) Maximum Annual Premium Section 7.8(c7.13(b) Merger Recitals 3.1 Merger Consideration Section 3.7(a)(i3.7(a) Merger Sub Preamble Minimum Condition Section 2.1(a)(i2.1(a) Multiemployer Plan Section 4.11(cNet Cash Position 4.7(h)

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii401(k) Acquisition Proposal Section 6.2(e)(iTermination Date 7.12(a) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i409A Authorities 4.11(f) Action 4.9 Affiliate Transaction 4.24 Agents 4.20(d) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(iiDate Preamble Appointment Time 2.3(a) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Cancelled Company Arrangements 7.17 Book Entry Shares Section 3.7(a)(ii3.8(c) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 Closing Section 3.3 Closing Date Section 3.3 COBRA Section 4.11(d) Company Preamble Company Common Stock Recitals Board Recommendation 7.2(a) Company Board Recommendation Change 7.2(b) Company Bylaws 4.1(b) Company Charter 4.1(b) Company Compensation Committee 7.17 Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(gEscrow Agreement 4.18(l) Company License-Out Agreements Section 4.16(hInsurance Policies 4.16 Company International Plan 4.11(g) Company Financial Advisor Section 4.10 Plans 4.11(a) Company Registered IP 4.18(b) Company SEC Reports Section 4.7(a) Company Securities Section 4.2(aDocuments 4.6(a) Company Shares Recitals Company Stockholder Approval 4.4(a) Company Stockholders 2.1(f) Company Stockholders’ Meeting 7.3(a) Confidential Customer Information 4.18(m) Confidentiality Agreement Section 10.4 Current Company 7.9 Continuing Director 2.3(a) Covered Securityholders 7.17 D&O Insurance Section 7.8(c7.13(c) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a) DGCL Recitals Delaware Secretary of State 3.2 Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(bEmployment Compensation Arrangement 7.17 ESPP 7.11(g) Exchange Fund Section 3.8(b) Expiration Time Section 2.1(d)(iExchange Ratio 7.11(b) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bExtended Termination Date 9.1(b) Recitals Recitals FAR 4.20(c) Final Exercise Date 7.11(g) Indebtedness 6.2(h) Indemnified Persons Section 7.8(aParties 7.13(a) Inventions Section 1.1 Independent Directors 2.3(b) Initial Termination Date 9.1(b) Leased Real Property 4.17(a) Material Contract Section 4.18(a4.15(a) Maximum Annual Premium Section 7.8(c7.13(c) Merger Recitals 3.1 Merger Consideration Section 3.7(a)(i) Merger Sub Preamble Minimum Condition Section 2.1(a)(i2.1(a) Multiemployer ▇▇▇▇▇▇ ▇▇▇▇▇▇▇ 4.25 Nonqualified Deferred Compensation Plan Section 4.11(c4.11(f) Offer Recitals Offer Documents 2.1(f)

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(iiAnti-Bribery Laws 3.22(a) Antiboycott Rules Section 4.22(aBurdensome Condition 6.2(b) Board Recommendation Section 2.2(b) Cancelled Canceled Company Shares Section 3.7(a)(ii2.7(a)(ii) Capitalization Date 3.2(a) Certificate of Merger Section 3.2 2.3 Certificates Section 3.8(c2.8(c)(i) Changes Section 1.1 Change of Recommendation/Termination Notice 5.3(c) Closing Section 3.3 2.2 Closing Date Section 3.3 COBRA Section 4.11(d2.2 Collaboration Agreement 3.19(a)(v) Company Preamble Company Common Stock Recitals Board Recommendation 5.3(a) Company Board Recommendation Change 5.3(b) Company Disclosure Letter Article IV III Company License-In Agreements Section 4.16(g) Company License-Out Agreements Section 4.16(hEquity Award Schedule 3.12(f) Company Financial Advisor Section 4.10 Advisors 3.11 Company Program Party 3.20(e) Company Program Requirements 3.20(d) Company Programs 3.20(d) Company SEC Reports Section 4.7(a3.7(a) Company Securities Section 4.2(a3.2(c) Company Shares Recitals Company Stockholder Approval 3.5 Company Stockholders’ Meeting 6.12(b) Company Termination Fee 8.3(b) Company Trade Secrets 3.17(i) Confidentiality Agreement Section 10.4 Current Company 9.4 D&O Insurance Section 7.8(c) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(aTail Policy 6.7(c) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a2.7(c)(i) Effective Time Section 3.2 2.3 Enforceability Exceptions Section 4.4 3.4 Environmental Permits Section 4.15(b) 3.16 Exchange Fund Section 3.8(b2.8(b) Expiration Time Section 2.1(d)(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b) Recitals Recitals Indemnified Persons Section 7.8(a6.7(a) Inventions Section 1.1 IP Contracts 3.17(k) Leased Real Property 3.18(b) Material Contract Section 4.18(a) Maximum Annual Premium Section 7.8(c3.19(a)(xix) Merger Recitals Merger Consideration Section 3.7(a)(i2.7(a)(i) Minimum Condition Section 2.1(a)(iMerger Sub Preamble Money Laundering Laws 3.22(b) Multiemployer Plan Section 4.11(cNew Plans 6.8(b) Old Plans 6.8(b) Option Consideration 2.7(d) Parent Preamble Paying Agent 2.8(a) Proxy Statement 3.6 PSU Consideration 2.7(f) Real Property Leases 3.18(b) Regulatory Agency 3.20(b) Regulatory Permits 3.20(b) RSU Consideration 2.7(e) Subsidiary Securities 3.2(e) Surviving Corporation 2.1 Termination Date 8.1(b)(i) Uncertificated Shares 2.8(c)(ii)

Additional Definitions. The Each of the following capitalized terms shall have has the respective meanings ascribed thereto meaning described in the respective sections corresponding section of this Jounce Lead Co-Co Agreement set forth opposite each of the capitalized terms indicated below: Adverse Study Effect 2.3.2(c)(4) Allocable Overhead Exhibit D Allowable Expenses Exhibit D Celgene Preamble Celgene Corp. Preamble Celgene RIVOT Preamble Co-Co Candidates Recitals; 2.2.3; Exhibit B Co-Co Diagnostic Products 2.2(a) Co-Co Enforcement Proceeding 6.5.2(d) Co-Co Materials Receiving Party 2.7.1 Co-Co Products Recitals Co-Co Step-In Proceeding 6.5.2(d) Co-Co Target 2.1.2; Exhibit B Co-Co Transferring Party 2.7.1 Commercialization Report 3.1.3 Competitive Infringement 6.5.1 Cost of Goods Sold or COGS Exhibit D Cure Period 8.3.1 [***] [***] Development Cost Report 2.3.6(c) Development Cost Share 2.3.4 Distribution Costs Exhibit D Full Amount 8.7.2 Gross Profit Exhibit D ▇▇▇▇▇-▇▇▇▇▇▇ Act 6.5.2(a) CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT WERE OMITTED AND REPLACED WITH “[***]”. A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECRETARY OF THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO AN APPLICATION REQUESTING CONFIDENTIAL TREATMENT PURSUANT TO RULE 406 PROMULGATED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. Indemnification Claim 7.3 Indemnitee 7.3 Indemnitor 7.3 [***] [***] Information Request 3.1.5(d) JCC 4.3.1 Jounce Preamble Jounce Co-Co Additional Study 2.3.2(c) Jounce Co-Co Additional Study Approval 2.3.2(c)(3) Jounce Co-Co Material Transfer Agreement 2.7.1 Jounce Co-Co Material Transfer Agreement Effective Date Exhibit E Jounce Co-Co Materials 2.7.1 Jounce Co-Co Product Patents 6.5.2(a) Jounce Co-Co Program Exhibit A Jounce Co-Co Purpose 2.7.1 Jounce Co-Co Selling Party 1.11 Jounce Co-Co Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) 8.1 Jounce Independent Product 2.9 Jounce Lead Co-Co Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(ii) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 Closing Section 3.3 Closing Date Section 3.3 COBRA Section 4.11(d) Company Preamble Company Common Stock Recitals Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(g) Company LicenseJounce Opt-Out Agreements Section 4.16(hNotice 4.4.1 Jounce Opt-Out Date 4.4.2 [***] [***] Jounce Lead Effective Date Preamble Jounce Reversion Products 8.7.1 Lump Sum 2.3.2(c)(3) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(aManufacturing Costs Exhibit D Marketing Costs Exhibit D Master Collaboration Agreement Recitals MSKCC Patents 6.3.3 Non-Proposing Party 2.3.2(c)(1) Company Securities Section 4.2(aOperating Profits or Losses Exhibit D Other Actives 1.15 Other Operating Income/Expenses Exhibit D Party or Parties Preamble Payee Party 5.7.3 Paying Party 5.7.3 Pharmacovigilance Agreement 2.4.5(a) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company D&O Insurance Section 7.8(cPharmacovigilance Expenses Exhibit D Product Recall Expenses Exhibit D Profit & Loss Share 5.6 Program Assets 2.9 Proposing Party 2.3.2(c) Customs Laws Section 4.22(aRecording Party Exhibit D Regulatory Expenses Exhibit D Report Exhibit D ROW Development Costs 2.3.4 CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT WERE OMITTED AND REPLACED WITH “[***]”. A COMPLETE VERSION OF THIS EXHIBIT HAS BEEN FILED SEPARATELY WITH THE SECRETARY OF THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO AN APPLICATION REQUESTING CONFIDENTIAL TREATMENT PURSUANT TO RULE 406 PROMULGATED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. Safety and CMC Data 2.4.3(b) Debt Financing Dispute Section 10.9(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b) Exchange Fund Section 3.8(b) Expiration Time Section 2.1(d)(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b) Recitals Recitals Indemnified Persons Section 7.8(a) Inventions Section 1.1 Material Contract Section 4.18(a) Maximum Annual Premium Section 7.8(c) Merger Recitals Merger Consideration Section 3.7(a)(i) Minimum Condition Section 2.1(a)(i) Multiemployer Plan Section 4.11(c)Safety Reason 8.2.2 Sales Costs Exhibit D Sublicense Revenues Exhibit D U.S. Administration Liabilities 7.5 U.S. Commercialization Costs 3.1.6 U.S. Commercialization Report 3.2.3 Worldwide Development Costs 2.3.4

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(iiDebt Financing 5.6(b)(ii) Antiboycott Rules Section 4.22(aBreach Cure Period 7.1(g) Board Recommendation Section 2.2(bBreach Termination Date 7.1(g) Cancelled Company Shares Section 3.7(a)(iiCertificate of Incorporation 1.5(a) Certificate of Merger Section 3.2 1.2 Certificates Section 3.8(c1.8(c) Changes Section 1.1 Chancery Court 8.10 Closing Section 3.3 1.3 Closing Date Section 3.3 COBRA Section 4.11(d1.3 Collective Bargaining Agreement 2.18(a) Communications Act 2.6 Company Preamble Company Common Stock Recitals Board Recommendation 2.3 Company Board Recommendation Change 4.3(a) Company Disclosure Letter Schedule Article IV II Company License-In Agreements Section 4.16(gParties 7.3(e)(i) Company License-Out Agreements Section 4.16(hPermits 2.20 Company Restricted Share 1.7(d)(i) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a2.9 Company Securities 2.7(c) Company Securities Section 4.2(aStockholder Meeting 5.4(a) Company Shares Recitals Systems 2.16(c) Confidentiality Agreement Section 10.4 Current Company 8.4 Consent 2.6 Continuation Period 5.11(b) Continuing Plans 5.11(a) D&O Insurance Section 7.8(c5.10(c) Customs Laws Section 4.22(aDebt Commitment Letter 3.10(b) Debt Financing Dispute Section 10.9(a3.10(b) Delaware Secretary of State 1.2 DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a1.7(c)(i) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b1.2 Employee Plans 2.18(a) Employment Laws 2.19(b) Equity Financing 3.10(b) Equity Financing Letter 3.10(b) Equity Financing Sources 3.10(b) ERISA Affiliate 2.18(b) Exchange Fund Section 3.8(b1.8(b) Expiration Time Section 2.1(d)(iFCC 2.6 FCC Approvals 2.6 Federal Communications Laws 2.26(a) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bFee Letter 3.10(b) Financing 3.10(b) Financing Letters 3.10(b) Franchise 2.6 Guarantee Recitals Guarantors Recitals Indemnified Persons Section 7.8(a5.10(a) Inventions Section 1.1 Leased Real Property 2.15(b) Leases 2.15(b) LFA 2.6 LFA Approvals 2.6 Material Contract Section 4.18(a2.13(a) Maximum Annual Premium Section 7.8(c5.10(c) Merger Recitals Merger Sub Preamble New Debt Commitment Letter 5.6(b)(ii) New Plans 5.11(c) Notice Period 3.4(d)(i) Old Plans 5.11(c) Option Consideration Section 3.7(a)(i1.7(d)(ii) Minimum Condition Section 2.1(a)(iOther Required Company Filing(s) Multiemployer Plan Section 4.11(c2.30 Owned Company Shares 1.7(a)(ii) Parent Preamble Parent Expenses 7.3(b)(ii) Parent Material Adverse Effect 3.1 Parent Parties 7.3(e)(ii) Payment Agent 1.8(a) Per Share Price 1.7(a)(i) Proxy Statement 2.30 Record Date 5.4(b) Required Information 5.6(b)(v)(A) Requisite Stockholder Approval 2.4 Rights 2.31 Rights Agreement 2.31 Rule 13a-15 2.10(b) Second Request 5.2(c) State Communications Laws 2.26(a) State PUC 2.6 State PUC Approvals 2.6 Subscribers 2.32 Subsidiary Securities 2.7(c) Surviving Corporation 1.1 Tax Returns 2.17(a) Termination Date 7.1(c) Transaction Committee Recitals Transaction Litigation 5.16 Uncertificated Shares 1.8(c) Warrant Consideration 1.7(d)(iii)

Additional Definitions. The Each of the following capitalized terms shall have has the respective meanings ascribed thereto described in the respective sections corresponding section of this Agreement set forth opposite each of the capitalized terms indicated below: Agreement Preamble Commercialization Milestone Event Section 5.2.3(a) Commercialization Milestone Payment Section5.2.3(a) [***] [***] Cure Period Section 10.2.1 Developing Section 1.23 Development Section 1.24 Development Milestone Event Section 5.2.1(a) Development Milestone Event Notice Section 5.2.1(a) Development Milestone Payment Section 5.2.1(a) Development Plan Section 3.1.2 Disclosing Party Section 7.1 Dispute Section 11.6.2(a) EEA Section 8.4.1(b) Effective Date Preamble Eisai Preamble Eisai Indemnitees Section 9.1 Eisai Transition Plan Section 10.6.1(d) Electronic Delivery Section 11.17 EMA Section 1.94 Executive Officer Section 3.4.3 Existing Drug Substance Inventory Section 4.3.1(a) Existing Raw Materials Inventory Section 4.3.1(b) Existing Transferred Inventory Section 4.3.1(a) Existing Regulatory Materials Section 3.2.3(a) FDA Section 1.94 GAAP Section 1.1 [***] [***] IAS/IFRS Section 1.1 ICC Section 11.6.2(b) ICD10 Section 1.51 ICH Guidelines Section 1.42 Indemnification Claim Notice Section 9.3.1 Indemnitee Section 9.3.1 Indemnitor Section 9.3.1 Infringement Section 6.3.1 Insolvency Event Section 10.4.1 [***] [***] Manufacturing Know-How and Materials Section 4.4.1 Manufacturing Technology Transfer Section 4.4.1 Manufacturing Technology Transfer Plan Section 4.4.1 MHLW Section 1.94 MHRA Section 1.94 Parties Preamble Party Preamble Patent Term Restoration Section 6.3.10 Receiving Party Section 7.1 Regulatory Milestone Event Section 5.2.2 Regulatory Milestone Payment Section 5.2.2 Regulatory Transition Activities Section 3.2.3(b) Royalty Reduction Trigger Section 1.61 Pharmavant Preamble Pharmavant Indemnitees Section 9.2 Pharmavant Manufacturing Know-How Section 10.6.1(d)(ix) Roivant Sciences Recitals Pharmavant Trademarks Section 6.6 Securities Regulators Section 7.3.1(a) Share Purchase Agreement Section 5.1(b) Tactical Plan Section 1.16 Term Section Reference Acceptable Confidentiality 10.1.1 Third Party Infringement Section 6.5.1 Transferred Regulatory Materials Section 3.2.3(b) Transitional Supply Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(ii) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 Closing Section 3.3 Closing Date Section 3.3 COBRA Section 4.11(d) Company Preamble Company Common Stock Recitals Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(g) Company License-Out Agreements Section 4.16(h) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a) Company Securities Section 4.2(a) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company D&O Insurance Section 7.8(c) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b) Exchange Fund Section 3.8(b) Expiration Time Section 2.1(d)(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b) Recitals Recitals Indemnified Persons Section 7.8(a) Inventions Section 1.1 Material Contract Section 4.18(a) Maximum Annual Premium Section 7.8(c) Merger Recitals Merger Consideration Section 3.7(a)(i) Minimum Condition Section 2.1(a)(i) Multiemployer Plan Section 4.11(c)4.3.2

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii401(k) Termination Date 7.10(a) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iAgreement 7.2(a) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(iiDate Preamble Antitrust Authority 7.5(c) Antiboycott Rules Section 4.22(aAntitrust Laws 7.5(c) Board Recommendation Section 2.2(bAppointment Time 2.3(a) Cancelled Company Arrangements 7.15 Articles of Merger 3.2 Book-Entry Shares Section 3.7(a)(ii3.8(c) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 Closing Section 3.3 Closing Date Section 3.3 COBRA Section 4.11(d) Company Preamble Company Common Stock Recitals Board Recommendation 4.4(b) Company Board Recommendation Change 7.2(a) Company Bylaws 4.1(b) Company Charter 4.1(b) Company Compensation Committee 7.15 Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(gRegistered IP 4.19(b) Company License-Out Agreements Section 4.16(hSEC Documents 4.6(a) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(aShareholder Approval 4.4(a) Company Securities Section 4.2(aShareholders 2.1(a) Company Shareholders’ Meeting 7.3(a) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company Continuing Directors 2.3(a) Covered Securityholders 7.15 D&O Insurance Section 7.8(c7.11(c) Customs Laws Section 4.22(aData Room 1.3(i) Debt Financing Dispute Section 10.9(a) DGCL Recitals Delaware Secretary of State 3.2 Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(aDivestiture Action 7.5(e) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(bESPP 4.2(a) Exchange Fund Section 3.8(b) Expiration Time Term Section 2.1(d)(iReference Extended Termination Date 9.1(b)(i) Financial Statements Incipio Incipio FCPA 4.20(a) Indebtedness 6.2(g) Indemnified Parties 7.11(a) Independent Directors 2.3(b) Initial Termination Date 9.1(b) Long-Form Merger Agreement Section 4.7(bRecitals Match Period 7.2(b) Recitals Recitals Indemnified Persons Section 7.8(a) Inventions Section 1.1 Material Contract Section 4.18(a4.15(a) Maximum Annual Premium Section 7.8(c7.11(c) Merger Recitals Merger Consideration Section 3.7(a)(i) Merger Sub Preamble Minimum Condition Section 2.1(a)(i2.1(a) Multiemployer Notice of Superior Proposal 7.2(b) Offer Recitals Offer Closing 2.1(d) Offer Documents 2.1(f) Offer Price Recitals Offer to Purchase 2.1(f) Parent Preamble Parent Disclosure Letter Article V Parent Insider 2.3(a) Payment Agent 3.8(a) Permits 4.10(a) Plan Section 4.11(c)of Merger 3.2 Proxy Statement 7.4(a) Representatives 7.1(a) Schedule 14D-9 2.2(b) Schedule TO 2.1(f) Short-Form Election 7.3(c) Short-Form Merger Recitals Short-Form Threshold 2.4(a) Surviving Corporation 3.1 Takeover Laws 4.21 Top-Up Closing 2.4(c) Top-Up Option 2.4(a) Top-Up Shares 2.4(a) Washington Secretary of State 3.2

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality 401(k) Plan Section 6.8(f) Acceptance Time Board Appointments Section 6.11 Acquisition Agreement Section 6.2(e)(iii6.2(a) Acquisition Proposal Adjusted Outstanding Share Number Section 6.2(e)(i2.1(a) Acquisition Sub Agreement Preamble Adverse Agreement Date Preamble Antitrust Authority Section 6.3(c) Antitrust Laws Section 6.3(c) Business Section 4.14 Company Preamble Company Board Recommendation Section 3.4(b) Company Board Recommendation Change Section 6.2(c)(i) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(ii) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 Closing Section 3.3 Closing Date Section 3.3 COBRA Section 4.11(d6.2(a) Company Preamble Bylaws Section 3.1(b) Company Common Stock Recitals Charter Section 3.1(b) Company Disclosure Letter Article IV III Company License-In Agreements Registered IP Section 4.16(g3.18(b) Company License-Out Agreements SEC Documents Section 4.16(h3.6(a) Company Financial Advisor Shareholders Section 4.10 Company SEC Reports Section 4.7(a2.1(a) Company Securities Senior Management Section 4.2(a) 4.9 Company Shares Recitals Confidentiality Agreement Delaware Federal Court Section 10.4 Current Company 8.10 Designated Courts Section 8.10 D&O Insurance Section 7.8(c6.9(b) Customs Laws Effects Section 4.22(a1.1(r) Debt Fairness Opinion Section 3.22 Financing Dispute Section 10.9(a4.5(b) DGCL Recitals Dissenting Company Shares Financing Commitment Section 3.7(c)(i4.5(b) EAR Indebtedness Section 4.22(a5.2(h) Effective Time Indemnified Parties Section 3.2 Enforceability Exceptions 6.9(a) Initial Director Resignations Section 4.4 Environmental Permits 6.11 Jefferies Section 4.15(b) Exchange Fund Section 3.8(b) Expiration Time Section 2.1(d)(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b) Recitals Recitals Indemnified Persons Section 7.8(a) Inventions Section 1.1 3.21 Material Contract Section 4.18(a3.15(a) Maximum Annual Premium Section 7.8(c) Merger Recitals Merger Consideration Section 3.7(a)(i6.9(b) Minimum Condition Section 2.1(a)(i2.1(a) Multiemployer Plan Offer Recitals Offer Closing Section 4.11(c2.1(d) Offer Documents Section 2.1(f) Offer Price Recitals Offer to Purchase Section 2.1(f) Parent Preamble Pre-Closing Period Section 6.4 Products Section 3.10(b) Purchaser Preamble Purchaser Disclosure Letter Article IV Permits Section 3.10(a) Representatives Section 6.1(a) Required Company Shareholder Vote Section 3.22 Schedule 14D-9 Section 2.2(a) Schedule TO Section 2.1(f) Specified Acquisition Transaction Section 7.3(b)(ii) Specified Definitive Acquisition Agreement Section 7.1(d)(ii) Strategic Investors Section 3.2 Takeover Laws Section 3.19 Termination Date Section 7.1 Termination Fee Section 7.3(b)(iii)

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii401(k) Acquisition Proposal Section 6.2(e)(iPlan 6.11(b) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iAdjusted Restricted Stock 2.8(a) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(iiAntitrust Approval 7.1 Assumed Option 2.8(e) Antiboycott Rules Section 4.22(aAssumed Restricted Stock Unit 2.8(f) Board Recommendation Section 2.2(bBook-Entry Shares 2.9(b) Cancelled Company Shares Section 3.7(a)(ii2.7(b) Capitalization Date 3.4(a) Cash Consideration 2.7(b) Certificate 2.9(b) Certificate of Merger Section 3.2 Certificates Section 3.8(c2.3(a) Changes Section 1.1 Closing Section 3.3 2.2 Closing Date Section 3.3 COBRA Section 4.11(d2.2 Collective Bargaining Agreements 3.16(a) Company Preamble Company Common Stock Recitals Board Recommendation 6.7(a) Company Board Recommendation Change 6.7(a) Company Disclosure Letter Schedule Article IV III Company License-In Agreements Section 4.16(gInsiders 6.14 Company Registered Intellectual Property 3.20(a) Company License-Out Agreements Section 4.16(hRestricted Stock 2.8(a) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a3.6(a) Company Securities Section 4.2(a3.4(c) Company Shares Recitals Stockholder Meeting 6.6(a) Confidentiality Agreement Section 10.4 Current Company 6.9 Consent 3.3(b) Continuing Employees 6.11(d) D&O Insurance Section 7.8(c6.12(b) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(aDelaware Secretary of State 2.3(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a2.7(b) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b2.3(a) Employee Plans 3.15(a) ERISA Affiliate 3.15(a) Exchange Fund Section 3.8(bAgent 2.9(a) (a) Expiration Time Section 2.1(d)(iFinal Surviving Corporation 2.1(b) Financial Statements Incipio Incipio First Step Merger Agreement Section 4.7(bRecitals Foreign Employees 3.15(j) In-Licenses 3.20(g) Incentives 3.14(o) (a) Integrated Merger Recitals Recitals Indemnified Persons Section 7.8(aInterim Surviving Corporation 2.1(a) Inventions Section 1.1 International Employee Plans 3.15(a) Intervening Event 6.7(b) Investment Company Act 3.11(e) IP Licenses 3.20(h) Leased Real Property 3.17 Leases 3.17 Legal Proceeding Matters 6.8(d) Material Contract Section 4.18(a3.13(a) Maximum Annual Premium Section 7.8(c6.12(b) Merger Recitals Merger Consideration Section 3.7(a)(i2.7(b) Minimum Condition Section 2.1(a)(iMerger Proposal 6.6(a) Multiemployer Plan Section 4.11(cMerger Sub One Preamble Merger Sub Two Preamble Option Exchange Program 2.8(b) Option Exchange Proposal 2.8(c) Out-Licenses 3.20(h) Paragon 3.24 Parent Preamble Parent Disclosure Schedule Article IV Parent SEC Reports 4.5(a) Permits 3.11(a) Proxy Statement/Prospectus 6.5(a) Qualifying Amendment 6.5(c) Registration Statement 6.5(a) Regulation M-A Filing 6.5(d) Regulatory Filings 3.11(c) Requisite Merger Approval 3.2(c) Requisite Option Exchange Approval 3.2(c) Restricted Stock Units 2.8(b) Reviewable Transaction 8.1(b) RoHS Directive 1.1(y) Second Step Merger Recitals Specified Company Representations 7.2(a) Specified Parent Representations 7.3(a) Stock Consideration 2.7(b) Subsidiary Securities 3.5(d) Tax Opinions 6.18 Termination Date 8.1(b) Termination Fee Amount 8.3(b) Trade Secrets 1.1(hh) Trademarks 1.1(hh)

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii2020 Bonus Plan 7.9(d) Acquisition Proposal Section 6.2(e)(i2020 Bonuses 7.9(d) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i401(k) Plan 7.9(e) 401(k) Plan Termination Date 7.9(e) Accepted Company Shares 3.7(a)(ii) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii) Antiboycott Rules Section Anti-Bribery Laws 4.22(a) Board Recommendation Section 2.2(bBalance Sheet Date 1.1 Burdensome Condition 7.2(a) Cancelled Canceled Company Shares Section 3.7(a)(ii) Capitalization Date 4.2(a) CARES Act 1.1 Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 Change of Recommendation/Termination Notice 6.3(c) Closing Section 3.3 Closing Date Section 3.3 COBRA Section 4.11(d4.12(d) Collaboration Agreement 4.19(a)(v) Company Preamble Company Common Stock Recitals Board Recommendation 6.3(a) Company Board Recommendation Change 6.3(b) Company Compensation Committee 3.7(g) Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(g) Company License-Out Agreements Section 4.16(hEquity Award Schedule 4.2(b) Company Financial Advisor Section 4.10 Advisors 4.11 Company Program Requirements 4.20(d) Company Programs 4.20(d) Company Regulatory Agency 4.20(b) Company Regulatory Permits 4.20(b) Company SEC Reports Section 4.7(a) Company Securities Section 4.2(a4.2(c) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company D&O Insurance Section Tail Policy 7.8(c) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a) Data 1.1 DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a) Domain Names 1.1 Effect 1.1 Effective Time Section 3.2 Effects 1.1 Employment Compensation Arrangement 4.23 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b) 4.16 Exchange Fund Section 3.8(b) Expiration Time Section 2.1(d)(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bFFCRA 1.1 FFDCA 1.1 Final Exercise Date 3.7(g) Recitals Recitals Final Offering Period 3.7(g) Foreign Antitrust Laws 1.1 Indemnified Persons Section 7.8(a) Indemnified Proceeding 7.8(b) Inventions Section 1.1 Material Contract Section 4.18(a) Maximum Annual Premium Section 7.8(c4.19(a) Merger Recitals Merger Consideration Section 3.7(a)(i) Merger Sub Preamble Minimum Condition Section 2.1(a)(i) Multiemployer Plan Section 4.11(c)Money Laundering Laws 4.22(b) New Plans 7.9(c) Offer Recitals Offer Documents 2.1(f)(i) Offer Price Recitals Offer to Purchase 2.1(a) Old Plans 7.9(c) Option Consideration 3.7(d) Parent Preamble Parent 401(k) Plans 7.9(e) Participant 4.12(e) Paying Agent 3.8(a) Plans 4.12(a) Proprietary Information 1.1 Real Property Leases 4.18(b) Remedy Actions 7.2(a) Retention Agreements Recitals RSU Consideration 3.7(e) Schedule 14D-9 2.2(a) Schedule TO 2.1(f)(i) Subsidiary Securities 4.2(e) Surviving Corporation 3.1 Termination Date 9.1(b)(i) Termination Fee 9.3(b) Trademarks 1.1 Uncertificated Shares 3.8(c) Works of Authorship 1.1

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto given to them in the respective sections Sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iAdvance Notice Period 5.2(d)(i)(1) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii5.2(a) Antiboycott Rules Section 4.22(aAlternative Financing 6.20(b) Board Recommendation Section 2.2(bBuyer Parties Preamble Bylaws 1.6(b) Cancelled Company Shares Section 3.7(a)(iiCapitalization Date 3.2(a) Certificate of Merger Section 3.2 1.3 Certificates Section 3.8(c2.3(c) Changes Section 1.1 Charter 1.6(a) Closing Section 3.3 1.4 Closing Date Section 3.3 COBRA Section 4.11(d) 1.4 Company Preamble Company Common Stock Recitals Board Recommendation 3.3(c) Company Board Recommendation Change 5.2(c)(i) Company Confidential Information 3.17(e) Company Data 3.17(l) Company Disclosure Letter Article IV III Company License-In Agreements Section 4.16(gFinancial Statements 3.5(c) Company License-Out Agreements Section 4.16(hMaterial Contracts 3.16(b) Company Financial Advisor Section 4.10 Preferred Stock 3.2(a) Company SEC Reports Section 4.7(a3.5(a) Company Securities Section 4.2(a) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company 9.6 Continuation Period 6.19(a) Covered Employees 6.19(a) D&O Insurance Section 7.8(cTail Policies 6.8(b) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(aData Security Incident 3.17(l) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i2.1(c)(i) EAR Section 4.22(aDTC 2.3(d) DTC Payment 2.3(d) Effective Time Section 3.2 1.3 Electronic Delivery 9.15 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(bLimitations 3.3(a) Exchange Fund Section 3.8(b2.3(b) Expiration Time Section 2.1(d)(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b) Recitals Recitals Guarantee 9.16 Guarantor Preamble Indemnified Persons Section 7.8(a6.8(a) Inventions Section 1.1 Material Contract Section 4.18(aInsurance Policies 3.20 Interim Period 5.1 Intervening Event 5.2(d)(i) Maximum Annual Premium Section 7.8(cLabor Agreement 3.12(a) Lease Agreement 3.16(a)(xi) Leased Real Property 3.14(b) Merger Recitals Merger Consideration Section 3.7(a)(iSub Preamble Merger Transactions Recitals New Litigation Claim 6.12 Note Recitals Notice Period Expiration 5.2(d)(i)(2) Minimum Condition Section 2.1(a)(iOther Required Company Filing 6.3(c) Multiemployer Plan Section 4.11(cOther Required Parent Filing 6.3(d) Owned Company Share 2.1(a)(iii)

Additional Definitions. The Each of the following capitalized terms shall have the respective meanings ascribed thereto definitions is set forth in the respective sections section of this Agreement set forth opposite each of the capitalized terms indicated below: Term 35 U.S.C. § 102(c) Patent Section Reference Acceptable Confidentiality 10.7 [**] Section 8.6(b)(iii) Accounting Standards Exhibit D Acquirer Program Section 8.6(b)(v)(D) Additional Revenue Exhibit D Additional Study Section 3.3 Additional Study Approval Section 3.3(c) Advertising and Market Research Expenses Exhibit D Affiliate Master Agreement Agios Preamble Agios Clinical-Scale Manufacturing Responsibilities Section 6.2(e)(iii4.1(a) Acquisition Proposal Agios Commercial-Scale Manufacturing Responsibilities Section 6.2(e)(i4.1(a) Acquisition Sub Agios Indemnified Parties Section 13.1(a) Agios Opt-Out Notice Section 2.3(a) Agios Opt-Out Date Section 2.3(b) Agios Pharmaceuticals Preamble Adverse Recommendation Change Agios Program Assets Section 6.2(c)(i) 12.4 Agreement Preamble Alternative Acquisition Annual Net Sales Exhibit D Antitrust Law Master Agreement Audit Team Section 6.2(c)(ii9.8(a) Antiboycott Rules Audit Rights Holder Section 4.22(a9.8(e) Board Recommendation Auditee Section 2.2(b9.8(e) Cancelled Company Shares Bankruptcy Code Section 3.7(a)(ii8.8 Business Day Master Agreement Celgene Preamble Celgene Corp. Preamble Celgene RIVOT Preamble Celgene Indemnified Parties Section 13.2(a) Certificate of Merger Celgene Clinical-Scale Manufacturing Responsibilities Section 3.2 Certificates 4.1(c) Celgene Commercial-Scale Manufacturing Responsibilities Section 3.8(c4.1(c) Changes Celgene Manufacturing Responsibilities Section 1.1 Closing 4.1(c) Challenge Section 3.3 Closing Date 14.3(d) Challenging Party Section 3.3 COBRA Section 4.11(d14.3(d) Company Preamble Company Common Stock Recitals Company Disclosure Letter Article IV Company LicenseCo-Co Buy-In Agreements Section 4.16(g3.4 Combination Product Exhibit D Commercialization/Commercialize Master Agreement Commercialization Expenses Exhibit D Commercialization Budget Section 6.2(a)(i) Company License-Out Agreements Section 4.16(h) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a) Company Securities Section 4.2(a) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company D&O Insurance Section 7.8(c) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b) Exchange Fund Section 3.8(b) Expiration Time Section 2.1(d)(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b) Recitals Recitals Indemnified Persons Section 7.8(a) Inventions Section 1.1 Material Contract Section 4.18(a) Maximum Annual Premium Section 7.8(c) Merger Recitals Merger Consideration Section 3.7(a)(i) Minimum Condition Section 2.1(a)(i) Multiemployer Commercialization Plan Section 4.11(c)6.2(a)(i) Commercially Reasonable Efforts Master Agreement Competitive Infringement Section 10.3(b) Competitive Program Section 8.6(b)(iv) Competitive Program Party Section 8.6(b)(iv) Control/Controlled Master Agreement Cooperating Party Section 11.3(b)(iii) Cover/Covering/Covered Master Agreement CPI Exhibit D Cure Period Section 14.3(b)(i) Damages Master Agreement

Additional Definitions. The Each of the following capitalized terms shall have the respective meanings ascribed thereto definitions is set forth in the respective sections Section of this Agreement set forth opposite each of the capitalized terms indicated below: Term Abandoned Patents Section Reference Acceptable 7.2(a) Action Section 7.3(b) Agents Section 8.1 Biosense Section 1.5 Commercialization Plan Section 4.2 Confidential Information Section 8.2 Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal 8.2 Courts Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change 13.1 Development Milestone Section 6.2(c)(i) Agreement Preamble Alternative Acquisition Agreement 6.2 Development Milestone Payment Section 6.2(c)(ii) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(ii) Certificate of Merger 6.2 Development Plan Section 3.2 Certificates Effective Date Preamble Incumbent Board Section 3.8(c1.8 Indemnified Party Section 10.3(a) Changes Indemnifying Party Section 1.1 Closing 10.3(a) Infringement Claim Section 3.3 Closing Date 7.3(a) Joint Intellectual Property Section 3.3 COBRA 7.1(c) Joint Inventions Section 4.11(d7.1(c) Company Preamble Company Common Stock Recitals Company Disclosure Letter Article Joint Patent Rights Section 7.2(b) MSs Section 6.2 Ocuphire Section 10.2(e) Other API Section 1.8 Paragraph IV Company License-In Agreements Section 4.16(g) Company License-Out Agreements Section 4.16(h) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a) Company Securities Section 4.2(a) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company D&O Insurance Section 7.8(c) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b) Exchange Fund Section 3.8(b) Expiration Time Section 2.1(d)(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b) Recitals Recitals Indemnified Persons Claim Section 7.8(a) Periodic Report Section 6.7 Product Liability Claim Section 10.1(b) Processa Preamble Processa Common Stock Section 6.1(a) Processa Excluded Affiliates Section 1.46 Processa Parties Section 10.2 Processa Pre-Existing Affiliates Section 1.46 Processa Sole Inventions Section 1.1 Material Contract 7.1(b) Product Liability Claims Section 4.18(a10.1(b) Maximum Annual Premium Royalty Term Section 7.8(c6.5(b) Merger Recitals Merger Consideration Ocuphire Preamble Ocuphire Parties Section 3.7(a)(i10.1 Ocuphire Sole Inventions Section 7.1(b) Minimum Condition Sales Milestone Section 2.1(a)(i6.4 Sales Milestone Payment Section 6.4 SEC Section 6.1(b) Multiemployer Plan Sole Inventions Section 4.11(c)7.1(b) Sublicense Payment Section 6.6(a) Sublicensee Intellectual Property Section 2.1(b) Taxes Section 6.9 Term Section 11.1 Third-Party Claims Section 10.1 Third-Party Patent Licenses Section 6.5(c) Upfront Fee Section 6.1(a) Upfront Shares Section 6.1(a) VWAP Section 6.2

Additional Definitions. The following capitalized terms defined elsewhere in this Agreement shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms belowtherein defined: Term Accounting Firm Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii2.3(e) Acquisition Proposal Recitals Acquisition Engagement Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i12.14(a) Agreement Preamble Alternative Acquisition Agreement Anti-Bribery Laws Section 6.2(c)(ii4.22 Assets Section 4.11 Audited Financial Statements Section 4.6(a) Antiboycott Rules Auditor Determination Section 4.22(a2.3(e) Board Recommendation Balance Sheet Date Section 2.2(b4.6(b) Cancelled Company Shares Base Purchase Price Section 3.7(a)(ii2.2 Claim Notice Section 10.2(d) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 Closing Section 3.3 3.1 Closing Certificate Section 2.3(b) Closing Date Section 3.3 COBRA 3.1 Company Recitals Company 401(k) Plan Section 4.11(d4.12(c) Company Preamble Company Common Stock Recitals Closing Certificate Section 9.3(a) Company Disclosure Letter Article ARTICLE IV Company License-In Agreements Registrations Section 4.16(g4.17(a) Company License-Out Agreements Consideration Schedule Section 4.16(h2.3(a) Company Financial Advisor Continuing Employees Section 4.10 Company SEC Reports 8.5(a) Contracting Parties Section 4.7(a8.10 D&O Costs Section 8.7(b) Company Securities D&O Expenses Section 4.2(a8.7(b) Company Shares Recitals Confidentiality D&O Indemnifiable Claim Section 8.7(b) D&O Indemnifying Party Section 8.7(b) D&O Indemnitee(s) Section 8.7(a) D&O Tail Policy Section 8.7(b) Debt Payments Section 3.2(b)(iii) Disputed Matters Section 2.3(e) Dispute Notice Section 2.3(e) Escrow Account Section 3.2(a)(ii) Escrow Agent Section 3.2(a)(ii) Escrow Agreement Section 10.4 Current Company D&O Insurance 3.2(a)(ii) Escrow Funds Section 7.8(c) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b3.2(a)(ii) Exchange Fund Act Section 3.8(b) Expiration Time 4.5 FCPA Section 2.1(d)(i4.22 Final Payment Adjustment Amount Section 2.3(c) Financial Statements Incipio Incipio Merger Section 4.6(b) Forward Looking Data Section 4.26 Government Contract Section 4.18(a)(xiii) HSR Act Section 4.5 Interim Period Section 7.1 IP Assignment Agreement Section 4.7(b4.17(l) IRS Section 4.12(b) Key Employees Recitals Key Employee Agreements Recitals Indemnified Persons Leased Real Property Section 7.8(a4.10(b) Inventions Licensed Intellectual Property Section 1.1 4.17(c) Material Contract Contracts Section 4.18(a) Maximum Annual Premium Material Customer Section 7.8(c4.20(a) Merger Material Distributor Section 4.20(a) Material Owned Intellectual Property Section 4.17(a) Material Supplier Section 4.20(a) MPC Section 8.1(b) Most Recent Balance Sheet Section 4.6(b) Nonparty Affiliates Section 8.10 Notice Period Section 10.2(b) Option Surrender Agreement Section 2.6(a) Party(ies) Preamble Pay-Off Letters Section 8.16 Permits Section 4.9(b) Policies Section 4.19 PPACA Section 4.12(h) Pre-Closing Certificate Section 2.3(a) Proprietary Information Section 8.2(a) Purchase Price Section 2.2 Purchased Shares Recitals Merger Consideration Purchaser Preamble Purchaser Closing Certificate Section 3.7(a)(i9.2(a) Minimum Condition R&W Insurance Policy Section 2.1(a)(i6.8 Real Property Lease Section 4.10(c) Multiemployer Plan Releasee Section 4.11(c8.10 Releasor Section 8.10 Representatives Section 4.27 Required Consents Section 3.2(a)(v) Review Period Section 2.3(c) Seller/Sellers Preamble Seller Affiliated Parties Section 8.8 Seller Representative Preamble Seller Representative Expense Amount Section 3.2(b)(vi) Termination Date Section 11.1(b) Third Party Action Notice Section 10.2(a) Transfer Taxes Section 8.6(b) Unaudited Financial Statements Section 4.6(b) WARN Section 4.13(e) Withholding Certificate Section 3.2(a)(iv)

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto given to them in the respective sections Sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii2009 Plan 3.7(b) Acquisition Proposal Section 6.2(e)(i2018 Plan 3.7(b) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iAdvisor 3.3(b) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii5.3(b) Antiboycott Rules Section 4.22(aAlternative Debt Financing 6.5(e) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(iiAnnouncement 6.14 Bylaws 3.1 Capitalization Date 3.7(a) Certificate of Merger Section 3.2 2.2 Certificates Section 3.8(c2.10(c) Changes Section 1.1 Charter 2.5(a) Chosen Courts 9.10(a) Closing Section 3.3 2.3 Closing Date Section 3.3 COBRA Section 4.11(d2.3 Collective Bargaining Agreement 3.19(a) Company Preamble Company Common Stock Recitals Board Recommendation 3.3(a) Company Board Recommendation Change 5.3(d)(i) Company Disclosure Letter Article IV III Company License-In Agreements Section 4.16(gIT Systems 3.16(l) Company License-Out Agreements Section 4.16(hLiability Limitation 8.3(f)(iii) Company Financial Advisor Section 4.10 Related Parties 8.3(f)(ii) Company SEC Reports Section 4.7(a3.9 Company Securities 3.7(c) Company Securities Section 4.2(aSeverance Plan 6.11(b) Company Shares Recitals Stockholder Meeting 6.4(a) Company Termination Fee 8.3(b)(i) Confidentiality Agreement Section 10.4 Current Company 9.4 Consent 3.6 Continuation Period 6.11(a) Copyrights 1.1(vv) Cut-off Date 5.3(b) D&O Insurance Section 7.8(c) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a6.10(c) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i2.7(c)(i) EAR Section 4.22(aDTC 2.10(d) Effect 1.1(q) Effective Time Section 2.2 Electronic Delivery 9.13 Employee Plans 3.18(a) Enforceability Limitations 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(bERISA Affiliate 3.18(b) Exchange Fund Section 3.8(b2.10(b) Expiration Time Section 2.1(d)(iFCPA 3.25(b) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bFDA 3.27(a) Go-Shop Period 5.3(a) Guarantee Recitals Guarantor Recitals Holder Damages 8.3(b)(iv) Indemnified Persons Section 7.8(a6.10(a) Inventions Section 1.1 International Employee Plans 3.18(i) Intervening Event 5.3(e)(i) IP Contracts 3.16(d) Leased Real Property 1.1(aaa) Marks 1.1(vv) Material Contract Section 4.18(aCustomer 1.1(eee)(iii) Material Lease 3.14(b) Material Supplier 1.1(eee)(iv) Maximum Annual Premium Section 7.8(c6.10(c) Merger Recitals Merger Consideration Section 3.7(a)(iSub Preamble New Plan 6.11(d) Minimum No-Shop Period Start Date 5.3(a) Notice Period 5.3(e)(ii)(3) Old Plans 6.11(d) Other Required Company Filing 6.3(b) Other Required Parent Filing 6.3(c) Owned Company Shares 2.7(a)(iii) Parent Preamble Parent Disclosure Letter Article IV Parent Liability Limitation 8.3(f)(i) Parent Related Parties 8.3(f)(i) Parent Termination Fee 8.3(c) Party Preamble Patents 1.1(vv) Payment Agent 2.10(a) Per Share Price 2.7(a)(ii) (a) Proxy Statement 6.3(a) Recent SEC Reports Article III Regulatory Authority 3.27(b) Regulatory Condition Section 2.1(a)(i6.2(b) Multiemployer Plan Section 4.11(cRegulatory Laws 3.27(a) Regulatory Permits 3.27(b) Reimbursement Obligations 6.6(f) (a) Required Financing Information 6.6(a)(v) Requisite Stockholder Approval 3.4 Safety Notices 3.27(c) Surviving Corporation 2.1 Tax Returns 3.17(a) Termination Date 8.1(c) Trade Control Laws 3.25(a)(i) Uncertificated Shares 2.10(c) Willful Breach 8.2(b)

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Cancelled Anti-Corruption Laws 2.17 Canceled Company Shares Section 3.7(a)(ii1.7(a)(ii) Capitalization Date 2.4(a) Certificate of Merger Section 3.2 1.2 Certificates Section 3.8(c1.8(c) Changes Section 1.1 Chosen Courts 8.9 Closing Section 3.3 1.3 Closing Date Section 3.3 1.3 COBRA Section 4.11(d2.15(d) Company Preamble Company Common Stock Recitals Balance Sheet Date 2.6 Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(gBoard Recommendation 5.1(a) Company License-Out Agreements Section 4.16(hBoard Recommendation Change 5.1(b) Company Financial Advisor Section 4.10 Advisors 2.19 Company Financial Statements 2.5(b) Company Plans 5.9(c) Company SEC Reports Section 4.7(a2.5(a) Company Securities Section 4.2(a2.4(a) Company Share Recitals Company Shares Recitals Confidentiality Agreement Section 10.4 Company Stockholder Meeting 5.2(a) Competing Acquisition Transaction 7.3(b) Current Company D&O Insurance Section 7.8(c5.5(b) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a2.24(d) DGCL Recitals Disclosure Schedule Article II Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a1.7(b)(i) Effective Time Section 3.2 1.2 Enforceability Exceptions Section 4.4 2.2(a) Environmental Permits Section 4.15(b) Authorizations 2.11 Exchange Fund Section 3.8(b1.8(b) Expiration Time Section 2.1(d)(iExon-▇▇▇▇▇▇ 2.3 Export Control Laws 2.24(a) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b) Recitals Recitals Indemnified Persons Section 7.8(a5.5(a) Inventions Section 1.1 Interim Period 4.1 Joint Notice 2.3 Material Contract Section 4.18(a2.14(a) Maximum Annual Premium Section 7.8(c5.5(b) Merger Recitals Merger Consideration Recitals Merger Sub Preamble New Plans 5.9(c) NOLs 2.10(j) Notice of Intended Recommendation Change 5.1(c) Old Plans 5.10(c) Option Consideration 1.7(c) Parent Preamble Table of Contents Term Section 3.7(a)(iReference Parent 125 Plan 5.9(d) Minimum Condition Section 2.1(a)(iPayment Agent 1.8(a) Multiemployer Plan Section 4.11(c)Plans 2.15(a) Proxy Statement 5.2(a) Real Property Leases 2.12(b) Regulatory Filings 5.4(a) Representatives 4.3(a) Required Vote 2.21 Restraint 6.1(c) RSU Consideration 1.7(d) Surviving Corporation 1.1 Termination Date 7.1(b) Termination Fee 7.3(b) Trade Control Laws 2.24(b) Support Agreement Recitals Uncertificated Shares 1.8(c) Willful and Material Breach 7.2

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iAdditional Termination Fee 6.17(a) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(iiApplicable Anti-Corruption Laws 3.20(c) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(bAssets 3.14 Commitment Letter 4.10(a) Cancelled Company Shares Section 3.7(a)(ii2.7(a)(ii) Capitalization Date 3.6(a) Certificate of Merger Section 3.2 2.2 Certificates Section 3.8(c2.8(c) Changes Section 1.1 claim 4.11 Closing Section 3.3 2.3 Closing Date Section 3.3 COBRA Section 4.11(d2.3 CMB Escrow Agent Recitals CMB Escrow Agreement Recitals CMB Escrow Amount 6.17(c) Collective Bargaining Agreement 3.18(a) Company Preamble Company Board Recommendation Recitals Company Board Recommendation Change 6.5(b) Company Common Stock Recitals Company Escrow Agent Recitals Company Escrow Agreement Recitals Company Escrow Amount 6.17(a) Company Disclosure Letter Article IV III Company License-In Agreements Section 4.16(gRelated Parties 8.3(b)(iv) Company License-Out Agreements Section 4.16(h) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a3.8 Company Securities 3.6(e) Company Securities Section 4.2(aStockholder Meeting 6.4(b) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company 9.4 Consent 3.5 Continuing Obligations 2.7(d)(ii) D&O Insurance Section 7.8(c6.10(c) Customs Laws Section 4.22(aDB Escrow Amount 6.17(b) Debt debt 4.11 Financing Dispute Section 10.9(a4.10(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a2.7(c)(i) Effective Time Section 3.2 2.2 Employee Plans 3.17(a) Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(bLimitations 3.2(b) Equity Award or Equity Awards 3.6(b)(v) ▇▇▇▇ ▇▇▇▇▇▇▇ Reference ERISA Affiliate 3.17(a) Exchange Fund Section 3.8(b2.8(b) Expiration Time Section 2.1(d)(iFinancing Agreements 6.15(d) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bGovernment Officials 3.20(d) Recitals Recitals Grant Date 3.6(d) Indemnified Persons Section 7.8(a6.10(a) Inventions Section 1.1 Material Contract Section 4.18(aInternational Employee Plans 3.17(a) Intervening Event Notice 6.5(c)(ii)(C) JoinderITAR Recitals3.20(h) Leased Real Property 3.13(b) Leases 3.13(b) Lender 4.10(a) Major Customer 3.27(a) Major Supplier 3.27(a) (a) Maximum Annual Premium Section 7.8(c6.10(c) Merger Recitals Merger Consideration Section 3.7(a)(iRecitals New Plans 6.11(c) Minimum Condition Section 2.1(a)(iOld Plans 6.11(c) Multiemployer Plan Section 4.11(cOwned Real Property 3.13(a) Parent Preamble Payment Agent 2.8(a) Permits 3.19 Proxy Statement 3.30 Representatives 5.2(b) Requisite Stockholder Approval 3.3 Restricted Stock Unit Consideration 2.7(f)(i) Solvent 4.11 Subsidiary Securities 3.7(c) Superior Proposal Amendment Notice 6.5(c)(i)(C) Superior Proposal Notice 6.5(c)(i)(C) Surviving Corporation 2.1 (a) Termination Date 8.1(b)(i) Termination Fee 8.3(b)(i) Uncertificated Shares 2.8(c) Unvested Company Option 2.7(d)(ii) Unvested Company SAR 2.7(e)(ii) Unvested Option Consideration 2.7(d)(ii) Unvested Restricted Stock Unit 2.7(f)(ii)

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: 11 Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iiiPreamble Agreement of Merger 2.2 Antitrust Restraint 6.5(d) Acquisition Proposal Section 6.2(e)(iAssets 3.21 Assumed Option 6.11(b) Acquisition Sub California Secretary of State 2.2 Cancelled Option 6.11(a) Capitalization Representation 7.2(a) Certificates 2.8(c) Change 1.1 Changes 1.1 China RoHS 1.1 Closing 2.3 Closing Date 2.3 Collective Bargaining Agreements 3.19(a) Combined Software 1.1 Company Preamble Adverse Company Board Recitals Company Board Recommendation 6.2(a) Company Board Recommendation Change Section 6.2(c)(i6.2(b) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(ii) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 Closing Section 3.3 Closing Date Section 3.3 COBRA Section 4.11(d) Company Preamble Company Common Stock Recitals Company Disclosure Letter Article IV III Company LicenseForm 10-In K Article III Company IP Agreements Section 4.16(g3.22(f) Company License-Out Agreements Section 4.16(hRegistered IP 3.22(b) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(aRepresentatives 6.1(b) Company Securities Section 4.2(a3.4(c) Company Shares Recitals Shareholders’ Meeting 6.3 Confidentiality Agreement Section 10.4 Current Company 6.9 Consent 3.5(b) Copyrights 1.1 D&O Insurance Section 7.8(c6.13(b) Customs Laws Section 4.22(aDemand Notice 2.7(c)(i) Debt Financing Dispute Section 10.9(aDissenting Shares 2.7(c)(i) DGCL Recitals Dissenting Company Shares Section 3.7(c)(iDomain Names 1.1 EAR 3.23(a) EAR Section 4.22(aECCNs 3.23(b) Effective Time 2.2 Employee Plans 3.18(a) ERISA Affiliate 3.18(a) Term Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b) Reference EU RoHS Directive 1.1 Exchange Fund Section 3.8(b2.8(b) Expiration Time Section 2.1(d)(iExport Controls 3.23(a) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bFIN 48 3.16(n) Recitals Recitals Foreign Employees 3.18(l) Funded International Employee Plan 3.18(b) Import Restrictions 3.23(a) Indemnified Persons Section 7.8(aParties 6.13(a) Inventions Section 1.1 International Employee Plans 3.18(a) ITAR 3.23(a) Leased Real Property 3.20(b) Leases 3.20(b) Material Contract Section 4.18(a3.11(a) Maximum Annual Premium Section 7.8(c6.13(b) Merger Recitals Merger Consideration Recitals Merger Sub Preamble NQDCP 5.2(g) OFAC 3.23(a) Option Consideration 6.11(a) Owned Real Property 3.20(a) Parent Preamble Patents 1.1 Payment Agent 2.8(a) Permits 3.13 Proxy Statement 3.8 Real Property 3.20(b) Requisite Shareholder Approval 3.3(c) Retirement Plan Termination Date 6.12(a) Retirement Plans 6.12(a) SEC Reports 3.6 Shares Recitals Significant Customer 3.30(a) Significant Supplier 3.30(b) Specified Representations 7.2(a) Subsidiary Securities 3.2(c) Surviving Corporation 2.1 Tail Policy 6.13(b) Takeover Laws 3.29 Tax Incentive 3.16(k) Termination Date 8.1(c) Term Section 3.7(a)(iReference Termination Fee Amount 8.3(b)(i) Minimum Condition Section 2.1(a)(iThird Party Leases 3.20(b) Multiemployer Plan Section 4.11(c)Trade Secrets 1.1 Trademarks 1.1 Triggering Event 8.1(e)(ii) Voting Agreement Recitals Voting Agreements Recitals Warranties 3.22(s) WEEE Directive 1.1

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto set forth in the respective sections of this Agreement Sections set forth opposite each of the capitalized terms below: Term Acquired Company; Acquired Companies RECITALS Aggregate Share Purchase Price Section Reference Acceptable Confidentiality 2.02(c) Agreement PREAMBLE Alternative Acquisition Agreement Section 6.2(e)(iii5.08(c)(ii) Acquisition Proposal Arbitration Notice Section 6.2(e)(i8.13(a) Acquisition Sub Preamble ATA BVI PREAMBLE ATA Learning PREAMBLE ATA Learning Share Purchase Price Section 2.02(c) ATA Learning Shares Section 2.01 ATA Learning SPA RECITALS ATA Online RECITALS ATA Online Share Purchase Price Section 2.02(b) ATA Online Shares Section 2.01 Bankruptcy and Equity Exception Section 4.08(b) Beijing AIC Section 2.04(a)(i) Business RECITALS Buyer; Buyers PREAMBLE Buyer 1 PREAMBLE Buyer 2 PREAMBLE Buyer 3 PREAMBLE Buyer 4 PREAMBLE Buyer 5 PREAMBLE Buyer 6 PREAMBLE Buyer 7 PREAMBLE Contracting Parties Section 8.16(a) Debt Commitment Letters Section 4.08(a) Debt Financing Section 4.08(a) Debt Financing Agreement Section 5.06(a) Deposit RECITALS Deposit Account Section 5.01 Deposit Date Section 3.07(b) Dispute Section 8.13(a) Dividend and Distribution Section 5.10 Dividend and Distribution Amount Section 5.10 Equity Commitment Letter Section 4.08(a) Equity Financing Section 4.08(a) First Closing Section 2.03(a) First Closing Date Section 2.03(a) Financing Section 4.08(a) Financing Documents Section 4.08(a) Foreign Exchange Approvals Section 5.10 Guarantor PREAMBLE HKIAC Section 8.13(b) HKIAC Rules Section 8.13(b) Long-stop Date Section 7.01(b) Non-Party Affiliates Section 8.16(a) Party; Parties PREAMBLE Pledge of Sponsor Acquired Shares Section 5.11 PRC; China PREAMBLE Proposing Person Section 5.08(b)(ii) Second Closing Section 2.03(b) Second Closing Date Section 2.03(b) Seller PREAMBLE Seller Board RECITALS Seller Adverse Recommendation Change Section 6.2(c)(i5.08(c)(i) Agreement Preamble Alternative Acquisition Agreement Seller Termination Fee Section 6.2(c)(ii7.03 Special Committee RECITALS Superior Proposal Notice Period Section 5.08(d)(ii) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(ii) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 Third Closing Section 3.3 2.03(c) Third Closing Date Section 3.3 COBRA Section 4.11(d2.03(c) Company Preamble Company Common Stock Recitals Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(g) Company License-Out Agreements Section 4.16(h) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a) Company Securities Section 4.2(a) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company D&O Insurance Section 7.8(c) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a) DGCL Recitals Dissenting Company Xing Wei RECITALS Zhongxiao RECITALS Zhongxiao Shares Section 3.7(c)(i2.01 Zhongxiao Share Purchase Price Section 2.02(a) EAR Zhongxiao SPA RECITALS 31.5% ATA Online Shares Section 4.22(a2.01(b) Effective Time 7.5% ATA Online Shares Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b) Exchange Fund Section 3.8(b) Expiration Time Section 2.1(d)(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b) Recitals Recitals Indemnified Persons Section 7.8(a) Inventions Section 1.1 Material Contract Section 4.18(a) Maximum Annual Premium Section 7.8(c) Merger Recitals Merger Consideration Section 3.7(a)(i) Minimum Condition Section 2.1(a)(i) Multiemployer Plan Section 4.11(c2.01(a)(ii)

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto defined in the respective sections of this Agreement set forth opposite each of the capitalized terms belowSection indicated: Defined Term Section Reference Acceptable Confidentiality Agreement ------------ ----------------- Accountants' Statement Section 6.2(e)(iii15.2 Accounting Principles Section 15.2(a) Acquisition Cost Section 19.1(b) Acquisition Proposal Section 6.2(e)(i14.2(b) Acquisition Sub Preamble Adverse Recommendation Change Transaction Section 6.2(c)(i19.1(a) Advantaged Party Section 20.3(c) Affected Party Section 23.6(a) Agreement Preamble Alternative Acquisition Agreement Applicable Notice Annex 2 Appraiser Annex 2 Asserted Liability Section 6.2(c)(ii25.6(a) Antiboycott Rules Assumed AT&T Liabilities Section 4.22(a15.1(b)(i) Board Recommendation Assumed BT Liabilities Section 2.2(b15.1(b)(ii) Cancelled Company Assumed Concert Purchase Debt Section 15.5(b) Assumed Liabilities Section 15.1(b)(ii) AT&T Preamble AT&T Assets Section 15.3(a)(i) AT&T GCS Business Financials Section 17.1(h) AT&T GCS Business MAE Section 17.1(e)(ii) AT&T Guarantees Section 15.3(d) AT&T Indemnified Parties Section 25.3 AT&T Initial Valuation Section 15.2(a) AT&T Leases Section 17.1(j)(i) AT&T Minimum Contribution Section 15.4(a) AT&T Parties Preamble AT&T Property Assets Section 17.1(j)(i) AT&T Specified Contracts Section 17.1(n)(i) Bankrupt Parent Section 27.1(a) Breach Notice Section 23.5(b) breaching party Section 23.4(a) BT Preamble BT Assets Section 15.3(a)(ii) BT GCS Business Financials Section 17.2(h) BT GCS Business MAE Section 17.2(e)(ii) BT Guarantees Section 15.3(e) BT Holdings Preamble BT Indemnified Parties Section 25.2 BT Initial Valuation Section 15.2(a) BT Leases Section 17.2(j)(i) BT Minimum Contribution Section 15.4(a) BT Parties Preamble BT Property Assets Section 17.2(j)(i) BT Specified Contracts Section 17.2(n)(i) Burdensome Condition Section 18.4(a) Business Unit Information Section 6.7(a)(i) Call Section 23.4(a) Call Shares Section 3.7(a)(ii23.4(a) Certificate of Merger Cap Section 3.2 Certificates 15.5(b) Capital Call Section 3.8(c16.2(a) Changes Capital Call Date Section 1.1 16.3 Capital Call Notice Section 16.3 Claim Section 24.3(a) Claims Notice Section 25.6(a) Closing Section 3.3 20.1(a) Closing Date Section 3.3 COBRA 20.1(a) College of Wise Counselors Section 4.11(d24.1(a) Company Preamble Company Common Stock Recitals Company Disclosure Letter Article IV Company License-In complying party Section 23.4(a) Concert Financials Section 17.2(h)(ii) Concert Holdings Section 15.5(a) Confidentiality Agreements Section 4.16(g18.10(a) Consumer Price Index Section 11.16 ConsumerCo Section 1.7 Contracts Annex 1 Covered Investor Breach Section 22.3(f) Covered Transaction Section 23.6(a) deadlock Section 6.3(a) Defaulting Shareholder Section 16.4(a) Designated Accountants Section 15.4(b) Disadvantaged Party Section 20.3(c) Distribution of Netco Section 13.2(b) District Court Section 24.3(a) Effective Date Section 23.6(a) Election Notice Section 23.4(a) Employee Matters Agreement Section 18.8(c) engaging party Section 19.3(b) EU Merger Regulations Section 18.3 Event of Default Section 22.3 fair market value Annex 2 Farland Section 11.18(a) Farland Equity Stake Section 11.18(b) Fiduciary Duty Standard Section 11.2(b) Fiscal Year Section 6.5 Funding Breach Section 16.4(a) GBCS Alliance Section 11.5(a) Group Companies Section 11.1 Indemnifying Party Section 25.6(a) Indemnitee Section 25.6(a) Indemnity Payment Section 25.8(c) Independent Auditor Section 6.8 Initial Contributed Assets Section 15.1(a) Initial Valuations Section 15.2(a) Investment Fund Agreement Section 18.8(a) Key Employee Annex 1 Key Governmental Approvals Section 18.4(a) Leverage Ratio Section 6.4(a) Losses Section 25.2 Management Board Valuation Section 15.2 Master Outsourcing Agreement Section 7.3(d) Material Acquisition Transaction Section 19.3(a) MCI-WorldCom Distribution Agreement Section 9.2(b) Minimum Contribution Section 15.4(a) New Assets Section 19.1(a) Newco Subsidiaries Recital B Non-Bankrupt Parent Section 27.1(a) Non-Competition Undertakings Section 11.2(a) Non-Defaulting Shareholder Section 16.4(a) non-engaging party Section 19.3(b) Non-Indemnifying Party Section 25.5(e) non-subject party Section 23.3(b) Other Parent Section 13.2(a) Other Party Annex 2 Peering Arrangements Section 2.1(g) Performance Notice Section 23.2(a) Post-Closing Tax Benefit Section 25.5(a) preferred supplier Section 10.1(b) Preferred Supplier Section 10.1(b) Pro Rata Basis Section 11.4(b) Proposing Party Annex 2 Provisional AOPB Section 6.3(a) Purchased Shares Section 15.5(b) Purchaser Section 10.1(b) Put Section 23.3(b) Put Notice Section 23.3(b) Put Shares Section 23.3(b) Qualified Holding Company License-Out Agreements Section 4.16(h5.5 Recipient Section 18.10(b) Company Financial Advisor Reduction Section 4.10 Company SEC Reports 20.3(b) Retail Price Index Section 4.7(a11.16 Revenue Limitation Section 11.4(b) Company RTP Acts Section 28.1(b) Special Efforts Section 11.2(a) Specified Entity Section 11.2(a) Specified Person Section 11.2(a) subject party Section 23.3(b) target parent Section 14.2(a) Tax Distribution Schedule 6.9 Tax Indemnifying Party Section 25.5(e) Tax Proceeding Section 25.5(e) Term Sheet Section 17.1(r)(vi) Third Party Supplier Section 10.1(b) Thistle BV Preamble Transfer Section 12.1(a) Transition Period Section 23.2(b) Transition Plan Section 18.8(e) Triggering Person Section 13.1 Triggering Transaction Section 13.1 Venture Business Material Adverse Effect Section 17.1(a) VLT Preamble Voting Securities Section 4.2(a14.1(a) Company Shares Recitals Confidentiality Agreement WIP Section 10.4 Current Company D&O Insurance Section 7.8(c) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b) Exchange Fund Section 3.8(b) Expiration Time Section 2.1(d)(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b) Recitals Recitals Indemnified Persons Section 7.8(a) Inventions Section 1.1 Material Contract Section 4.18(a) Maximum Annual Premium Section 7.8(c) Merger Recitals Merger Consideration Section 3.7(a)(i) Minimum Condition Section 2.1(a)(i) Multiemployer Plan Section 4.11(c15.4(a)

Additional Definitions. The Each of the following capitalized terms shall have the respective meanings ascribed thereto meaning defined in the respective corresponding sections of this Agreement set forth opposite each of the capitalized terms indicated below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) Agreement Preamble Alternative Acquisition Effective Date Preamble Company Preamble SB Oils Preamble JV Companies Preamble Solazyme, Inc. Preamble Solazyme Brazil Preamble Solazyme Group Preamble Original Joint Venture Agreement Section 6.2(c)(iiRecitals Moema Facility Recitals Initial Joint Venture Recitals Original Solazyme Development Agreement Recitals Joint Venture Recitals Party 1.2 Reais 1.2 Project Plan 2.1(a) Antiboycott Rules Section 4.22(aProject Term 2.2 Solazyme Project Technology 2.6 Transferring Party 3.1(a) Board Recommendation Section 2.2(bRecipient 3.1(a) Cancelled Company Shares Section 3.7(a)(iiExhibit A – † Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. Transferred Materials 3.1(a) Certificate of Merger Section 3.2 Certificates Section 3.8(cResults 3.1(c) Changes Section 1.1 Closing Section 3.3 Closing Date Section 3.3 COBRA Section 4.11(dAuthorized Transferee 3.1(d) Solazyme Platform Research 4.1 Solazyme Platform Technology 4.2 Technology Maintenance Fee 4.3 Solazyme Technical Services Technology 5.1 Retainer Year 5.2(b) Solazyme Technology 6.1(a)(vi) Actively Utilized 6.6 Estimated Royalty Payment 7.5 Royalty Report 7.6 Actual Royalty Payment 7.6(b) Indemnified Taxes 8.6 Excluded Taxes 8.6 Additional Amounts 8.6 Confidential Information 11.1 Solazyme Indemnitee 12.1(a)(i) Company Preamble Indemnitee 12.1(b)(i) Indemnitee 12.1(c) Indemnitor 12.1(c) Term 13.1 Joint Venture Agreement Definition of JV Agreements Administrative Services Agreement Definition of JV Agreements Sales and Distribution Agreements Definition of JV Agreements Exhibit A – † Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. Exhibit A – † Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. THIS RESEARCH AND DEVELOPMENT PROJECT PLAN NO. [1] (the “Project Plan”) is made and entered into as of ______, 201_ (the “Effective Date”), by and between Solazyme Bunge Renewable Oils Coöperatief U.A., a Dutch cooperative (the “Company”) and Solazyme, Inc., a Delaware corporation with a principal place of business at ▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇, ▇▇▇▇▇ ▇▇▇ ▇▇▇▇▇▇▇▇▇, ▇▇ ▇▇▇▇▇ (“Solazyme, Inc.”), and relates to the Amended and Restated Solazyme Development Agreement dated October 27, 2015 (the “Solazyme Development Agreement”). Pursuant to the Solazyme Development Agreement, Solazyme, Inc. has agreed to perform certain research and development for the Company Common Stock Recitals in accordance with written Project Plans, such as this one, entered into from time-to-time. Solazyme, Inc. and the Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(g) Company License-Out Agreements Section 4.16(h) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a) Company Securities Section 4.2(a) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company D&O Insurance Section 7.8(c) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b) Exchange Fund Section 3.8(b) Expiration Time Section 2.1(d)(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b) Recitals Recitals Indemnified Persons Section 7.8(a) Inventions Section 1.1 Material Contract Section 4.18(a) Maximum Annual Premium Section 7.8(c) Merger Recitals Merger Consideration Section 3.7(a)(i) Minimum Condition Section 2.1(a)(i) Multiemployer Plan Section 4.11(c)hereby agree as follows:

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto given to them in the respective sections Sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iAcceptance Time 2.1(e) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii7.3(a) Antiboycott Rules Section 4.22(aAlternative Debt Financing 8.3(c) Board Recommendation Section 2.2(bAlternative Debt Financing Agreements 8.3(c) Cancelled Alternative Debt Financing Commitment 8.3(c) Annual Bonus 8.9(b) Annual Bonus Payment Date 8.9(b) Buyer Parties Preamble Bylaws 5.1 Capitalization Date 5.6(a) Cash Replacement Amount 3.5(c)(ii) Cash Replacement Option Amount 3.5(c)(ii) Cash Replacement Company Shares Section 3.7(a)(iiRSA Amount 3.5(b)(ii) Cash Replacement Company RSU Amount 3.5(a)(ii) Centerview 5.3(b) Certificate of Merger Section 3.2 3.1(c) Certificates Section 3.8(c3.3(a) Changes Section 1.1 Charter 5.1 Chosen Courts 11.10(a) Closing Section 3.3 3.1(b) Closing Date Section 3.3 COBRA Section 4.11(d3.1(b) Collective Bargaining Agreement 5.18(a) Company Preamble Company 401(k) Plan 8.9(d) Company Board Recommendation 5.3(a) Company Common Stock Recitals Company Disclosure Letter Article IV V Company License-In Agreements Section 4.16(gEquity Awards 5.6(b) Company License-Out Agreements Section 4.16(hOption Consideration 3.5(c)(i) Company Financial Advisor Section 4.10 PSA Consideration 3.5(d) Company PSU Consideration 3.5(e) Company Related Parties 10.3(f) Company RSA Consideration 3.3(b) Company RSU Consideration 3.5(a)(i) Company SEC Reports Section 4.7(a) 5.8 Company Securities Section 4.2(a5.6(c) Company Shares Recitals Compensation Continuation Period 8.9(a) Confidentiality Agreement Section 10.4 11.4 Consent 5.5 Consideration Fund 3.3(a) Continuation Period 8.9(a) Current Company D&O Insurance Section 7.8(c8.8(b) Customs Laws Section 4.22(aDebt Fee Letter 6.11(a) Debt Financing Dispute Section 10.9(a6.11(a) Debt Financing Commitment 6.11(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a3.4 Dollars 1.3(e) Effective Time Section 3.2 3.1(c) Electronic Delivery 11.13 Employee Plan 5.17(a) Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(bLimitations 5.2 Equity Award Consideration 3.5(e) Exchange Fund Section 3.8(bEquity Commitment Letter Recitals Equity Financing 6.11(a) Excluded Shares 2.1(a) Expiration Time Section 2.1(d)(i2.1(c) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bFinal Purchase Period 3.5(f) Financing 6.11(a) Financing Commitments 6.11(a) FDA 5.23(a) FDA Act 5.22(a) Guarantee Recitals Guarantor Recitals Indemnified Person Insured Persons Section 7.8(a8.8(a) Inventions Section 1.1 Material Contract Section 4.18(a8.8(b) Inside Date 3.1(b) Intervening Event 7.3(d)(i) Investors Recitals Lease 5.13(b) Leased Real Property 5.13(b) Maximum Annual Premium Section 7.8(cAmount 8.8(b) Merger Recitals Merger Consideration Section 3.7(a)(i3.2(a) Minimum Condition Section 2.1(a)(iMerger Sub Merger Sub Stockholder Approval Preamble Preamble New Plan 8.9(c) Multiemployer Notice Period 7.3(d)(ii)(2) Offer Recitals Offer Conditions 2.1(a) Offer Commencement Date 2.1(a) Offer Documents 2.1(f) Offer Price Recitals Outside Date 10.1(c) Parent Preamble Parent 401(k) Plan Section 4.11(c8.9(d) Party Preamble Paying Agent 3.3(a) Payoff Letters 8.16 Permits 5.19 Prohibited Modifications 8.3(a) Recommendation Change 7.3(c)(i) Reimbursement Obligations 8.4(f) Related Party Transaction 5.25 Repaid Indebtedness 8.16 Representatives 7.3(a) Required Amount 6.11(c) Schedule 14D-9 2.1(f) Schedule TO 2.1(f) Share Recitals Stockholder List Date 2.2(a) Surviving Corporation Recitals Takeover Statute 5.3(c) Tax Proceeding 5.16(c)

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iAdditional Termination Fee 6.17(a) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(iiApplicable Anti-Corruption Laws 3.20(c) Antiboycott Arbitration Rules Section 4.22(a9.10(a) Board Recommendation Section 2.2(bAssets 3.14 Bank Letter 4.10(a) Cancelled Company Shares Section 3.7(a)(ii2.7(a)(ii) Capitalization Date 3.6(a) Centre 9.10(a) Certificate of Merger Section 3.2 2.2 Certificates Section 3.8(c2.8(c) Changes Section 1.1 claim 4.11 Closing Section 3.3 2.3 Closing Date Section 3.3 COBRA Section 4.11(d2.3 CMB Escrow Agent Recitals CMB Escrow Agreement Recitals CMB Escrow Amount 6.17(c) Collective Bargaining Agreement 3.18(a) Commitment Letters 4.10(a) Company Preamble Company Board Recommendation Recitals Company Board Recommendation Change 6.5(b) Company Common Stock Recitals Company Escrow Agent Recitals Company Escrow Agreement Recitals Term Section Reference Company Escrow Amount 6.17(a) Company Disclosure Letter Article IV III Company License-In Agreements Section 4.16(gRelated Parties 8.3(b)(iv) Company License-Out Agreements Section 4.16(h) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a3.8 Company Securities 3.6(e) Company Securities Section 4.2(aStockholder Meeting 6.4(a) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company 9.4 Consent 3.5 Continuing Obligations 2.7(d)(ii) D&O Insurance Section 7.8(c6.10(c) Customs Laws Section 4.22(aDB Escrow Agent Recitals DB Escrow Agreement Recitals DB Escrow Amount 6.17(b) debt 4.11 Debt Financing Dispute Section 10.9(a4.10(a) DGCL Recitals Dispute 9.10(a) Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a2.7(c)(i) Effective Time Section 3.2 2.2 Employee Plans 3.17(a) Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(bLimitations 3.2(b) Equity Award or Equity Awards 3.6(b)(v) Equity Commitment Letter 4.10(a) Equity Financing 4.10(a) ERISA Affiliate 3.17(a) Exchange Fund Section 3.8(b2.8(b) Expiration Time Section 2.1(d)(iFinancing 4.10(a) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bFinancing Agreements 6.15(d) Recitals Recitals FINSA 3.5(d) Government Officials 3.20(d) Grant Date 3.6(d) Indemnified Persons Section 7.8(a6.10(a) Inventions Section 1.1 Material Contract Section 4.18(aInternational Employee Plans 3.17(a) Intervening Event Notice 6.5(c)(ii)(C) Joinder Recitals Joint Notice 3.5(d) Leased Real Property 3.13(b) Leases 3.13(b) Lender 4.10(a) Major Customer 3.27(a) Major Supplier 3.27(a) (a) Maximum Annual Premium Section 7.8(c6.10(c) Merger Recitals Term Section Reference Merger Consideration Section 3.7(a)(iRecitals New Plans 6.11(c) Minimum Condition Section 2.1(a)(iOld Plans 6.11(c) Multiemployer Plan Section 4.11(cOwned Real Property 3.13(a) Parent Preamble Payment Agent 2.8(a) Permits 3.19 PRC Overseas Investment Approvals 4.4(e) Proxy Statement 3.30 Representatives 5.2(b) Requisite Stockholder Approval 3.3 Restricted Stock Unit Consideration 2.7(f)(i) Solvent 4.11 Subsidiary Securities 3.7(c) Summitview Affiliate Recitals Superior Proposal Amendment Notice 6.5(c)(i)(C) Superior Proposal Notice 6.5(c)(i)(C) Surviving Corporation 2.1 Taiwan Approvals 4.4(f) (a) Termination Date 8.1(b)(i) Termination Fee 8.3(b)(i) Uncertificated Shares 2.8(c) Unvested Company Option 2.7(d)(ii) Unvested Company SAR 2.7(e)(ii) Unvested Option Consideration 2.7(d)(ii) Unvested Restricted Stock Unit 2.7(f)(ii) Unvested Restricted Stock Unit Consideration 2.7(f)(ii) Unvested SAR Consideration 2.7(e)(ii) Vested Company Option 2.7(d)(i) Vested Company SAR 2.7(e)(i) Vested Option Consideration 2.7(d)(i) Vested Restricted Stock Unit 2.7(f)(i) Vested SAR Consideration 2.7(e)(i)

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto given to them in the respective sections Sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iAdvisor 3.3(b) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(iiBylaws 3.1 Capitalization Date 3.7(a) Certificate of Merger Section 3.2 2.2 Certificates Section 3.8(c2.10(c) Changes Section 1.1 Charter 2.5(a) Chosen Courts 9.10(a) Closing Section 3.3 2.3 Closing Date Section 3.3 COBRA Section 4.11(d2.3 Collective Bargaining Agreement 3.19(a) Company Preamble Company Common Stock Recitals Board Recommendation 3.3(a) Company Board Recommendation Change 5.3(d)(i) Company Disclosure Letter Article IV III Company License-In Agreements Section 4.16(gLiability Limitation 8.3(f)(iii) Company License-Out Agreements Section 4.16(hRelated Parties 8.3(f)(iii) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a3.9 Company Securities 3.7(c) Company Securities Section 4.2(aStockholder Meeting 6.4(a) Company Shares Recitals Termination Fee 8.3(b)(i) Confidentiality Agreement Section 10.4 Current Company 9.4 Consent 3.6 Copyrights 1.1(rr) Covered Severance Plan Employees 6.11(b) Cut-Off Date 5.3(b) D&O Insurance Section 7.8(c) Customs Laws Section 4.22(a6.10(c) Debt Financing Dispute Section 10.9(a6.6(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i2.7(c)(i) EAR Section 4.22(aDSPP Participation Schedule 3.73.7(b) DTC 2.10(d) Effect 1.1(q) Effective Time Section 2.2 Electronic Delivery 9.13 Enforceability Limitations 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(bEquity Commitment Letter Recitals Equity Financing 4.11(a) ERISA Affiliate 3.18(b) Exchange Fund Section 3.8(b2.10(b) Expiration Time Section 2.1(d)(iGo-Shop Period 5.3(a) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b) Guarantor Recitals Guaranty Recitals Indemnified Persons Section 7.8(a6.10(a) Inventions Section 1.1 International Employee Plans 3.18(j) Intervening Event 5.3(e)(i) IP Contracts 3.16(d) Lease 3.14(b) Leased Real Property 3.14(b) Marks 1.1(rr) Material Contract Section 4.18(aCustomer 1.1(vv)(iii) Maximum Annual Premium Section 7.8(c6.10(c) Merger Recitals Merger Consideration Section 3.7(a)(iSub Preamble No-Shop Period Start Date 5.3(a) Minimum Condition Section 2.1(a)(iNotice Period 5.3(e)(ii)(3) Multiemployer Plan Section 4.11(cOther Required Company Filing 6.3(b) Other Required Parent Filing 6.3(c) Owned Company Shares 2.7(a)(iii) Parent Preamble Parent Disclosure Letter Article IV Parent Liability Limitation 8.3(f)(i) Parent Related Parties 8.3(f)(i) Party Preamble Patents 1.1(rr) Payment Agent 2.10(a) Permits 3.20 Per Share Price 2.7(a)(ii) Proxy Statement 6.3(a) Recent SEC Reports Article III Reimbursement Obligations 6.6(f) Representatives 5.3(a) Required Financing Information 6.6(a)(iv) Requisite Stockholder Approval 3.4 Surviving Corporation Article II (a) Termination Date 8.1(c) Uncertificated Shares 2.10(c)

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii401(k) Acquisition Proposal Section 6.2(e)(iPlan 6.11(b) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iAdjusted Restricted Stock 2.8(a) Agreement Preamble Alternative Acquisition Agreement Term Section 6.2(c)(iiReference Antitrust Approval 7.1 Assumed Option 2.8(e) Antiboycott Rules Section 4.22(aAssumed Restricted Stock Unit 2.8(f) Board Recommendation Section 2.2(bBook-Entry Shares 2.9(b) Cancelled Company Shares Section 3.7(a)(ii2.7(b) Capitalization Date 3.4(a) Cash Consideration 2.7(b) Certificate 2.9(b) Certificate of Merger Section 3.2 Certificates Section 3.8(c2.3(a) Changes Section 1.1 Closing Section 3.3 2.2 Closing Date Section 3.3 COBRA Section 4.11(d2.2 Collective Bargaining Agreements 3.16(a) Company Preamble Company Common Stock Recitals Board Recommendation 6.7(a) Company Board Recommendation Change 6.7(a) Company Disclosure Letter Schedule Article IV III Company License-In Agreements Section 4.16(gInsiders 6.14 Company Registered Intellectual Property 3.20(a) Company License-Out Agreements Section 4.16(hRestricted Stock 2.8(a) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a3.6(a) Company Securities Section 4.2(a3.4(c) Company Shares Recitals Stockholder Meeting 6.6(a) Confidentiality Agreement Section 10.4 Current Company 6.9 Consent 3.3(b) Continuing Employees 6.11(d) D&O Insurance Section 7.8(c6.12(b) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(aDelaware Secretary of State 2.3(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a2.7(b) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b2.3(a) Employee Plans 3.15(a) ERISA Affiliate 3.15(a) Exchange Fund Agent 2.9(a) (a) Final Surviving Corporation 2.1(b) First Step Merger Recitals Foreign Employees 3.15(j) In-Licenses 3.20(g) Incentives 3.14(o) (a) Integrated Merger Recitals Interim Surviving Corporation 2.1(a) International Employee Plans 3.15(a) Term Section 3.8(bReference Intervening Event 6.7(b) Expiration Time Section 2.1(d)(iInvestment Company Act 3.11(e) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bIP Licenses 3.20(h) Recitals Recitals Indemnified Persons Section 7.8(aLeased Real Property 3.17 Leases 3.17 Legal Proceeding Matters 6.8(d) Inventions Section 1.1 Material Contract Section 4.18(a3.13(a) Maximum Annual Premium Section 7.8(c6.12(b) Merger Recitals Merger Consideration Section 3.7(a)(i2.7(b) Minimum Condition Section 2.1(a)(iMerger Proposal 6.6(a) Multiemployer Plan Section 4.11(cMerger Sub One Preamble Merger Sub Two Preamble Option Exchange Program 2.8(b) Option Exchange Proposal 2.8(c) Out-Licenses 3.20(h) Paragon 3.24 Parent Preamble Parent Disclosure Schedule Article IV Parent SEC Reports 4.5(a) Permits 3.11(a) Proxy Statement/Prospectus 6.5(a) Qualifying Amendment 6.5(c) Registration Statement 6.5(a) Regulation M-A Filing 6.5(d) Regulatory Filings 3.11(c) Requisite Merger Approval 3.2(c) Requisite Option Exchange Approval 3.2(c) Restricted Stock Units 2.8(b) Reviewable Transaction 8.1(b) RoHS Directive 1.1(y) Second Step Merger Recitals Specified Company Representations 7.2(a) Specified Parent Representations 7.3(a) Stock Consideration 2.7(b) Subsidiary Securities 3.5(d) Tax Opinions 6.18 Termination Date 8.1(b) Termination Fee Amount 8.3(b) Trade Secrets 1.1(hh) Trademarks 1.1(hh)

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii401(k) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iTermination Date 6.13(a) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(iiAppraisal Rights Provisions 2.12(a) Antiboycott Rules Section 4.22(aAssets 3.21 Cash Consideration 2.7(a)(1) Board Recommendation Section 2.2(bCertificates 2.8(a) Cancelled Company Shares Section 3.7(a)(ii) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 Closing Section 3.3 2.3 Closing Date Section 3.3 COBRA Section 4.11(d2.3 Collective Bargaining Agreements 3.19(a) Company Preamble Company Common Stock Recitals Board Recommendation 6.2(a) Company Board Recommendation Change 6.2(b) Company Disclosure Letter Schedule Article IV III Company License-In Agreements Section 4.16(gIntellectual Property 3.22(a) Company License-Out Agreements Section 4.16(hProduct 3.22(a) Company Financial Advisor Section 4.10 Registered Intellectual Property 3.22(b) Company Restricted Stock 2.7(d) Company Rights Plan Recitals Company SEC Reports Section 4.7(a3.6(a) Company Securities Section 4.2(a3.4(c) Company Shares Recitals Special Representations 7.3(a) Company Stockholder Approval 3.3(c) Company Stockholders’ Meeting 6.3 Company Triggering Event 8.1(f)(ii) Confidentiality Agreement Section 10.4 Current Company 6.10 Copyrights 3.22(a)(2) D&O Insurance Section 7.8(c6.14(b) Customs Laws Section 4.22(aDelaware Secretary of State 2.2 Dissenting Shares 2.12(a) Debt Financing Dispute Section 10.9(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(aStockholders 2.12(a) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b2.2 Eligible Company Stock Option 2.7(a)(5) Employee Plans 3.18(a) ERISA Affiliate 3.18(a) Exchange Agent 2.8(a) Exchange Fund 2.8(b) Exclusivity Agreement 6.1(b) First Certificate of Merger 2.2 First Merger 2.1(a) Term Section 3.8(bReference First Merger Surviving Entity 2.1(a) Expiration Time Section 2.1(d)(iForm S-4 6.6(a) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bIn-Licenses 3.22(k) Recitals Recitals Incentives 3.16(m) Indemnified Persons Section 7.8(aParties 6.14(a) Inventions Section 1.1 Intellectual Property Rights 3.22(a) International Employee Plans 3.18(a) IP Licenses 3.22(l) Leased Real Property 3.20(b) Leases 3.20(b) Material Contract Section 4.18(a3.11(a) Maximum Annual Premium Section 7.8(c6.14(b) Merger Recitals 2.1 Merger Communication 6.11(b) Merger Consideration 2.7(a) Merger Sub 1 Preamble Merger Sub 2 Preamble Modified Stock Option 6.12(a)(2) Modified RSU 6.12(a)(2) Open Source License 3.22(a)(4) Open Source Materials 3.22(a)(4) Option Exchange Ratio 2.7(a)(5) Out-Licenses 3.22(l) Parent Preamble Parent Disclosure Schedule Article IV Parent Intellectual Property 4.13(a) Parent Registered Intellectual Property 4.13(b) Parent SEC Reports 4.5 Parent Securities 4.3(c) Parent Special Representations 7.2(a) Patents 3.22(a)(2) Permits 3.13 Proxy Statement 3.8 Registered Intellectual Property 3.22(a)(6) Rollover RSU 6.12(b) Rollover Stock Option 6.12(b) Second Certificate of Merger 2.1(b) Second Merger 2.1(b) Second Merger Surviving Entity 2.1(b) Source Code 3.22(a)(7) Subsidiary Securities 3.2(c) Surviving Entity 2.1(b) Tax Opinions 6.19 Term Section 3.7(a)(iReference Technology 3.22(a)(1) Minimum Condition Section 2.1(a)(iTermination Fee Amount 8.3(b)(1) Multiemployer Plan Section 4.11(cTrade Secrets 3.22(a)(2) Trademarks 3.22(a)(2) Uncertificated Shares 2.8(a)

Additional Definitions. The following capitalized Each of the terms shall have set forth below has the respective meanings ascribed thereto meaning set forth in the respective sections of this Agreement provision set forth opposite each of such term in the capitalized terms belowfollowing table: Term Accounting Firm Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii1.3(d) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) Additional HM Purchaser Recitals Agreement Preamble Alternative Acquisition Agreement Expiration Date Section 6.2(c)(ii9.1(c) Antiboycott Rules Books and Records Section 4.22(a) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(ii) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 6.5 Closing Section 3.3 2.1 Closing Date Section 3.3 COBRA 2.1 Closing Debt Amount Section 4.11(d1.2(a)(i)(B) Company Confidential Information Section 6.4(a) Disputed Item Section 1.3(b) Eagle Preamble Company Common Stock Recitals Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(g) Company License-Out Agreements Section 4.16(h) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a) Company Securities Section 4.2(a) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company D&O Insurance Section 7.8(c) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a) Eagle Parties Preamble Effective Time Section 3.2 Enforceability Exceptions 2.5 Estimated Partnership Cash Section 4.4 Environmental Permits 1.2(a)(i)(A) Estimated Working Capital Section 4.15(b1.2(a)(i)(C) Exchange Fund Final Adjustment Amount Section 3.8(b1.3(a) Final CFO Certificate Section 1.3(a) Final Payment Section 1.3(e) HM Preamble HM Parties Preamble HMSC Put Option Recitals Initial Adjustment Amount Section 1.2(b) Initial Adjustment Statement Section 1.2(a)(i) Initial Purchase Price Section 1.2(b) Losses Section 10.2 Negotiation Period Section 1.3(c) Objection Date Section 1.3(b) Objection Notice Section 1.3(b) Other Tax Proceeding Section 6.7(f) Parent Companies Preamble Parties Preamble Partnership Recitals Partnership Agreement Recitals Purchase Price Section 1.3(g) Purchasers Preamble Purchaser Indemnified Parties Section 10.2 Purchaser Party Release Section 2.3(d) Put Option Agreement Recitals Record Retention Period Section 6.5 -34- Seller[s] Preamble Seller Indemnified Parties Section 10.3 Seller Party Release Section 2.2(c) Subject Partnership Interests Recitals Survival Expiration Time Date Section 2.1(d)(i10.1 Surviving Indemnification Rights Section 6.2 Tax Proceeding Section 6.7(e) Financial Statements Incipio Incipio Merger Agreement Third-Party Claims Section 4.7(b) 10.4 TLCC Partners Recitals Recitals Indemnified Persons Section 7.8(a) Inventions Section 1.1 Material Contract Section 4.18(a) Maximum Annual Premium Section 7.8(c) Merger Recitals Merger Consideration Section 3.7(a)(i) Minimum Condition Section 2.1(a)(i) Multiemployer Plan Section 4.11(c)TLCC Put Option Recitals

Additional Definitions. The In addition, each of the following capitalized terms definitions shall have the respective meanings ascribed thereto set forth in the respective sections of this Agreement set forth opposite each section of the capitalized terms Agreement indicated below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iiiAAA 2.5(b)(iii) Actual 2008 Revenues 2.6(a)(ii) Acquisition Proposal Section 6.2(e)(i6.3(d) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iAffiliated Indebtedness 4.30(a)(iii) Agreement Preamble Alternative Acquisition Recitals Arbitrator 2.5(b)(iii) Assignment of Inventions Agreement Section 6.2(c)(ii6.1(o) Antiboycott Rules Section 4.22(aCash Escrow 2.4(a)(ii) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(ii) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 Closing Section 3.3 2.3 Closing Date Section 3.3 2.3 Closing Date Working Capital 2.5(b)(i) COBRA Section 4.11(dCoverage 4.25(d) Company Preamble Company Common Stock Recitals Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(gTax Returns 4.14(a) Company LicenseRecitals Consulting Agreement 6.1(l) Employment Agreement 6.1(k) Escrow Agent Escrow Agreement Escrow Agent’s Wire Transfer Instructions 2.4(a)(ii) Escrow Agreement 2.4(c) Escrow Shares 2.4(a)(ii) Estimated 2008 Revenues 2.6(a)(i) Final Post-Out Agreements Section 4.16(h) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a) Company Securities Section 4.2(a) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company D&O Insurance Section 7.8(c) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b) Exchange Fund Section 3.8(b) Expiration Time Section 2.1(d)(iClosing Revenue Report 2.6(a)(iii) Financial Statements Incipio Incipio Merger 4.9 Leases 4.21(e) License Agreements 4.22(g) Material Contract(s) 4.12(a) Non-Competition and Non-Solicitation Agreement Section 4.7(b6.1(j) Non-Disclosure Agreement 8.2 Post-Closing Revenue Report 2.6(a)(ii) Products 4.31 Purchase Price 2.2 Purchaser Recitals Recitals Purchaser’s Accountants 2.6(a)(ii) Purchaser Indemnified Persons Section 7.8(a7.3 Reference Balance Sheet Date 4.9 Reference Working Capital 2.5(a) Inventions Section 1.1 Material Contract Section 4.18(aRelease(s) Maximum Annual Premium Section 7.8(c2.4(b)(ii) Merger Revenue Dispute Notice Period 2.6(a)(iii) Revenue Disputed Matters 2.6(a)(iv) Revenue Dispute Resolution Period 2.6(a)(iii) Revenue Notice of Disagreement 2.6(a)(iii) Revenue-Related Adjustment 2.6(a)(v)(A) Revenue-Related Adjustment Reduction 2.6(a)(v)(A) SEC 5.6 Seller and Sellers Recitals Merger Consideration Section 3.7(a)(iSellers’ Accountant 2.5(b)(ii) Minimum Condition Section 2.1(a)(iSellers’ Indemnified Persons 7.4 Sellers’ Representative 2.7(a) Multiemployer Plan Section 4.11(cSeller Wire Transfer Instructions 2.4(a)(i) Share(s)s Recitals Survival Date 7.1(b) Upfront Payment 8.14 Tangible Personal Property 4.23(a) Third Party Claim 7.7 Working Capital Dispute Notice Period 2.5(b)(ii) Working Capital Dispute Resolution Period 2.5(b)(ii) Working Capital Disputed Matters 2.5(b)(iii) Working Capital Notice of Disagreement 2.5(b)(ii)

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto given to them in the respective sections Sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iAdvisor 3.3(a) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii5.3(a) Antiboycott Rules Section 4.22(aAnti-Corruption Laws 3.26(b) Buyer Parties Preamble Bylaws 3.1 Capitalization Date 3.7(a) Cash Replacement Company PSU Amounts 2.11(b)(ii) Cash Replacement Company RSU Amounts 2.11(a)(ii) Cash Replacement Holdings Incentive Unit Amounts 2.11(e)(ii) Cash Replacement Holdings RSU Amounts 2.11(d)(ii) Cash Replacement Option Amounts 2.11(c)(i) Certificates 2.12(c) Charter 2.8(a) Chosen Courts 9.10(a) Class B Per Share Price 2.10(b)(iii) Class C Per Share Price 2.10(b)(iv) Closing 2.6 Closing Date 2.6 Collective Bargaining Agreement 3.19(a) Company Preamble Company Board Recommendation Section 2.2(b3.3(a) Cancelled Company Shares Section 3.7(a)(iiBoard Recommendation Change 5.3(c)(i) Company Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 Closing Section 3.3 Closing Date Section 3.3 COBRA Section 4.11(d2.5(b) Company Preamble Class B Stock Recitals Company Class C Stock Recitals Company Common Stock Recitals Company Disclosure Letter Article IV III Company License-In Agreements Section 4.16(gEquity Awards 3.7(b) Company License-Out Agreements Section 4.16(hLiability Limitation 8.3(e)(ii) Company Financial Advisor Section 4.10 Merger Recitals Company Merger Effective Time 2.5(b) Company Parties Preamble Company Plans 6.11(c) Company Related Parties 8.3(e)(ii) Company SEC Reports Section 4.7(a3.9 Company Securities 3.7(c) Company Securities Section 4.2(aTermination Fee 8.3(b)(i) Company Shares Recitals Comparable Plans 6.11(c) Confidentiality Agreement Section 10.4 Current Company 9.4 Consent 3.6 Continuation Period 6.11(c) Copyrights 1.1(bbb) D&O Insurance Section 7.8(c) Customs Laws Section 4.22(a6.10(c) Debt Financing Dispute Section 10.9(a6.6(a)(i) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i2.10(d)(i) EAR Section 4.22(aDLLCA Recitals DPA 3.26(g) Effective Time Section DTC 2.12(d) DTC Payment 2.12(d) Effect 1.1(s) Electronic Delivery 9.13 Employee Plan 3.18(a) Enforceability Limitations 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(bePrivacy Directive 1.1(ee) Equity Commitment Letter Recitals Equity Financing 4.11(a) ERISA Affiliate 3.18(a) ESPP 2.11(h) Exchange Fund Section 3.8(b2.12(b) Expiration Date 2.1(c) Extension Deadline 2.1(d)(iii) GDPR 1.1(ee) Guarantor Recitals Guaranty Recitals Holdings Preamble Holdings Certificate of Merger 2.5(a) Holdings LLCA 3.1 Holdings Merger Recitals Holdings Merger Effective Time Section 2.1(d)(i2.5(a) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b) Recitals Recitals Indemnified Persons Section 7.8(a6.10(a) Inventions Section 1.1 Initial Expiration Date 2.1(c) International Employee Plans 3.18(a) Intervening Event 5.3(d)(i) IP Contracts 3.16(f) Lease 3.14(b) Leased Real Property 3.14(b) LLC Agreement 2.8(d) Marks 1.1(bbb) Material Contract Section 4.18(aRelationships 1.1(fff)(v) Maximum Annual Premium Section 7.8(c6.10(c) Merger Mergers Recitals Merger Consideration Section 3.7(a)(i) Sub I Preamble Merger Sub II Preamble Minimum Condition Section 2.1(a)(iANNEX I New Plans 6.11(d) Multiemployer Plan Section 4.11(cNotice Period 5.3(d)(ii)(3) Offer Recitals Offer Acceptance Consideration 2.2(a)(iii) Offer Acceptance Time 2.2(a)(iii) Offer Commencement Date 2.1(c) Offer Conditions 2.1(b)(i) Offer Documents 2.1(f)(i) Offer Prices Recitals Offer to Purchase 2.1(f)(i) Offering Period 2.11(h) Old Plans 6.11(d) Original Agreement Recitals Other Required Company Filing 6.3(a) Other Required Parent Filing 6.3(b) Owned Company Share 2.10(b)(v) Owned Holdings Unit 2.10(a)(iii) Parent Disclosure Letter Article IV Parent Entities Preamble Parent Liability Limitation 8.3(e)(i) Parent Related Parties 8.3(e)(i) Party Preamble Patents 1.1(bbb) Payment Agent 2.12(a) Per Share Price 2.10(b)(ii) Per Unit Price 2.10(a)(ii) Permits 3.20 Recent SEC Reports Article III Reimbursement Obligations 6.6(g) Representatives 5.3(a) Schedule 14D-9 2.2(b)(i) Schedule TO 2.1(f)(i) Special Majority Condition ANNEX I Stockholder List Date 2.3 Sublease 3.14(c) Surviving Corporation 2.4(b) Surviving Entities 2.4(b) Surviving LLC 2.4(a) Tax Returns 3.17(a) Tender Agreements Recitals Termination Date 8.1(c) Trade Control Laws 3.26(a) Uncertificated Shares 2.12(c) Uncertificated Units 2.12(c) Unvested Company Option 2.11(c)(i) Unvested Company PSUs 2.11(b)(ii) Unvested Company RSU 2.11(a)(ii) Unvested Holdings Incentive Unit 2.11(e)(ii) Unvested Holdings RSU 2.11(d)(ii) Vested Company PSU Consideration 2.11(b)(i) Vested Company RSU Consideration 2.11(a)(i) Vested Company Option Consideration 2.11(c)(i) Vested Holdings Incentive Unit Consideration 2.11(e)(i) Vested Holdings RSU Consideration 2.11(d)(i)

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto given to them in the respective sections Sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii$ 1.3(e) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iEntity Recitals Advisor 3.3(b) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii5.5(a) Antiboycott Rules Section 4.22(aBylaws 2.3(b) Board Recommendation Section 2.2(bCapitalization Date 3.7(a) Cancelled Company Shares Section 3.7(a)(iiCash Consideration Recitals CCC 4.35(a) Certificate of Merger Section 3.2 Certificates Section 3.8(cCFPOA 4.35(a) Changes Section 1.1 Charter 2.3(a) Chosen Courts 9.10 Closing Section 3.3 2.2 Closing Date Section 3.3 COBRA Section 4.11(d2.2 Collective Bargaining Agreement 3.19(a) Company Preamble Company Common Stock Recitals Board Recommendation 3.3(a) Company Board Recommendation Change 5.5(c)(i) Company Disclosure Letter Article IV III Company License-In Agreements Section 4.16(gEmployee Plans 3.18(a) Company License-Out Agreements Section 4.16(hIP Contracts 3.16(c) Company Financial Advisor Section 4.10 Lease 3.14(a) Company Leased Real Property 3.14(a) Company Material Customer 3.30(a) Company Material Supplier 3.30(b) Company Related Parties 8.3(f)(ii) Company SEC Reports Section 4.7(a3.9 Company Securities 3.7(c) Company Securities Section 4.2(aStockholder Meeting 6.4(a) Company Shares Recitals Termination Fee 8.3(b)(i) Company Transaction Documents 3.2 Confidentiality Agreement Section 10.4 Current Company 9.4 Consent 3.6 D&O Insurance Section 7.8(c6.9(c) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(aDerivative Security 2.1(b)(ii) DGCL 2.3(a) Electronic Delivery 9.14 Enforceability Limitations 3.2 Financing Recitals Dissenting Company Shares Section 3.7(c)(iHoldings Recitals Holdings Employee Plans 4.29(a) EAR Section 4.22(aHoldings IP Contracts 4.27(c) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(bHoldings Lease 4.25(a) Exchange Fund Section 3.8(bHoldings Leased Real Property 4.25(a) Expiration Time Section 2.1(d)(iHoldings Securities 4.20(b) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b) Recitals Recitals Indemnified Persons Section 7.8(a6.9(a) Inventions Section 1.1 Material Contract Section 4.18(aIndigo Recitals Information Statement 6.3(a) Intervening Event 5.5(d)(i) Maximum Annual Premium Section 7.8(c6.9(c) Merger Net Working Capital Shortfall 6.25(a) Net Working Capital Statement 6.25(a) Notice Period 5.5(d)(ii)(C) Other Party 8.3(e) Parent Preamble Parent Disclosure Letter Article IV Parent Material Customer 4.38(a) Parent Material Supplier 4.38(b) Parent Related Parties 8.3(f)(i) Parent Termination Fee 8.3(c)(i) Parent Termination Fee Event 8.3(c)(i) Party Preamble Payor 8.3(e) Permits 3.20 Proxy Statement 6.3(a) Purchased Shares 2.1(b)(i) Recent SEC Reports Article III Reimbursement Obligations 6.6(f) Representatives 5.5(a) Requisite Stockholder Approvals 3.4 SEC Clearance Date 6.3(d) Share Amount 2.1(b)(iv) SpinCo Recitals Merger Consideration Section 3.7(a)(iSpin-Off Recitals Spin-Off Registration Statement 6.18(a) Minimum Condition Section 2.1(a)(iStockholders’ Agreement Recitals Tangible Company Assets 3.14(b) Multiemployer Plan Section 4.11(c)Tangible Holdings Assets 4.25(b) Tax Returns 3.17(a) Termination Date 8.1(c) Transactions Recitals V7 Recitals Voting Agreement Recitals Voting Matters Recitals WARN Act 3.19(c) WAS Recitals

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto to such terms in the respective sections following Sections of this Agreement set forth opposite each of the capitalized terms below: Term Agreement. Call Option Notice Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii10.2(b) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(ii) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 Closing Section 3.3 Call Right Closing Date Section 3.3 COBRA 10.2(b) Capital Contribution Default Section 4.11(d4.1(d) Capital Note Section 4.1(d)(ii) CB Acceptance Notice Section 10.6(b) CB Member Section 10.6(a) CB Notice Period Section 10.6(a) CB Offer Section 10.6(a) CB Offer Notice Section 10.6(a) CB Units Section 10.6(a) Certificate Section 2.2 Class A Managers Section 5.1(b)(i)(A) Class A Member Call Option Section 10.2(a) Class B Default Section 10.4 Class B Managers Section 5.1(b)(i)(B) Committee(s) Section 5.5 Company Preamble Company Common Stock Recitals Company Disclosure Letter Article IV Company License-In Agreements Sale Notice Section 4.16(g10.7(c) Company LicenseTax Liability Section 7.11(e) Confidential Information Section 2.10 Drag-Out Agreements Along Sale Section 4.16(h10.1(a) Company Financial Advisor Dragged Members Section 4.10 Company SEC Reports Section 4.7(a) Company Securities Section 4.2(a) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company D&O Insurance Section 7.8(c) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a9.1(a) Effective Time Date Preamble Exercising Member Section 3.2 Enforceability Exceptions 6.1(d)(iv) Indemnitee Section 4.4 Environmental Permits 11.3(a) Initial Class A Contribution Section 4.15(b4.1(a) Exchange Fund Initial Class B Contribution Section 3.8(b4.1(b) Expiration Time Offer Election Period Section 2.1(d)(i10.6(a) Financial Statements Incipio Incipio Merger Agreement Offered Units Section 4.7(b5.1(c) Recitals Recitals Indemnified Persons Offering Member Section 7.8(a6.1(c) Inventions Offering Member Notice Section 1.1 Material Contract 6.1(c)(i) Officer(s) Section 4.18(a5.6 Option Units Section 10.2(a) Maximum Annual Premium Partnership Representative Section 7.8(c7.11(a) Merger Recitals Merger Consideration Pass-Thru Member Section 3.7(a)(i7.11(d) Minimum Condition Permitted Transfer Section 2.1(a)(i6.1(a) Multiemployer Plan Permitted Transferee Section 4.11(c6.1(b) Proposed Purchaser Section 6.1(d)(i) Purchase Offer Section 10.7(a) Purchasing Member Section 6.1(c)(iv) ROFO Section 6.1(c) ROFO Acceptance Notice Section 6.1 (c)(iv) ROFO Notice Period Section 6.1(c)(ii) ROFR Section 6.1(d) ROFR Acceptance Notice Section 6.1(d)(iv) ROFR Notice Period Section 6.1(d)(ii) Sale Election Notice Section 10.7(a) Sale Election Period Section 10.7(a) Sale Process Section 10.7(a) Sale Right Section 10.7(a) Subject Units Section 6.1(d) Subsequent Capital Contribution Section 4.1(d) Tax Distributions Section 7.10 Tax Matters Member Section 7.11(a) Tax Matters Partner Section 7.11(a) Tax Proceeding Section 7.11(c)(ii) Transfer Notice Section 6.1(d)(i) Transferring Member Section 7.1(d) Waived ROFO Transfer Period Section 6.1(c)(v) Waived ROFR Transfer Period Section 6.1(d)(v)

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto given to them in the respective sections Sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iAdditional Stockholder Approval 3.4 Advisor 3.3(a) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii5.3(a) Antiboycott Rules Section 4.22(aAnti-Corruption Laws 3.26(b) Board Recommendation Section 2.2(bBuyer Parties Preamble Bylaws 3.1 Capitalization Date 3.7(a) Cancelled Cash Replacement Company Shares Section 3.7(a)(iiPSU Amounts 2.8(b)(ii) Certificate of Merger Section 3.2 Cash Replacement Company RSU Amounts 2.8(a)(ii) Cash Replacement Holdings Incentive Unit Amounts 2.8(e)(ii) Cash Replacement Holdings RSU Amounts 2.8(d)(ii) Cash Replacement Option Amounts 2.8(c)(i) Certificates Section 3.8(c2.9(c) Changes Section 1.1 Charter 2.5(a) Chosen Courts 9.10(a) Class B Per Share Price 2.7(b)(iii) Class C Per Share Price 2.7(b)(iv) Closing Section 3.3 2.3 Closing Date Section 3.3 COBRA Section 4.11(d2.3 Collective Bargaining Agreement 3.19(a) Company Preamble Company Common Stock Recitals Board Recommendation 3.3(a) Company Board Recommendation Change 5.3(c)(i) Company Certificate of Merger 2.2(b) Company Disclosure Letter Article IV III Company License-In Agreements Section 4.16(gEquity Awards 3.7(b) Company License-Out Agreements Section 4.16(hLiability Limitation 8.3(e)(ii) Company Financial Advisor Section 4.10 Merger Recitals Company Merger Effective Time 2.2(b) Company Parties Preamble Company Plans 6.11(c) Company Related Parties 8.3(e)(ii) Company SEC Reports Section 4.7(a3.9 Company Securities 3.7(c) Company Securities Section 4.2(aStockholder Meeting 6.4(a) Company Shares Recitals Termination Fee 8.3(b)(i) Comparable Plans 6.11(c) Confidentiality Agreement Section 10.4 Current Company 9.4 Consent 3.6 Continuation Period 6.11(c) Copyrights 1.1(eee) D&O Insurance Section 7.8(c) Customs Laws Section 4.22(a6.10(c) Debt Financing Dispute Section 10.9(a6.6(a)(i) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i2.7(d)(i) EAR Section 4.22(aDLLCA Recitals DPA 3.26(g) Effective Time Section DTC 2.9(d) DTC Payment 2.9(d) Effect 1.1(v) Electronic Delivery 9.13 Employee Plans 3.18(a) Enforceability Limitations 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(bePrivacy Directive 1.1(hh) Equity Commitment Letter Recitals Equity Financing 4.11(a) ERISA Affiliate 3.18(a) ESPP 2.8(h) Exchange Fund Section 3.8(b2.9(b) Expiration Time Section 2.1(d)(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b) Recitals Recitals Indemnified Persons Section 7.8(a) Inventions Section 1.1 Material Contract Section 4.18(a) Maximum Annual Premium Section 7.8(c) Merger Recitals Merger Consideration Section 3.7(a)(i) Minimum Condition Section 2.1(a)(i) Multiemployer Plan Section 4.11(cGDPR 1.1(hh)

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term 102 Amounts Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i2.8(d)(i) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii5.3(b) Antiboycott Rules Approval Section 4.22(a) Board Recommendation 3.5 Assignee Section 2.2(b) Cancelled Company 10.3 Book-Entry Shares Section 3.7(a)(ii2.8(c)(ii) Buyer Recitals Capitalization Date Section 3.6(a) Certificate of Merger Section 3.2 2.3 Certificates Section 3.8(c2.8(c) Changes Charter Documents Section 1.1 3.1 Closing Section 3.3 2.2 Closing Date Section 3.3 COBRA 2.2 Code Section 4.11(d2.8(f) Collective Bargaining Agreement Section 3.17(a) Companies Registrar Section 2.3 Company Preamble Company Common Stock Recitals 102 Options Section 2.8(d)(i) Company 102 PSUs Section 2.8(d)(i) Company 1▇▇ ▇▇▇▇ Section 2.8(d)(i) Company 102 Securities Section 2.8(d)(i) Company 102 Shares Section 2.8(b) Company Board Recommendation Section 7.3(a) Company Board Recommendation Change Section 5.3(b) Company Designated Directors Section 6.5 Company Disclosure Letter Article IV III Company License-In Agreements Plans Section 4.16(g6.2(c) Company License-Out Agreements Section 4.16(h) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a3.8(a) Company Securities Section 4.2(a3.6(b) Company Shareholder Approval Section 3.2 Company Shareholders Meeting Section 7.3(a) Company Shares Recitals Section 2.7(a) Confidentiality Agreement Section 10.4 Current Company 7.8 consolidated financial statements Section 3.9(a) Copyrights Section 1.1 D&O Insurance Section 7.8(c6.1(c) Customs Laws Designs Section 4.22(a) Debt Financing Dispute Section 10.9(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a) 1.1 Effective Time Section 3.2 Enforceability Exceptions 2.3 Employee Plans Section 4.4 Environmental Permits Section 4.15(b3.16(a) Exchange Fund Section 3.8(b2.8(b) Expiration Time FCPA Section 2.1(d)(i3.19(b) Financial Statements Incipio Incipio Merger Agreement FDA Section 4.7(b3.19(c) Recitals IAA Section 7.2(a) ICL Recitals Indemnified Persons Section 7.8(a6.1(a) Information Agent Section 2.8(a) Interim Option Tax Ruling Section 7.9(a) Intervening Event Recommendation Change Notice Section 5.3(d) Inventions Section 1.1 Israeli Employee Section 3.17(d) Israeli Employees Section 3.17(d) IT Systems Section 3.14(i) ITA Section 2.8(f) Joint Venture Interests Section 3.7(f) Leased Real Property Section 3.13(b) Leases Section 3.13(b) Letter of Transmittal Section 2.8(c) Material Contract Section 4.18(a3.12 Material Employee Plans Section 3.16(a) Maximum Annual Premium Section 7.8(c6.1(c) Merger Recitals Merger Consideration Section 3.7(a)(i2.7(a) Minimum Condition Merger Proposal Section 2.1(a)(i7.4(a) Multiemployer Merger Sub Preamble Notice Date Section 7.3(a) OECD Convention Section 3.19(b) Option Consideration Section 2.7(c) Options Tax Ruling Section 7.9(a) Outside Date Section 9.1(c) Parent Preamble Parent Plans Section 6.2(c) Patents Section 1.1 Paying Agent Section 2.8(a) Permits Section 3.18(a) Prohibited Payment Section 3.19(b) Proxy Statement Section 7.3(a) PSUs Consideration Section 2.7(d) Recommendation Change Notice Section 5.3(d) Registered Intellectual Property Section 3.14(a) Related Party Section 3.23 Reporting Tail Endorsement Section 6.1(c) RSUs Consideration Section 2.7(d)(i) Section 102 Plan Section 4.11(c)3.16(g) Subsidiary Securities Section 3.7(d) Surviving Company Section 2.1 Tax Returns Section 3.15(a) Termination Fee Section 9.3(b)(i) Trade Control Laws Section 3.19(d) Trade Secrets Section 1.1 Trademarks Section 1.1 Transition Period SEC Report Section 7.10(b) Uncertificated Shares Section 2.8(c)(ii) Withholding Drop Date Section 2.8(f) Withholding Tax Ruling Section 7.9(b) Works of Authorship Section 1.1

Additional Definitions. The following capitalized terms used in this Agreement shall have the respective meanings ascribed thereto assigned in the respective sections of this Agreement set forth opposite each of the capitalized terms belowAgreement: EXHIBIT 10.1 FOIA Confidential Treatment Requested Execution Version Term Defined In Acquiring Party Section Reference Acceptable Confidentiality 8.1(d) Alternative Use Section 6.5(c)(i) Amendment No. 4 to Patent Cross License Agreement Section 6.2(e)(iii2.1(c)(iii) Acquisition Proposal Appointing Party Section 6.2(e)(i6.9(b)(i) Acquisition Sub Preamble Adverse Recommendation Change [*] Section 6.2(c)(i6.5(c)(ii)(B) Agreement Preamble Alternative Acquisition Closing Section 2.1(a) Committee Representatives Section 6.9(b)(i) Common R&D Agreement Section 6.2(c)(ii2.1(c)(i) Antiboycott Rules Common R&D Development Expenses Section 4.22(a6.8(a)(i) Board Recommendation Costs Section 2.2(b6.5(c)(i) Cancelled Company Shares Cross License Agreement Section 3.7(a)(ii2.1(c)(iii) Certificate of Merger Defaulting Party Section 3.2 Certificates 6.12(d) EC Party/Excess Capacity Party Section 3.8(c6.7(b)(i) Changes Embedded NAND Product Section 1.1 Closing 6.7(c)(ii) Employer Section 3.3 Closing 6.10(b)(vii) Engineers Section 6.10 Environmental Indemnification Agreement Section 2.1(b)(vii) Equipment Section 6.5(c)(i) Evaluation Wafers Section 6.8(a)(iii) Financing Section 6.12(b)(iii) Flash Alliance Section 2.1(b) FA Foundry Agreement Section 2.1(b)(iv) FA Operating Agreement Section 2.1(b)(ii) FA Operative Documents Section 2.1(b) FA Patent Indemnification Agreement Section 2.1(b)(vi) FA Termination Date Section 3.3 COBRA Section 4.11(d8.1(b) Company Preamble Company Common Stock Recitals Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(g) Company License-Out Agreements Section 4.16(h) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a) Company Securities FA Shares Section 4.2(a) Company Shares FP Master Agreement Recitals Confidentiality FP NAND Flash Memory Products Section 3.3(a) FVC Japan Master Agreement Recitals FVC Japan NAND Flash Memory Products Section 3.3(a) Headcount Plan Section 6.10 * Indicates that certain information contained herein has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. EXHIBIT 10.1 FOIA Confidential Treatment Requested Execution Version Term Defined In ICs Section 3.2 Intellectual Property Section 4.7 Investing Party Section 6.5(c)(i) Joint Operative Documents Section 2.1(c) Lease Agreement Section 10.4 Current Company D&O Insurance 2.1(b)(viii) Management Committee Section 7.8(c6.9 Minimum RUP Commitment Section 6.5(c)(i) Customs Laws Master Operative Documents Section 4.22(a) Debt Financing Dispute 2.2 NAND Flash Memory Integrated Circuits Section 10.9(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a) Effective Time 6.13 NAND Flash Memory Products Section 3.2 Enforceability Exceptions NAND Process Technology Section 4.4 Environmental Permits 6.3(a) Non-Defaulting Party Section 4.15(b6.12(d) Exchange Fund Non-Investing Party Section 3.8(b6.5(c)(i) Expiration Time Non-Originating Party Section 2.1(d)(i6.7(e) Financial Statements Incipio Incipio Merger Originating Party Section 6.7(e) Parties Heading Product Development Agreement Section 4.7(b2.1(c)(ii) Recitals Recitals Indemnified Persons Proprietary NAND Flash Memory Products Section 7.8(a6.7(d) Inventions Purchase and Supply Agreements Section 1.1 Material Contract 2.1(b)(v) Qualification Wafers Section 4.18(a6.8(a)(iv) Maximum Annual Premium Section 7.8(c) Merger Recitals Merger Consideration Section 3.7(a)(i) Minimum Condition Section 2.1(a)(i) Multiemployer Ramp-Up Plan Section 4.11(c6.5(b) Remaining Y4 Personnel Section 8.1(j) Requesting Party Section 8.1(d)(i) [*] Section 6.5(c)(ii) [*] Section __ SanDisk Heading SanDisk Corporation Heading SanDisk Financing Section 6.12(b)(iii) SanDisk Ireland Heading SanDisk Purchase and Supply Agreement Section 2.1(b)(v) SanDisk Team Section__ SanDisk Termination Capacity Section 8.1(e)(i) Selling Party Section 8.1(d) * Indicates that certain information contained herein has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions. EXHIBIT 10.1 FOIA Confidential Treatment Requested Execution Version Term Defined In Share Purchase Agreement Section 2.1(b)(i)

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto given to them in the respective sections Sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iAdvisor 3.3(b) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii5.3(a) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(iiBylaws 3.1 Capitalization Date 3.7(a) Certificate of Merger Section 3.2 2.2 Certificates Section 3.8(c2.9(c) Changes Section 1.1 Charter 2.5(a) Chosen Courts 9.10(a) Closing Section 3.3 2.3 Closing Date Section 3.3 COBRA Section 4.11(d2.3 Collective Bargaining Agreement 3.19(a) Company Preamble Company Common Stock Recitals Board Recommendation 3.3(a) Company Board Recommendation Change 5.3(c)(i) Company Disclosure Letter Article IV III Company License-In Agreements Section 4.16(gLiability Limitation 8.3(e)(ii) Company License-Out Agreements Section 4.16(hPlans 6.11(c) Company Financial Advisor Section 4.10 Related Parties 8.3(e)(ii) Company SEC Reports Section 4.7(a3.9 Company Securities 3.7(c) Company Securities Section 4.2(aStock-Based Award Consideration 2.8(a) Company Shares Recitals Stockholder Meeting 6.4(a) Company Termination Fee 8.3(b)(i) Comparable Plans 6.11(c) Confidentiality Agreement Section 10.4 Current Company D&O Insurance Section 7.8(c) Customs Laws Section 4.22(a9.4 Consent 3.6 Copyrights 1.1(hh) Debt Financing Dispute Section 10.9(a6.6(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i2.7(c)(i) EAR Section 4.22(aD&O Insurance 6.10(c) DTC 2.9(d) Effect 1.1(m) Effective Time Section 2.2 Electronic Delivery 9.13 Employee Plans 3.18(a) Enforceability Limitations 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(bEquity Commitment Letter 4.11(a) Equity Financing 4.11(a) ERISA Affiliate 3.18(a) ESPP 2.8(e) Exchange Fund Section 3.8(b2.9(b) Expiration Time Section 2.1(d)(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b) Guarantor Recitals Guaranty Recitals Indemnified Persons Section 7.8(a6.10(a) Inventions Section 1.1 International Employee Plans 3.18(a) Intervening Event 5.3(d)(i) IP Contracts 3.16(e) Lease 3.14(b) Leased Real Property 3.14(b) Marks 1.1(hh) Material Contract Section 4.18(aCustomers 1.1(mm)(iii) Maximum Annual Premium Section 7.8(c6.10(c) Merger Recitals Merger Sub Preamble New Plans 6.11(d) Notice Period 5.3(d)(ii)(3) Old Plans 6.11(d) Option Consideration Section 3.7(a)(i2.8(b) Minimum Condition Section 2.1(a)(iOther Required Company Filing 6.3(b) Multiemployer Plan Section 4.11(cOther Required Parent Filing 6.3(c) Owned Company Shares 2.7(a)(iii) Parent Preamble Parent Disclosure Letter Article IV Parent Liability Limitation 8.3(e)(i) Parent Related Parties 8.3(e)(i) Party Preamble Patents 1.1(hh) Payment Agent 2.9(a) Permits 3.20 Per Share Price 2.7(a)(ii) Proxy Statement 6.3(a) Recent SEC Reports Article III Reimbursement Obligations 6.6(f) Representatives 5.3(a) Required Financing Information 6.6(a)(iv) Requisite Stockholder Approval 3.4 Sublease 3.14(c) Surviving Corporation Article II Tax Returns 3.17(a) Trade Control Laws 3.26(a)(i) Termination Date 8.1(c)

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto given to them in the respective sections Sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iA-CAM 3.28(f) Agreement Preamble Alternate Debt Financing 6.5(d) Alternative Acquisition Agreement Section 6.2(c)(ii5.3(b) Antiboycott Rules Section 4.22(aBurdensome Condition 6.2(d) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(iiBylaws 3.1 Capitalization Date 3.7(a) Certificate of Merger Section 3.2 2.2 Certificates Section 3.8(c2.9(c) Changes Section 1.1 Charter 2.5(a) Chosen Courts 9.10(a) Closing Section 3.3 2.3 Closing Date Section 3.3 COBRA Section 4.11(d2.3 Collective Bargaining Agreement 3.20(a) Company Preamble Company Common Stock Board Recitals Company Board Recommendation 3.3(a) Company Board Recommendation Change 5.3(d)(i) Company Disclosure Letter Article IV III Company License-In Agreements Section 4.16(gRelated Parties 8.3(f)(ii) Company License-Out Agreements Section 4.16(hRSU Consideration 2.8(a) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a3.9(a) Company Securities Section 4.2(a3.7(c) Company Shares Recitals Stockholder Meeting 6.4(a) Company Subsidiaries 3.8(a) Comparable Plans 6.11(c) Confidentiality Agreement Section 10.4 Current Company 9.4 Consent 3.6 Continuation Period 6.11(c) Copyrights 1.1(oo) Cut-Off Date 5.3(b) D&O Insurance Section 7.8(c6.10(c) Customs Laws Section 4.22(aDebt Commitment Letters 4.11(a) Debt Financing Dispute Section 10.9(a4.11(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i2.7(c)(i) EAR Section 4.22(aDTC 2.9(d) Effect 1.1(p) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b2.2 Electronic Delivery 9.14 Employee Plans 3.19(a) Exchange Fund Section 3.8(bEquity Commitment Letter 4.11(a) Expiration Time Section 2.1(d)(iEquity Financing 4.11(a) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bERISA Affiliate 3.19(b) Existing Indemnification Agreements 6.10(a) FCC Consents 3.6 FCC Submissions 6.2(a) Fee Letter 4.11(a) Financing 4.11(a) Financing Letters 4.11(a) Guarantee Recitals Guarantors Recitals Indemnified Persons Section 7.8(aPerson 6.10(a) Inventions Section 1.1 Insurance Policies 3.24 Lease 3.15(b) Leased Real Property 3.15(b) Legal Restraint 7.1(c) Licenses 3.21 Local Consents 3.6 Localities 3.6 Marks 1.1(oo) Material Contract Section 4.18(a) Customers 3.14 Material Suppliers 3.14 Maximum Annual Premium Section 7.8(c6.10(c) Merger Recitals Merger Sub Preamble Network Facilities Maps 3.30(a) New Debt Commitment Letters 6.5(d) New Plans 6.11(d) No-Shop Period Start Date 5.3(a) Notice Period 5.3(e)(i)(3) Old Plans 6.11(d) Opinion Provider 3.3(b) Option Consideration Section 3.7(a)(i2.8(b) Minimum Condition Section 2.1(a)(iOther Required Company Filing 6.3(b) Multiemployer Plan Section Owned Company Shares 2.7(a)(iii) Owned Real Property 3.15(a) Parent Preamble Parent Related Parties 8.3(f)(i) Party Preamble Patents 1.1(oo) Paying Agent 2.9(a) Payment Fund 2.9(b) Per Share Price 2.7(a)(ii) Proxy Statement 6.3(a) PSC Consents 3.6 PSC Submissions 6.2(a) Recent SEC Reports III Reimbursement Obligations 6.6(f) Related Person Contract 3.25 Remedy Actions 6.2(d) Required Amount 4.11(c) Required Financial Information 6.6(a)(ix) Requisite Stockholder Approval 3.4 Sublease 3.15(b) Surviving Corporation 2.1 Termination Date 8.1(c) Uncertificated Shares 2.9(c) USF HCL 3.28(f) Voting Agreement Recitals WARN Act 3.20(f)

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(iiAML 6.2(a) Antiboycott Rules Section 4.22(aAssets 3.14 Assumed Options 2.7(d)(i) Board Recommendation Section 2.2(bBalance Sheet Date 3.10(a) Cancelled Company Shares Section 3.7(a)(iiCertificates 2.8(c) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 2.2 Closing Section 3.3 2.3 Closing Date Section 3.3 COBRA Section 4.11(d2.3 Collective Bargaining Agreement 3.18(a) Company Preamble Company Common Stock Recitals Acquisition Agreement 5.2(a) Company Board Recommendation 3.1(b) Company Disclosure Letter Article IV Art. III Company License-In Agreements Section 4.16(gFinancial Statements 3.9(a) Company License-Out Intellectual Property Agreements Section 4.16(h3.15(b) Company Financial Advisor Section 4.10 Rights Plan Recitals 8 Table of Contents Company SEC Reports Section 4.7(a3.8 Company Securities 3.7(c) Company Securities Section 4.2(a) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company Stockholder Meeting 5.4 Consent 3.4 D&O Insurance Section 7.8(c6.7(c) Customs Laws Section 4.22(aDeferred Compensation Plan 2.7(e)(v) Debt Financing Dispute Section 10.9(aDelaware Secretary of State 2.2 Designated Open Source 3.15(k) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a2.7(c)(i) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b2.2 Employee Plans 3.17(a) ERISA Affiliate 3.17(a) Exchange Fund Section 3.8(b2.8(b) Expiration Time Section 2.1(d)(iExchange Ratio 2.7(d)(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bFunded International Employee Plan 3.17(i)(ii) Recitals Recitals ▇▇▇▇▇▇▇▇ ▇▇▇ 3.5 Hangzhou Queenhive 3.5 Incentives 3.16(n) Indemnified Persons Section 7.8(a6.7(a) Inventions Section 1.1 Material Contract Section 4.18(aInternational Employee Plans 3.17(a) Intervening Event 5.3(a)(ii) Leased Real Property 3.13(b) Leases 3.13(b) (a) Maximum Annual Premium Section 7.8(c6.7(c) Merger 2.1 Merger Sub Preamble Option Consideration 2.7(d)(ii) Other Required Company Filings 3.29 Out of the Money Options 2.7(d)(i) Owned Company Common Stock 2.7(a)(ii) Owned Real Property 3.13(a) Parent Preamble Parent Stock 2.7(d)(i) Parent’s 401(k) Plan 2.7(e)(iv) (a) Per Share Price 2.7(a)(i) Permits 3.19 Proxy Statement 3.29 Public Grants 3.30 Recommendation Change 5.3(a) Representatives 5.2(a) Requisite Stockholder Approval 3.2 Table of Contents Rights Plan Amendment Recitals Merger Share Consideration Section 3.7(a)(i2.7(a)(i) Minimum Condition Section 2.1(a)(iSubsidiary Securities 3.6(d) Multiemployer Surviving Corporation 2.1 Tax Returns 3.16(a) Terminating Plan Section 4.11(c2.7(e) Termination Date 8.1(b) Transaction Expenses 8.3(b)(v) Unassumed Options 2.7(d)(ii) Unvested Options 2.7(d)(i)

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii2009-2010 PARI R&D Grant 7.3 Accounting Firm 2.10(d) Acquisition Proposal Section 6.2(e)(iAccounting Report 2.10(a) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iAgreed Adjustments 2.10(c) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(iiAppraiser 2.5(c) Antiboycott Rules Section 4.22(aAssumed Claims 2.3(b) Board Recommendation Section 2.2(bAssumed Liability 2.3 Assumed Liabilities 2.3 Business Financial Statements 3.5 Buyer Preamble Buying Entity 2.5(c) Cancelled Company Shares Section 3.7(a)(iiBuying Entities 2.5(c) Certificate of Merger Section 3.2 Certificates Section 3.8(cBuyer Indemnified Parties 11.1 Cash Portion 2.5(a) Changes Section 1.1 Closing Section 3.3 2.8(a) Closing Date Section 3.3 COBRA Section 4.11(d2.8(a) Company Preamble Company Common Stock Recitals Company Disclosure Letter Article IV Company License-In Collective Bargaining Agreements Section 4.16(g3.14(a) Company License-Out Agreements Section 4.16(h) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a) Company Securities Section 4.2(a) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company D&O Insurance Section 7.8(c6.4(a) Customs Laws Section 4.22(aConsent 3.3(b) Debt Financing Dispute Section 10.9(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(iNotice 2.10(b) EAR Section 4.22(a3.8(a) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b2.8(c) Exchange Fund Section 3.8(b) Expiration Time Section 2.1(d)(iEscrow Agreement Recitals Excluded Asset 2.2 Excluded Assets 2.2 Excluded Liabilities 2.4 Excluded Liability 2.4 FAR 3.20(a) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bSchedules Date 2.1(a) Recitals Recitals Incentives 3.12(n) Indemnified Persons Section 7.8(aParties 11.2 Indemnity Basket 11.3(b) Inventions Section 1.1 In-Licenses 3.18(h) IP-Licenses 3.18(i) ITAR 3.8(a) Leased Real Property 3.15(b) Leases 3.15(b) Material Contract Section 4.18(a3.11(a) Maximum Annual Premium Section 7.8(cMaterial In-Licenses 3.18(h) Merger Material IP-Licenses 3.18(i) Material Out-Licenses 3.18(i) Montreal Business 1.1(d) Montreal Business Financial Statements 3.5 Montreal Interim Financial Statements 3.5 Non-Assignable Asset 2.9(a) Out-Licenses 3.18(i) Potentially Insured Claims 11.5 Pre-Closing Taxes 8.1(a) Pre Closing Tax Period 8.1(a) Preliminary Purchase Price Allocation 2.5(c) Purchase Price 2.5(a) Related Agreements Recitals Merger Consideration Section 3.7(a)(iSalem Leased Property 6.8 Seller Preamble Seller Disclosure Schedule Article III Seller Inventory 3.24(a) Minimum Condition Section 2.1(a)(iSeller Licensee 3.18(b) Multiemployer Plan Section 4.11(c)Seller Registered Intellectual Property 3.18(a) Selling Entities 2.5(c) Selling Entity 2.5(c) Seller Indemnified Parties 11.2 SOF Business 1.1(d) SOF Business Financial Statements 3.5 SOF Interim Financial Statements 3.5 Straddle Period 8.1(a) Termination Date 10.1(b) Third Party Insurance 11.5 Transfer Taxes 2.6 Transferred Asset 2.1 Transferred Assets 2.1 Transferred Claims 2.1(e) Transferred Contracts 2.1(c) Transferred Intellectual Property 2.1(b) Transferred Permits 2.1(d) Transferred Tangible Property 2.1(a) Transition Services Agreement Recitals Visible Lasers 6.11

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto given to them in the respective sections Sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iAdvisors 3.3(c) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii5.3(a) Antiboycott Rules Section 4.22(aAnti-Corruption Laws 3.26(b) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(iiBuyer Parties Preamble Bylaws 3.1 Capitalization Date 3.7(a) Certificate of Merger Section 3.2 2.2 Certificates Section 3.8(c2.10(c) Changes Section 1.1 Charter 2.5(a) Chosen Courts 9.10(a) Closing Section 3.3 2.3 Closing Date Section 3.3 COBRA Section 4.11(d2.3 Collective Bargaining Agreement 3.19(a) Company Preamble Company Common Stock Recitals Board Recommendation 3.3(b) Company Disclosure Letter Article IV III Company License-In Agreements Section 4.16(gEquity Awards 3.7(b) Company License-Out Agreements Section 4.16(hLiability Limitation 8.3(e)(ii) Company Financial Advisor Section 4.10 Related Parties 8.3(e)(ii) Company SEC Reports Section 4.7(a3.9 Company Securities 3.7(c) Company Securities Section 4.2(aStockholder Meeting 6.4(a) Company Shares Recitals Termination Fee 8.3(b)(i) Confidentiality Agreement Section 10.4 9.4 Converted Cash Award 2.8(a)(ii) Consent 3.6 Continuation Period 6.11(b) Copyrights 1.1(vv) Current Company Offering Period 2.9 D&O Insurance Section 7.8(c6.10(c) Customs Data Protection Laws Section 4.22(a1.1(cc) Debt Financing Dispute Section 10.9(a6.6(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i2.7(d)(i) EAR Section 4.22(aDPA 3.26(g) DTC 2.10(d) DTC Payment 2.10(d) Effect 1.1(s) Effective Time Section 2.2 Electronic Delivery 9.13 Employee Plan 3.18(a) Enforceability Limitations 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(bePrivacy Directive 1.1(cc) Equity Commitment Letter Recitals Equity Financing 4.11(a) ERISA Affiliate 3.18(b) Exchange Fund Section 3.8(b2.10(b) Expiration Time Section 2.1(d)(iGDPR 1.1(cc) (a) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b) Guarantee Recitals Guarantor Recitals Indemnified Persons Section 7.8(a6.10(a) Inventions Section 1.1 International Employee Plans 3.18(a) Intervening Event 5.3(d)(i) IP Contracts 3.16(f) Lease 3.14(b) Leased Real Property 3.14(b) Marks 1.1(vv) Material Contract Section 4.18(aRelationships 1.1(zz)(iv) Maximum Annual Premium Section 7.8(c6.10(c) Merger Recitals Merger Sub Preamble New Plans 6.11(c) No-Shop Period Start Date 5.3(a) Notice Period 5.3(d)(ii)(2) Old Plans 6.11(c) Other Required Company Filing 6.3(b) Other Required Parent Filing 6.3(c) Owned Company Share 2.7(a)(iii) Parent Preamble Parent Disclosure Letter Article IV Parent Liability Limitation 8.3(e)(i) Parent Related Parties 8.3(e)(i) Party Preamble Patents 1.1(vv) Payment Agent 2.10(a) Payoff Letters 6.22 Per Share Price 2.7(a)(ii) Permits 3.20 Proxy Statement 6.3(a) Recent SEC Reports Article III Recommendation Change 5.3(c)(i) Reimbursement Obligations 6.6(f) Reinvestment Stockholders Recitals Repaid Indebtedness 6.22 Representatives 5.3(a) Requisite Stockholder Approval 3.4 Rollover Shares Recitals Schedule 13e-3 6.3(a) Special Committee Recitals Special Committee Recommendation 3.3(a) Sublease 3.14(c) Support Agreements Recitals Surviving Corporation 2.1 Tax Returns 3.17(a) Termination Date 8.1(c) Trade Control Laws 3.26(a) Uncertificated Shares 2.10(c) Unvested Company Option 2.8(a)(ii) Unvested Company RSU 2.8(b)(ii) Vested Company Option 2.8(a)(i) Vested Company Option Consideration Section 3.7(a)(i2.8(a)(i) Minimum Condition Section 2.1(a)(iVested Company RSU 2.8(b)(i) Multiemployer Plan Section 4.11(cVested Company RSU Consideration 2.8(b)(i)

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto given to them in the respective sections Sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iiiAdvisors 3.3(b) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iAggregate Consideration 3.7(e) Agreement Preamble Agreement Date Preamble Alternative Acquisition Agreement Section 6.2(c)(ii5.4(b) Antiboycott Rules Section 4.22(aAlternative Debt Financing 6.5(d) Board Recommendation Section 2.2(bApplicable Termination 8.3(b)(i) Cancelled Articles of Merger 2.2 Audited Financial Statements 3.10(a) Audited Financials Date 3.10(a) Bylaws 3.1 Capitalization Date 3.7(a) Cash Replacement Company Shares Section Restricted Stock Amount 3.7(a)(ii) Certificate of Merger Section 3.2 Certificates Section 3.8(c2.9(c) Changes Section 1.1 Charter 2.5(a) Chosen Courts 9.10(a) Closing Section 3.3 2.3 Closing Date Section 3.3 COBRA Section 4.11(d2.3 Collective Bargaining Agreement 3.19(a) Company Preamble Company Common Stock Recitals Board Recommendation 3.3(a) Company Board Recommendation Change 5.4(c)(i) Company Breach Notice Period 8.1(e) Company Disclosure Letter Article IV III Company License-In Agreements Section 4.16(g) OTC Reports 3.9 Company License-Out Agreements Section 4.16(h) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(aRelated Parties 8.3(f)(i) Company Securities Section 4.2(a3.7(c) Company Shares Recitals Termination Fee 8.3(b)(i) Confidentiality Agreement Section 10.4 Current Company D&O Insurance Section 7.8(cAgreements 9.4 Consent 3.6 Copyrights 1.1(vv) Customs Laws Section 4.22(aCovered Persons 6.9(a) COVID-19 1.1(x)(xi) COVID-19 Measures 1.1(x)(xi) Debt Commitment Letter 4.11(b) Debt Financing Dispute Section 10.9(a4.11(b) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i2.7(c)(i) EAR Section 4.22(aDTC 2.9(d) DTC Payment 2.9(d) Effect 1.1(x) Effective Time Section 2.2 Electronic Delivery 9.13 Employee Plans 3.18(a) Enforceability Limitations 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(bEnforcement Expenses 8.3(e) Equity Commitment Letter 4.11(a) Equity Financing 4.11(a) Event Notice Period 5.4(d)(i)(B)(2)(I) Exchange Fund Section 3.8(b2.9(b) Expiration Time Section 2.1(d)(i) FCC 3.6 FCC Consent 3.6 FCC Filings 3.6 Financial Statements Incipio Incipio Merger Agreement Section 4.7(b3.9(a) Financing 4.11(b) Financing Conditions 4.11(c) Financing Letters 4.11(b) Guarantor(s) Recitals Guaranty(ies) Recitals Indemnified Persons Section 7.8(aInjunction 8.1(b) Inventions Section 1.1 Material Contract Section 4.18(aInterim Period 5.1 Intervening Event 5.4(d)(i) KBCA Recitals Kentucky PSC Notification 3.6 Latest Financial Statements 3.10(a) Latest Financials Date 3.10(a) Lease 3.14(b) Leased Real Property 3.14(b) Maximum Annual Premium Section 7.8(c6.9(c) Marks 1.1(vv) Material Customers 1.1(bbb)(ii)(A) Material Vendors 1.1(bbb)(ii)(B) Merger Recitals Merger Sub Preamble Open Source Software 1.1(ccc) Organizational Documents 3.1 OTCQX Disclosure Guidelines 3.9 OTC Market 6.18 OTC Rules 3.9 Owned Company Shares 2.7(a)(iii) Owned Real Property 3.14(a) Parent Preamble Parent Breach Notice Period 8.1(g) Parent Liability Limitation 8.3(f)(i) Parent Related Parties 8.3(f)(i) Parent Termination Fee 8.3(c) Party(ies) Preamble Patents 1.1(vv) Payment Agent 2.9(a) Per Share Price 2.7(a)(ii) Permits 3.20 Privacy Requirements 3.16(h) Prohibited Financing Modifications 6.5(b) Proposal Notice Period 5.4(d)(ii)(3) Protected Information 3.16(h) Proxy Statement 6.3(a) Reimbursement Obligations 6.6(b) Relinquishment Applications 3.6 Representatives 5.4(a) Required Amounts 4.11(f) Requisite Shareholder Approval 3.4 RSA Consideration Section 3.7(a)(i2.8(a)(i) Minimum Condition Section 2.1(a)(iSecurity Incident 3.16(h) Multiemployer Plan Section 4.11(cSpecified Acquisition 5.3 Support Agreements Recitals Surviving Corporation. 2.1 Tax Proceeding 3.17(c) Termination Date 8.1(c) Trade Control Laws 3.26(a)(i) Uncertificated Shares 2.9(c) Vested Shares 2.8(a)(i)

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto given to them in the respective sections Sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iAdvisor 3.3(b) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii5.3(a) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(iiBylaws 3.1 Capitalization Date 3.7(a) Certificate of Merger Section 3.2 2.2 Certificates Section 3.8(c2.9(c) Changes Section 1.1 Charter 2.5(a) Chosen Courts 9.10 Closing Section 3.3 2.3 Closing Date Section 3.3 COBRA Section 4.11(d2.3 Collective Bargaining Agreement 3.19(a) Company Preamble Company Common Stock Recitals Board Recommendation 3.3(a) Company Board Recommendation Change 5.3(c)(i) Company Disclosure Letter Article IV III Company License-In Agreements Section 4.16(gLiability Limitation 8.3(e)(ii) Company License-Out Agreements Section 4.16(hPlans 6.11(c) Company Financial Advisor Section 4.10 Related Parties 8.3(e)(ii) Company SEC Reports Section 4.7(a3.9 Company Securities 3.7(c) Company Securities Section 4.2(aStock-Based Award Consideration 2.8(a) Company Shares Recitals Stockholder Meeting 6.4(a) Company Termination Fee 8.3(b)(i) Comparable Plans 6.11(c) Confidentiality Agreement Section 10.4 Current Company D&O Insurance Section 7.8(c) Customs Laws Section 4.22(a9.4 Consent 3.6 Copyrights 1.1(hh) Debt Financing Dispute Section 10.9(a6.6(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i2.7(c)(i) EAR Section 4.22(aD&O Insurance 6.10(c) DTC 2.9(d) DTC Payment 2.9(d) Effect 1.1(m) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b2.2 Electronic Delivery 9.13 Employee Plans 3.18(a) Equity Commitment Letters 4.11(a) Equity Financing 4.11(a) Exchange Fund Section 3.8(b2.9(b) Expiration Time Section 2.1(d)(iExport Control Laws 3.26(a)(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b) Guarantor Recitals Guaranties Recitals Indemnified Persons Section 7.8(a6.10(a) Inventions Section 1.1 International Employee Plans 3.18(a) Intervening Event 5.3(d)(i) IP Contracts 3.16(e) Lease 3.14(b) Leased Real Property 3.14(b) Marks 1.1(hh) Material Contract Section 4.18(aCustomers 1.1(mm)(iii) Maximum Annual Premium Section 7.8(c6.10(c) Merger Recitals Merger Sub Preamble New Plans 6.11(d) Notice Period 5.3(d)(ii)(3) Old Plans 6.11(d) Option Consideration Section 3.7(a)(i2.8(b) Minimum Condition Section 2.1(a)(iOther Required Company Filing 6.3(b) Multiemployer Plan Section 4.11(cOther Required Parent Filing 6.3(c) Owned Company Shares 2.7(a)(iii) Parent Preamble Parent Liability Limitation 8.3(f)(i) Parent Related Parties 8.3(f)(i) Party Preamble Patents 1.1(hh) Payment Agent 2.9(a) Permits 3.20 Per Share Price 2.7(a)(ii) Proxy Statement 6.3(a) Recent SEC Reports Article III Reimbursement Obligations 6.6(f) Representatives 5.3(a) Required Financing Information 6.6(a)(iv) Requisite Stockholder Approval 3.4 Sublease 3.14(c) Surviving Corporation Article II Tax Returns 3.17(a) Termination Date 8.1(c)

Additional Definitions. The Each of the following capitalized terms shall have the respective meanings ascribed thereto definitions is set forth in the respective sections section of this Agreement set forth opposite each of the capitalized terms indicated below: DEFINITION SECTION [***] Loss of Market Exclusivity Section 1.1 –Loss of Market Exclusivity definition [***] or More Loss of Market Exclusivity Section 1.1 – Loss of Market Exclusivity definition 35 U.S.C. § 102(c) Patent Section 10.7 Academic Essential Provisions Section 8.6(b)(iii) Acquirer Program Section 8.6(b)(v)(C) Additional Amounts Section 1.1 – Control definition Adjusted Deferred Loss Exhibit E Agreement Preamble Alliance Manager Section 2.1(d) Allocable Overhead Exhibit E Audit Rights Holder Section 9.8(e) Audit Team Section 9.8(a) Auditee Section 9.8(e) Bankruptcy Code Section 8.8 BeiGene Preamble BeiGene Cayman Preamble BeiGene Switzerland Preamble BeiGene Indemnified Parties Section 13.2 BioAtla Preamble BioAtla Indemnified Parties Section 13.1 BeiGene Territory Royalty Rate Section 9.5(b) Capital Account Exhibit F CFIUS 12.2 CFIUS Clearance 12.4 DEFINITION SECTION Challenge Section 14.3(e) Challenging Party Section 14.3(e) Claim Section 13.1 Clinical Combination Activities 8.6(c) Co-Development Opt-Out Section 3.6(a) Co-Development Opt-Out Date 3.6(a) Co-Development Opt-Out Notice Section 3.6(a) Co-Development Opt-Out Notice Period Section 3.6(a) Co-Development Percentage Section 9.2(a) Combination Product Section 1.1—Net Sales Definition Combination Trial 8.1(c) Combination Regimen Section 1.1- Net Sales definition Commercialization Budget Section 6.2(c) Commercialization Costs Exhibit E Commercialization Plan Section 6.2(a) Committee Section 2.1(a) Competitive Infringement Section 10.3(b) Competitive Program Section 8.6(b)(iv) Competitive Program Party Section 8.6(b)(iv) Cooperating Party Section 11.3(b)(iii) Costs of Goods Sold or COGS Exhibit E CPI Section 1.1—FTE Rate definition Cure Period Section 14.3(c)(i) Deferred Loss Exhibit E Deferred Loss Notice Exhibit E Development Budget Section 3.1(a)(i) Disclosing Party Section 11.1 Dispute Section 15.1 Distribution Costs Exhibit E Earlier Patent Section 10.7 Effective Date Preamble Electronic Delivery Section 15.17 Exclusivity Period Section 8.6(a) Existing Regulatory Materials Section 12.2(p) Ex-US ROW Agreement 15.19(a) Ex-US ROW Partnership 15.19(b) force majeure event Section 15.8 Global Safety Database Section 5.3 ICC Section 15.2 Indemnified Party Section 13.3 Indemnitor Section 13.3 Indirect Taxes Section 9.9(b)(iii) DEFINITION SECTION Interest Rate Exhibit E Initial Enforcement Party Section 10.3(b) JCC Section 2.1(a) JDC Section 2.1(f) JRC Section 2.1(a) JSC Section 2.1(a) K-1 Exhibit F Licensed Branding Section 6.5(c) Licensing Party Section 8.5(c) Manufacturing Costs Exhibit E Manufacturing Plan Section 4.2 Marketing Costs Exhibit E Material Breach Section 14.3(c)(i) Negotiating Party Section 8.6(b)(v)(A) Negotiation Period Section 8.6(b)(v)(A) Non-Paying Party 9.9(b)(i) Offering Party Section 8.6(b)(v)(A) Operating Profits or Losses Exhibit E Other Operating Income/Expense Exhibit E Other Product Section 1.1—Net Sales definition Parent Entity Section 1.1—Change of Control definition Partners Exhibit F Partnership Exhibit F Partnership Representative Exhibit F Party or Parties Preamble Patent Coordinator Section 2.1(a) Patent Prosecution Expenses Section 10.2(c) Paying Party Section 9.9(b)(i) Pharmacovigilance Agreement Section 5.3 Pharmacovigilance Expenses Exhibit E Product Recall Expenses Exhibit E Product Trademarks Section 6.5(a) Prosecuting Party Section 10.2(d)(ii) Pursuing Party Section 14.3(e) Recipient Party 9.9(b)(i) Receiving Party Section 11.1 Redacted Version Section 11.3(b)(i) Regulatory Expenses Exhibit E Regulatory Interactions Section 5.1(b) Replacement Agreement 15.19(b) Report Exhibit E Requesting Party Section 11.3(b)(iii) DEFINITION SECTION ROFN Candidate Section 8.6(b)(v)(A) ROFN Notice Section 8.6(b)(v)(A) ROW Product Revenue Exhibit E ROW Profit & Loss Share Exhibit E Royalty Rate Section 9.5(a) Royalty Term Section Reference Acceptable Confidentiality 9.5(b) Rules Section 15.2 Sales Costs Exhibit E Sales Milestone Events Section 9.3(b) SEC Section 11.3(b)(i) Segregation Activities Section 8.6(b)(v)(C) 1.1 Net Sales definition Single Price Combination Regimen Section 1.1—Net Sales definition Step-In Enforcement Party Section 10.3(c) Sublicense Revenues Exhibit E Term Section 14.1 Third Party Agreement Section 6.2(e)(iii9.6(b) Acquisition Proposal Third Party Contractors Section 6.2(e)(i8.2(a)(ii) Acquisition Sub Preamble Adverse Recommendation Change Third Party Infringement Section 6.2(c)(i10.3(a) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(ii) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 Closing Section 3.3 Closing Date Section 3.3 COBRA Section 4.11(d) Company Preamble Company Common Stock Recitals Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(g) Company License-Out Agreements Section 4.16(h) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a) Company Securities Section 4.2(a) Company Shares Recitals Confidentiality Agreement Third Party Infringement Action Section 10.4 Current Company D&O Insurance Third Party Products Liability Action Section 7.8(c13.5(a) Customs Laws Working Group Section 4.22(a) Debt Financing Dispute Section 10.9(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b) Exchange Fund Section 3.8(b) Expiration Time Section 2.1(d)(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b) Recitals Recitals Indemnified Persons Section 7.8(a) Inventions Section 1.1 Material Contract Section 4.18(a) Maximum Annual Premium Section 7.8(c) Merger Recitals Merger Consideration Section 3.7(a)(i) Minimum Condition Section 2.1(a)(i) Multiemployer Plan Section 4.11(c2.1(c)

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(iiAML 6.2(a) Antiboycott Rules Section 4.22(aAssets 3.14 Assumed Options 2.7(d)(i) Board Recommendation Section 2.2(bBalance Sheet Date 3.10(a) Cancelled Company Shares Section 3.7(a)(iiCertificates 2.8(c) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 2.2 Closing Section 3.3 2.3 Closing Date Section 3.3 COBRA Section 4.11(d2.3 Collective Bargaining Agreement 3.18(a) Company Preamble Company Common Stock Recitals Acquisition Agreement 5.2(a) Company Board Recommendation 3.1(b) Company Disclosure Letter Article IV Art. III Company License-In Agreements Section 4.16(gFinancial Statements 3.9(a) Company License-Out Intellectual Property Agreements Section 4.16(h3.15(b) Company Financial Advisor Section 4.10 Rights Plan Recitals Company SEC Reports Section 4.7(a3.8 Company Securities 3.7(c) Company Securities Section 4.2(a) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company Stockholder Meeting 5.4 Consent 3.4 D&O Insurance Section 7.8(c6.7(c) Customs Laws Section 4.22(aDeferred Compensation Plan 2.7(e)(v) Debt Financing Dispute Section 10.9(aDelaware Secretary of State 2.2 Designated Open Source 3.15(k) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a2.7(c)(i) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b2.2 Employee Plans 3.17(a) ERISA Affiliate 3.17(a) Exchange Fund Section 3.8(b2.8(b) Expiration Time Section 2.1(d)(iExchange Ratio 2.7(d)(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bFunded International Employee Plan 3.17(i)(ii) Recitals Recitals ▇▇▇▇▇▇▇▇ ▇▇▇ 3.5 Hangzhou Queenhive 3.5 Incentives 3.16(n) Indemnified Persons Section 7.8(a6.7(a) Inventions Section 1.1 International Employee Plans 3.17(a) Intervening Event 5.3(a)(ii) Leased Real Property 3.13(b) Leases 3.13(b) Material Contract Section 4.18(a3.12(a) Maximum Annual Premium Section 7.8(c6.7(c) Merger Recitals 2.1 Merger Sub Preamble Option Consideration Section 3.7(a)(i2.7(d)(ii) Minimum Condition Section 2.1(a)(iOther Required Company Filings 3.29 Out of the Money Options 2.7(d)(i) Multiemployer Owned Company Common Stock 2.7(a)(ii) Owned Real Property 3.13(a) Parent Preamble Parent Stock 2.7(d)(i) Parent’s 401(k) Plan Section 4.11(c2.7(e)(iv) (a) Per Share Price 2.7(a)(i) Permits 3.19 Proxy Statement 3.29 Public Grants 3.30 Recommendation Change 5.3(a) Representatives 5.2(a) Requisite Stockholder Approval 3.2

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto given to them in the respective sections Sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iiiAdvisor 3.3(b) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iAggregate Consideration 3.7(e) Agreement Preamble Agreement Date Preamble Alternative Acquisition Agreement Section 6.2(c)(ii5.3(a) Antiboycott Rules Section 4.22(aBylaws 3.1 Capitalization Date 3.7(a) Board Recommendation Section 2.2(bCash Replacement Company RSU Award Amounts 2.8(a)(ii) Cancelled Company Shares Section 3.7(a)(iiCash Replacement Option Amounts 2.8(b)(ii) Certificate of Merger Section 3.2 2.2 Certificates Section 3.8(c2.9(c) Changes Section 1.1 Charter 2.5(a) Chosen Courts 9.10(a) Closing Section 3.3 2.3 Closing Date Section 3.3 COBRA Section 4.11(d2.3 Collective Bargaining Agreement 3.19(a) Company Preamble Company Common Stock Recitals Board Recommendation 3.3(a) Company Board Recommendation Change 5.3(d)(i) Company Breach Notice Period 8.1(e) Company Disclosure Letter Article IV III Company License-In Agreements Section 4.16(gEquity Awards 1.1(o) Company License-Out Agreements Section 4.16(hLiability Limitation 8.3(f)(ii) Company Financial Advisor Section 4.10 Plans 6.11(b) Company Related Parties 8.3(f)(ii) Company SEC Reports Section 4.7(a3.9 Company Securities 3.7(c) Company Securities Section 4.2(aStockholder Meeting 6.4(a) Company Shares Recitals Termination Fee 8.3(b)(i) Comparable Plans 6.11(b) Confidentiality Agreement Section 10.4 Current Company 9.4 Consent 3.6 Copyrights 1.1(oo) D&O Insurance Section 7.8(c6.10(c) Customs Laws Section 4.22(aDebt Documents 6.6(a)(xii) Debt Financing Dispute Section 10.9(a6.6(a)(i) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i2.7(c)(i) EAR Section 4.22(aDTC 2.9(d) DTC Payment 2.9(d) Effect 1.1(s) Effective Time Section 2.2 Electronic Delivery 9.13 Employee Plans 3.18(a) Enforceability Limitations 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(bEnforcement Expenses 8.3(e) Exchange Fund Section 3.8(bEquity Commitment Letter Recitals Equity Financing 4.11(a) Expiration Time Section 2.1(d)(iERISA Affiliate 3.18(a) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bESPP 2.8(e) Recitals Recitals Indemnified Persons Section 7.8(a) Inventions Section 1.1 Material Contract Section 4.18(a) Maximum Annual Premium Section 7.8(c) Merger Recitals Merger Consideration Section 3.7(a)(i) Minimum Condition Section 2.1(a)(i) Multiemployer Plan Section 4.11(cEvent Notice Period 5.3(e)(i)(1)

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iiiPreamble Agreement of Merger 2.2 Antitrust Restraint 6.5(d) Acquisition Proposal Section 6.2(e)(iAssets 3.21 Assumed Option 6.11(b) Acquisition Sub California Secretary of State 2.2 Cancelled Option 6.11(a) Capitalization Representation 7.2(a) Certificates 2.8(c) Change 1.1 Changes 1.1 China RoHS 1.1 Closing 2.3 Closing Date 2.3 Collective Bargaining Agreements 3.19(a) Combined Software 1.1 Company Preamble Adverse Company Board Recitals Company Board Recommendation 6.2(a) Company Board Recommendation Change Section 6.2(c)(i6.2(b) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(ii) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 Closing Section 3.3 Closing Date Section 3.3 COBRA Section 4.11(d) Company Preamble Company Common Stock Recitals Company Disclosure Letter Article IV III Company LicenseForm 10-In K Article III Company IP Agreements Section 4.16(g3.22(f) Company License-Out Agreements Section 4.16(hRegistered IP 3.22(b) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(aRepresentatives 6.1(b) Company Securities Section 4.2(a3.4(c) Company Shares Recitals Shareholders’ Meeting 6.3 Confidentiality Agreement Section 10.4 Current Company 6.9 Consent 3.5(b) Copyrights 1.1 D&O Insurance Section 7.8(c6.13(b) Customs Laws Section 4.22(aDemand Notice 2.7(c)(i) Debt Financing Dispute Section 10.9(aDissenting Shares 2.7(c)(i) DGCL Recitals Dissenting Company Shares Section 3.7(c)(iDomain Names 1.1 EAR 3.23(a) EAR Section 4.22(aECCNs 3.23(b) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b2.2 Employee Plans 3.18(a) ERISA Affiliate 3.18(a) EU RoHS Directive 1.1 Exchange Fund 2.8(b) Export Controls 3.23(a) FIN 48 3.16(n) Term Section 3.8(bReference Foreign Employees 3.18(l) Expiration Time Section 2.1(d)(iFunded International Employee Plan 3.18(b) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bImport Restrictions 3.23(a) Recitals Recitals Indemnified Persons Section 7.8(aParties 6.13(a) Inventions Section 1.1 International Employee Plans 3.18(a) ITAR 3.23(a) Leased Real Property 3.20(b) Leases 3.20(b) Material Contract Section 4.18(a3.11(a) Maximum Annual Premium Section 7.8(c6.13(b) Merger Recitals Merger Consideration Recitals Merger Sub Preamble NQDCP 5.2(g) OFAC 3.23(a) Option Consideration 6.11(a) Owned Real Property 3.20(a) Parent Preamble Patents 1.1 Payment Agent 2.8(a) Permits 3.13 Proxy Statement 3.8 Real Property 3.20(b) Requisite Shareholder Approval 3.3(c) Retirement Plan Termination Date 6.12(a) Retirement Plans 6.12(a) SEC Reports 3.6 Shares Recitals Significant Customer 3.30(a) Significant Supplier 3.30(b) Specified Representations 7.2(a) Subsidiary Securities 3.2(c) Surviving Corporation 2.1 Tail Policy 6.13(b) Takeover Laws 3.29 Tax Incentive 3.16(k) Termination Date 8.1(c) Termination Fee Amount 8.3(b)(i) Third Party Leases 3.20(b) Trade Secrets 1.1 Trademarks 1.1 Triggering Event 8.1(e)(ii) USML 3.23(b) Term Section 3.7(a)(iReference Voting Agreement Recitals Voting Agreements Recitals Warranties 3.22(s) Minimum Condition Section 2.1(a)(i) Multiemployer Plan Section 4.11(c)WEEE Directive 1.1

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) Action 10.9 Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii5.3(b) Antiboycott Rules Section 4.22(aAlternative Financing 6.2(c) Board Recommendation Section 2.2(bAlternative Financing Documents 6.2(c) Cancelled Available Company Shares Section 3.7(a)(iiCash Financing 6.2(b) Certificate of Merger Section 3.2 Certificates Section 3.8(c2.8(c) Change 1.1 Changes Section 1.1 Closing Section 3.3 2.2 Closing Date Section 3.3 COBRA Section 4.11(d) 2.2 Company Preamble Company Common Stock Recitals Benefit Plans 3.14(a) Company Board Recommendation 5.3(a) Company Board Recommendation Change 5.3(b) Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(g) Company License-Out Agreements Section 4.16(h) Company Financial Advisor Section 4.10 III Company SEC Reports Section 4.7(a3.9 Company Securities 3.7(c) Company Securities Section 4.2(aShareholders Meeting 7.3(d) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company Consent 3.6 D&O Insurance Section 7.8(c6.1(c) Customs Laws Section 4.22(aDebt Commitment Letter 4.10(a) Debt Financing 4.10(a) Dispute Section 10.9(a10.9 Dissenting Shareholder 2.7(c) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a2.7(c) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b2.3 Equity Commitment Letters 4.10(a) Equity Financing 4.10(a) Exchange Fund Section 3.8(b2.8(b) Expiration Time Section 2.1(d)(iFacility Agreement 4.10(a) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bFCPA 1.1 Fee Letter 4.10(a) Recitals Financing 4.10(a) Financing Commitments 4.10(a) HKIAC 10.9 HKIAC Rules 10.9 Holdco Recitals Indemnified Persons Section 7.8(a6.1(a) Inventions Section 1.1 Leased Real Property 3.15(b) Limited Guarantee Recitals Material Contract Section 4.18(aContracts 3.12(a) Maximum Annual Premium Section 7.8(c6.1(c) Measurement Date 3.7(a) Merger Recitals Merger Sub Preamble Negotiation Period 5.3(c) Operating Subsidiary 1.1 Outside Date 9.1(b) Parent Preamble Paying Agent 2.8(a) Per ADS Merger Consideration Section 3.7(a)(i2.7(a)(ii) Minimum Condition Section 2.1(a)(iPer Share Merger Consideration 2.7(a)(ii) Multiemployer Permits 3.15 Plan Section 4.11(cof Merger Recitals Proxy Statement 7.3(a) Real Property Leases 3.15(b) Recommendation Change Notice 5.3(c) Registrar of Companies 2.3 Rollover Shareholders Recitals Rollover Shares Recitals Shareholder Approval 3.4 Schedule 13E-3 3.6 Special Committee Recitals Sponsor 4.10(a) Subsidiary Securities 3.8(c) Support Agreement Recitals Surviving Corporation 2.1 Takeover Statute 3.23 Tax Returns 3.16(b) Trade Secrets 1.1 Uncertificated Shares 2.8(c)

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii6.2(f)(iii) Acquisition Proposal Section 6.2(e)(i6.2(f)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i6.2(d)(i) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii6.2(d)(ii) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(ii) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 Closing Section 3.3 Closing Date Section 3.3 COBRA Section 4.11(d) Company Preamble Company Common Stock Recitals Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(g) Company License-Out Agreements Section 4.16(h) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a) Company Securities Section 4.2(a) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company D&O Insurance Section 7.8(c) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b) Exchange Fund Section 3.8(b) Expiration Time Section 2.1(d)(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b) Recitals Recitals Indemnified Persons Section 7.8(a) Inventions Section 1.1 Material Contract Section 4.18(a) Maximum Annual Premium Section 7.8(c) Merger Recitals Merger Consideration Section 3.7(a)(i) Minimum Condition Section 2.1(a)(i) Multiemployer Plan Section 4.11(c)) Offer Recitals Offer Documents 2.1(g)(i) Offer Price Recitals Offer to Purchase 2.1(a) Option Consideration 3.7(d) Parent Preamble Patent Rights 1.1 Payment Agent 3.8(a) Plans 4.11(a) Real Property Leases 4.17(b) Restraint 8.1(b) Restricted Territories 4.22(a)(i) RSU Consideration 3.7(e) Sanctions Laws 4.22(a) Schedule 14D-9 2.2(b) Schedule TO 2.1(g)(i) Solicitation Period End-Date 6.2(a) Subsidiary Securities 4.2(b) Superior Proposal 6.2(f)(ii) Surviving Corporation 3.1 Termination Date 9.1(b) Termination Fee 1.1 Trade Compliance Laws 4.22(a) Trademarks 1.1 Uncertificated Shares 3.8(c) Works of Authorship 1.1

Additional Definitions. The For purposes of this Agreement, the following capitalized terms shall have the respective meanings ascribed thereto specified in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Adjournment Proposal Section 6.2(e)(i5.2(e) Acquisition Sub Preamble Adverse Recommendation Change Advance Section 6.2(c)(i) 5.15 Agreement Preamble Alternative Acquisition Agreement Antitrust Laws Section 6.2(c)(ii5.5(a) Antiboycott Rules Antitrust Matters Section 4.22(a5.5(b) Board Recommendation Assets Section 2.2(b3.18 Book-Entry Shares Section 2.9(d) Cancelled Company Shares RSU Section 3.7(a)(ii2.11(d) Cancelled Stock Option Section 2.11(b) Certificate Section 2.9(d) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 2.2 Closing Section 3.3 2.3 Closing Date Section 3.3 COBRA Section 4.11(d) 2.3 Company Preamble Company Common Stock Board Recitals Company Board Recommendation Recitals Company Board Recommendation Change Section 5.3(c) Company Disclosure Letter Schedule Article IV III Company LicenseForm 10-In K Article III Company IP Agreements Section 4.16(g3.19(c) Company License-Out Agreements Products Section 4.16(h3.19(a) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a) 3.6 Company Securities Section 4.2(a3.4(c) Company Shares Recitals Stockholders Meeting Section 5.2(e) Company Stockholder Meeting Proposals Section 5.2(a) Company Subsidiary Securities Section 3.2(c) Confidentiality Agreement Section 10.4 5.4(d) Consent Section 3.5(b) Consideration Fund Section 2.10(a) Current Company D&O Insurance Option Section 7.8(c2.11(b) Customs Laws Current Policy Coverage Section 4.22(a5.9(b) Debt Financing Dispute Current Restricted Share Section 10.9(a2.11(c) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a) 2.12 Effective Time Section 3.2 Enforceability Exceptions 2.2 Employee Plans Section 4.4 Environmental Permits 3.15(a) Equity Commitment Section 4.15(b4.6 Equity Funding Section 4.6 Equity Investor Recitals ERISA Affiliate Section 3.15(a) Exchange Fund ESPP Section 3.8(b3.4(c) Expiration Time Expense Cap Section 2.1(d)(i7.3(c) Financial Statements Incipio Incipio Merger Agreement Identified Company Representations Section 4.7(b6.2(a)(i) Recitals Recitals Indemnified Persons Section 7.8(a5.9(a) Inventions International Employee Plans Section 1.1 3.15(a) Intervening Event Section 5.3(e) Leased Real Property Section 3.17(b) Leases Section 3.17(b) Material Contract Section 4.18(a) Maximum Annual Premium Section 7.8(c3.10(a) Merger Recitals Merger Consideration Section 3.7(a)(i2.9(a) Minimum Condition Merger Proposal Section 2.1(a)(i5.2(e) Multiemployer Plan Merger-Related Proposals Section 4.11(c5.2(e) Merger Sub Preamble Open source Section 3.19(j) Outside Date Section 7.1(b)(i) Owned Real Property Section 3.17(a) Parent Preamble Parent Disclosure Schedule Article IV Parent Plans Section 5.7(b) Permits Section 3.11(a) Paying Agent Section 2.10(a) Prior Agreement Recitals Proxy Statement Section 5.2(a) Qualifying Amendment Section 5.2(c) Regulation M-A Filing Section 5.2(d) Requisite Stockholder Approval Section 3.22 ▇▇▇▇▇▇▇▇-▇▇▇▇▇ Act Section 3.6 Surviving Corporation Recitals Transferred Employees Section 5.7(a)

Additional Definitions. The Each of the following capitalized terms shall have the respective meanings ascribed thereto definitions is set forth in the respective sections section of this Agreement set forth opposite each of the capitalized terms indicated below: Term Acquiror Definition of ‘Change of Control’ in ARTICLE I Act Section Reference Acceptable 5.6.1 Agreement Preamble Auditor Section 4.7.2 Bankruptcy Code Section 3.3.1 BPCIA Section 5.6.2 Change of Control ARTICLE I Claims Section 8.1 Competing Infringing Activities Section 5.5 [*] Section [*] Confidential Information Section 6.1 Development and Regulatory Milestone Payment Section 4.2 Development and Regulatory Milestone Payments Section 4.2 Disclosing Party Section 6.1 [*] Section [*] Effective Date Preamble Existing Confidentiality Agreement Section 6.2(e)(iii6.1(e) Acquisition Proposal Future IP Section 6.2(e)(i5.1.2 Indemnified Party Section 8.3.1 Indemnifying Party Section 8.3.1 Inventory Section 7.2(m) Acquisition Sub Losses Section 8.1 Novartis Preamble Adverse Recommendation Change Novartis Indemnitees Section 6.2(c)(i8.2 Novartis Patents Section 5.1.2 Novartis Product Section 9.4.4(b) Parties Preamble Party Preamble Payment Breach Section 9.2 Phase I/II Definition of ‘Phase II Clinical Trial’ in ARTICLE I Phase II Definition of ‘Phase II Clinical Trial’ in ARTICLE I [*] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. Phase III Definition of ‘Phase III Clinical Trial’ in ARTICLE I pivotal Definition of ‘Phase III Clinical Trial’ in ARTICLE I Process Section 2.5.2 Product Marks Section 5.8 [*] Section [*] Receiving party Section 6.1 [*] Section [*] Rights Definition of ‘Control’ in ARTICLE I Royalty Term Section 4.3.2(a) Sales & Royalty Report Section 4.4.2 Selling Party Definition of ‘Net Sales’ in ARTICLE I Servier Definition of ‘Servier Loan’ in ARTICLE I Servier Liens Section 4.1.1(a) Servier Loan Agreement Preamble Alternative Acquisition Agreement Definition of ‘Servier Loan’ in ARTICLE I Servier Loan Repayment Section 6.2(c)(ii4.1.1(a) Antiboycott Rules Servier Payoff Estimated Amount Section 4.22(a4.1.1(a) Board Recommendation [*] Section 2.2(b) Cancelled Company Shares [*] Term Section 3.7(a)(ii) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 Closing Section 3.3 Closing Date Section 3.3 COBRA Section 4.11(d) Company Preamble Company Common Stock Recitals Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(g) Company License-Out Agreements Section 4.16(h) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a) Company Securities Section 4.2(a) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company D&O Insurance Section 7.8(c) Customs 9.1 Trade Control Laws Section 4.22(a) Debt Financing Dispute 11.7 XOMA Preamble XOMA Indemnitees Section 10.9(a) DGCL Recitals Dissenting Company Shares 8.1 [*] Section 3.7(c)(i) EAR [*] [*] Section 4.22(a) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b) Exchange Fund Section 3.8(b) Expiration Time Section 2.1(d)(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b) Recitals Recitals Indemnified Persons Section 7.8(a) Inventions Section 1.1 Material Contract Section 4.18(a) Maximum Annual Premium Section 7.8(c) Merger Recitals Merger Consideration Section 3.7(a)(i) Minimum Condition Section 2.1(a)(i) Multiemployer Plan Section 4.11(c)[*]

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iAcceptance Time 2.1(f) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(iiAnnual Incentive Award 3.6(d)(vii) Antiboycott Rules Section 4.22(aAssumed Option 3.6(d)(ii) Board Recommendation Section 2.2(bAssumed Unit 3.6(d)(iv) Book-Entry Shares 3.7(b)(i) Cancelled Company Shares Section 3.7(a)(ii3.6(b)(ii) Capitalization Date 4.4(a) Certificate 3.7(b)(i) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 Closing Section 3.3 Closing 3.2 Closing Date Section 3.3 COBRA Section 4.11(d) 3.2 Company Preamble Company Common Stock Recitals Balance Sheet Date 1.1(j) Company Board Recommendation 2.2(b) Company Board Recommendation Change 7.4(a) Company Disclosure Letter Article IV Company License-Facilities 4.10 Company In Agreements Section 4.16(gLicenses 4.12(e) Company License-Out Agreements Section 4.16(hIP Licenses 4.12(f) Company Financial Advisor Section Material Contract 4.13(a) Company Non-U.S. Employee Plans 4.15(i) Company Out Licenses 4.12(f) Company Permits 4.19 Company Qualified Plan 4.15(e) Company Real Property Leases 4.10 Company Registered Intellectual Property Rights 4.12(a) Company Related Party 11.8 Company SEC Reports Section 4.7(a4.6 Company Shares 1.1(o) Company Securities Section 4.2(aStock Awards 4.4(d) Company Shares Recitals Stock Option 3.6(d)(i) Company Stock Plans 4.4(b) Company Subsidiary Documents 4.1(c) Company Terminating Plans 8.7(a) Compensation Committee 8.7(e) Confidentiality Agreement Section 10.4 Current Company 8.5(i) Converted Incentive Award 3.6(d)(vii) Converted Performance Option 3.6(d)(v) Converted Performance Unit 3.6(d)(vi) Copyrights 1.1(qq) D&O Insurance Section 7.8(cPolicy 8.9(b) Customs Laws Section 4.22(aDebt Commitment Letter 5.6(b) Debt Financing Dispute Section 10.9(a5.6(b) Delaware Secretary of State 3.3 DGCL Recitals Dissenting Company Shares Section 3.7(c)(i3.6(c) EAR Section 4.22(a▇▇▇▇-▇▇▇▇▇ Act 4.6 Effect 1.1(s) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 3.3 Environmental Permits Section 4.15(b) Exchange Fund Section 3.8(b4.17(c) Expiration Time Section 2.1(d)(iDate 2.1(e) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bExport Controls 4.18(c)(i) Recitals Recitals Financing Sources 8.3(b) Import Restrictions 4.18(c)(i) Indemnified Persons Section 7.8(aParties 8.9(a) Inventions Section 1.1 Material Contract Section 4.18(aInventory 4.12(k) Maximum Annual Premium Section 7.8(c8.9(b) Merger Recitals Merger Consideration Section 3.6(b)(i) Merger Sub Preamble Offer Recitals Offer Conditions 2.1(b) Offer Documents 2.1(g) Offer Price Recitals Option Award Amount 3.6(d)(i) Parent Preamble Patent 1.1(qq) Payment Agent 3.7(a)(i) Minimum Condition Section 2.1(a)(iPayment Fund 3.7(a)(ii) Multiemployer Plan Section 4.11(cPre-Recommendation Change Notice 7.4(a)(i) Representatives 7.1 Schedule 14D-9 2.2(a) Schedule TO 2.1(g) SIG 4.12(i) Significant Company Customer 4.23(a) Significant Company Supplier 4.23(b) Substitute Financing 8.3(b) Support Agreement(s) Recitals Surviving Corporation 3.1 Takeover Statute 4.24(a) Termination Date 10.1(c) Termination Fee Amount 10.3(b)(i) Trademarks 1.1(qq) Trade Secrets 1.1(qq) Unit Award Amount 3.6(d)(iii) Unvested Company Performance Option 3.6(d)(v) Unvested Company Performance Unit 3.6(d)(vi) Vested Company Option 3.6(d)(i) Vested Company Unit 3.6(d)(iii) WARN Act 4.16(e)

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii2016 Warrant 2.7(f)(ii) Acquisition Proposal Section 6.2(e)(i2016 Warrant Consideration 2.7(f)(ii) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iAccepted Company Shares 2.7(a)(ii) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Cancelled Canceled Company Shares Section 3.7(a)(ii2.7(a)(ii) Capitalization Date 3.4(a) Certificate of Merger Section 3.2 2.2 Certificates Section 3.8(c2.8(c) Changes Section 1.1 Chosen Courts 9.9(b) Closing Section 3.3 2.3 Closing Date Section 3.3 2.3 COBRA Section 4.11(d3.16(d) Company Preamble Company Common Stock Recitals Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(gBoard Recommendation 3.2(b) Company License-Out Agreements Section 4.16(hBoard Recommendation Change 6.1(b) Company Financial Advisor Section 4.10 Advisors 3.21 Company Plans 6.9(c) Company SEC Reports Section 4.7(a) Company Securities Section 4.2(a3.5(a) Company Shares Recitals Confidentiality Agreement Section 10.4 Competing Acquisition Transaction 8.3(b) Covered Securityholders 3.24 Current Company D&O Insurance Section 7.8(c) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a6.4(c) DGCL Recitals Disclosure Schedule Article III Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a2.7(b)(i) Effective Time Section 3.2 2.2 Employment Compensation Arrangement 3.24 Enforceability Exceptions Section 4.4 3.2 Environmental Permits Section 4.15(b3.12(b) Exchange Fund Section 3.8(b2.8(b) Expiration Time Section 2.1(d)(i1.1(c)(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bFCPA 3.19 FDA Permits 3.17(b) Recitals Recitals Healthcare Laws 3.17(a) Indemnified Persons Section 7.8(a6.4(b) Indemnified Proceeding 6.4(b) Inventions Section 1.1 10.1 Know-How 10.1 Leased Real Property 3.13(b) Material Contract 3.15(a) Term Section 4.18(a) Reference Maximum Annual Premium Section 7.8(c6.4(c) Merger Recitals Merger Consideration Section 3.7(a)(i2.7(a)(i) Merger Sub Preamble Minimum Condition Section 2.1(a)(i1.1(a)(i) Multiemployer Plan Section 4.11(c)3.16(c) New Plans 6.9(c) Notice of Intended Recommendation Change 6.1(c) Offer Recitals Offer Documents 1.1(e)(i) Offer Price Recitals Offer to Purchase 1.1(a) Old Plans 6.9(c) Option Consideration 2.7(c) Parent Preamble Parent Common Stock 2.7(c) Payment Agent 2.8(a) Plans 3.16(a) Real Property Leases 3.13(b) Representatives 5.3(a) Restraint 7.1(b) Restricted Share Wage Consideration 2.7(g) RSU Consideration 2.7(d) Schedule 14D-9 1.2(a) Schedule TO 1.1(e)(i) Software 10.1 Solvent 4.10 Stock Award Exchange Ratio 2.7(c) Stockholder List Date 1.2(b) Surviving Corporation 2.1 Termination Date 8.1(b) Termination Fee 8.3(b) Trademarks 10.1 Uncertificated Shares 2.8(c) Works of Authorship 10.1

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(iiFinancing 6.4(b) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(iiAssets 3.14 B▇▇▇ Capital Recitals Certificates 2.8(c) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 2.2 Closing Section 3.3 2.3 Closing Date Section 3.3 COBRA Section 4.11(d2.3 Collective Bargaining Agreement 3.18(a) Company Preamble Company Common Stock Recitals Board Recommendation 3.1(b) Company Disclosure Letter Article IV Art. III Company License-In Intellectual Property Agreements Section 4.16(g3.15(b) Company License-Out Agreements Section 4.16(h) Company Financial Advisor Section 4.10 Rights Plan Recitals Company SEC Reports 3.8 Term Section 4.7(aReference Company Securities 3.7(c) Company Securities Section 4.2(a) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company Stockholder Meeting 5.4 Consent 3.4 D&O Insurance Section 7.8(c6.8(c) Customs Laws Section 4.22(aDebt Commitment Letters 4.10(a) Debt Financing Dispute Section 10.9(a4.10(a) Delaware Secretary of State 2.2 DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a2.7(c)(i) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b2.2 Employee Plans 3.17(a) Equity Commitment Letter 4.10(a) Equity Financing 4.10(a) ERISA Affiliate 3.17(a) Exchange Fund Section 3.8(b2.8(b) Expiration Time Section 2.1(d)(iFinancing 4.10(a) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bFinancing Commitment Letters 4.10(a) Funded International Employee Plan 3.17(h)(ii) Guarantors Recitals Huawei Recitals Indemnified Persons Section 7.8(a6.8(a) Inventions Section 1.1 International Employee Plans 3.17(a) Leased Real Property 3.13(b) Leases 3.13(b) Limited Guarantees Recitals Material Contract Section 4.18(a3.12(a) Maximum Annual Premium Section 7.8(c6.8(c) Merger 2.1 Merger Sub Preamble Newco Preamble Other Required Company Filings 3.29(a) Other Required Newco Filings 4.6(a) Payment Agent 2.8(a) Per Share Price 2.7(a)(i) Permits 3.19 Proxy Statement 3.29(a) Recommendation Change 5.3(a) Required Information 6.4(a) Requisite Stockholder Approval 3.2 Rights Plan Amendment Recitals Merger Consideration Section 3.7(a)(iSpecified Person 8.3(g) Minimum Condition Section 2.1(a)(iSubsidiary Securities 3.6(b) Multiemployer Plan Section 4.11(cSurviving Corporation 2.1 Tax Returns 3.16(a) Termination Date 8.1(b)

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto set forth in the respective sections Sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iiiAcquisition Preamble Acquisition Proposal 6.5(a) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iTransaction 6.5(a) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(iiAggregate Financing 5.6 Balance Sheet 4.8(a) Antiboycott Rules Section 4.22(aBalance Sheet Date 4.8(b) Board Recommendation Section 2.2(bof Directors Recitals (a) Cancelled Company Shares Section 3.7(a)(iiCEO Recitals CEO Term Sheet Recitals Certificate 3.1(c) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 2.3 Closing Section 3.3 2.2 Closing Date Section 3.3 COBRA Section 4.11(d) 2.2 Commitment Letters 5.6 Company Preamble Company Common Stock Recitals Board Recommendation 4.2(b) Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(gFinancial Advisor 4.21 Company Intellectual Property Rights 4.19(a) Company License-Out Agreements Section 4.16(h) Company Financial Advisor Section 4.10 Organizational Documents 4.1 Company SEC Reports Section 4.7(a) Company Securities Section 4.2(a4.3(b) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company D&O Insurance Section 7.8(cContinuing Employees 6.14(a) Customs Laws Section 4.22(aCustomer Information 4.19(d) Debt Financing Dispute Section 10.9(a5.6 Definitive Financing Agreements 6.8(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a3.4(a) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 2.3 Environmental Permits Section 4.15(bLaws 4.18 Exchange Act 4.3(e) Exchange Fund Section 3.8(bExisting Bylaws 2.5(b) Expiration Time Section 2.1(d)(iExisting Charter 2.5(a) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bFinancing Commitment 5.6 Hazardous Materials 4.18 HSR Act 4.5 Indemnified Parties 6.9(a) Recitals Recitals Indemnified Persons Section 7.8(aInventory 4.13(b) Inventions Section 1.1 IRS 4.15(a) JWC 5.6 LC Satisfaction 6.8(d) Leased Real Property 4.12(a) Material Contract Section 4.18(aContracts 4.14(a) Maximum Annual Aggregate Premium Section 7.8(c6.9(c) Merger Recitals NASDAQ 4.5 New Plans 6.14(b) Option Consideration 3.2(a) OSIM 5.6 Owned Real Property 4.12(b) Parent Preamble Parent Disclosure Letter Article V Parent Expenses 8.3(a)(ii) Paying Agent 3.5(a) Payoff Amount 6.8(d) Payoff Letter 6.8(d) Per Share Merger Consideration Section 3.7(a)(i3.1(c) Minimum Condition Section 2.1(a)(iPermits 4.10(b) Multiemployer Plan Section 4.11(cPost-Signing Returns 6.13(a) Preferred Stock 4.3(a) Privacy Policy 4.19(d) Proxy Statement 6.3(b) Real Property 4.12(b) Real Property Leases 4.12(a) Real Property Subleases 4.12(d) Required Stockholder Approval 4.2(a) Revised Offer 6.5(d) Schedule 13E-3 6.3(b) Securities Act 4.3(d) SOX 4.7(a) Special Committee Recitals Stock Award Consideration 3.2(b) Stockholders Agreement 4.3(d) Stockholders Meeting 6.4 Subject Property 4.18 Superior Proposal 6.5(b) Surviving Corporation 2.1 Takeover Statute 4.2(b) Temasek 5.6 Third Party 6.5(a) Transaction Related Legal Proceeding 6.12 2004 Draft 10-K 4.7(a) 2005 Budget 6.2(p) WARN Act 4.16(e)

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term 102 Amounts Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii2.8(d)(i) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i5.2(b)(i) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii5.2(b)(ii) Antiboycott Rules Approval Section 4.22(a3.5 Benchmark Section 3.26 Capitalization Date Section 3.6(a) Board Recommendation CERCLA Section 2.2(b) Cancelled Company Shares Section 3.7(a)(ii) 1.1 Certificate of Merger Section 3.2 2.3 Certificates Section 3.8(c2.8(c) Changes Charter Documents Section 1.1 3.1 Closing Section 3.3 2.2 Closing Date Section 3.3 COBRA 2.2 Closing Net Cash Section 4.11(d6.2(f) Code Section 2.12(a) Collective Bargaining Agreement Section 3.18(b) Companies Registrar Section 2.3 Company Preamble Company Common Stock 102 Options Section 2.8(d)(i) Company 102 Shares Section 2.8(b) Company Board Recitals Company Disclosure Letter Article IV III Company License-In Agreements Ground Stations Section 4.16(g3.24 Company Reports Section 3.8(a) Company License-Out Agreements Shareholder Approval Section 4.16(h) 3.2 Company Financial Advisor Shareholders Meeting Section 4.10 Company SEC Reports Section 4.7(a) Company Securities Section 4.2(a5.9(a) Company Shares Recitals Section 2.7(a)(i) Confidentiality Agreement Section 10.4 Current Company D&O Insurance 5.3 control Section 7.8(c) Customs Laws 1.1 Copyrights Section 4.22(a) Debt Financing Dispute Section 10.9(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a) 1.1 Effective Time Section 3.2 Enforceability Exceptions 2.3 Employee Plans Section 4.4 Environmental Permits 3.17(a) Encouragement Law Section 4.15(b3.16(s) Estimated Closing Certificate Section 5.17(a) Excess Earnout Certificate Section 5.17(a) Exchange Fund Section 3.8(b2.8(b) Expiration Time Expense Reimbursement Section 2.1(d)(i7.3(b) FCC Section 3.5 FCPA Section 3.20(b) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b3.9(a) Recitals Funded International Employee Plan Section 3.17(e) Guarantor Preamble ICL Recitals Indemnified Persons Person Section 7.8(a5.6(a) Independent Accountant Section 5.17(b) Interim Option Tax Ruling Section 5.14(a) Inventions Section 1.1 Israeli Employees Section 3.18(e) IT Systems Section 3.15(i) ITA Section 2.12(a) Joint Venture Interests Section 3.7(b) Leased Real Property Section 3.13(b) Leases Section 3.13(b) Letter of Transmittal Section 2.8(c) Major Stations Section 3.24 Material Contract Section 4.18(a3.12(a) Maximum Annual Premium Material Customer Section 7.8(c3.12(a) Material Employee Plans Section 3.17(a) Material Permits Section 3.19(a) Material Supplier Section 3.12(a) Merger Recitals Merger Consideration Section 3.7(a)(i2.7(a)(i) Minimum Condition Merger Proposal Section 2.1(a)(i5.10(a) Multiemployer Plan Merger Sub Preamble MOC Section 4.11(c)3.5 Objection Notice Section 5.17(b) OECD Convention Section 3.20(b) Option Consideration Section 2.7(c)(i) Option Tax Ruling Section 5.14(a) Outside Date Section 7.1(b)(i) Owned Real Property Section 3.13(a) Parent Preamble Patents Section 1.1 Paying Agent Section 2.8(a) Permits Section 3.19(a) Prohibited Payment Section 3.20(b) Proxy Statement Section 5.9(a) Registered Intellectual Property Section 3.15(a) RSUs Consideration Section 2.7(d)(i) Section 14 Arrangement Section 3.18(a) Special Enterprise Section 3.16(s) Surviving Company Section 2.1 Tax Returns Section 3.16(a) Temporary Order Section 3.16(t) Termination Fee Section 7.3(c) Trade Secrets Section 1.1

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(ii) Certificate Articles of Merger Section 3.2 2.2 Assets 3.14 Capitalization Date 3.7(a) Certificates Section 3.8(c2.8(c) Changes Section 1.1 Charter 2.5(a) Closing Section 3.3 2.3 Closing Date Section 3.3 COBRA Section 4.11(d2.3 Collective Bargaining Agreement 3.19(a) Commitment Letters 4.10(a) Company Preamble Company Common Stock Recitals Board Recommendation 3.3(a) Company Board Recommendation Change 6.5(a) Company Disclosure Letter Article IV III Company License-In Intellectual Property Agreements Section 4.16(g3.16(b)(ii) Company License-Out Agreements Section 4.16(h) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a3.9 Company Securities 3.7(c) Company Securities Section 4.2(aStockholder Meeting 6.4(a) Company Shares Recitals Comparable Plans 6.12(b) Confidentiality Agreement Section 10.4 Current Company 9.4 Consent 3.6 Continuing Plans 6.12(a) D&O Insurance Section 7.8(c6.11(c) Customs Laws Section 4.22(aDebt Commitment Letter 4.10(a) Debt Financing Dispute Section 10.9(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a4.10(a) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b2.2 Employee Plans 3.18(a) Equity Commitment Letter 4.10(a) Equity Financing 4.10(a) ERISA Affiliate 3.18(a) Exchange Fund Section 3.8(b2.8(b) Expiration Time Section 2.1(d)(iFinancing 4.10(a) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bFunded International Employee Plan 3.18(h)(ii) Guarantee Recitals Guarantor Recitals Indemnified Persons Section 7.8(a6.11(a) Inventions Section 1.1 In-Licenses 3.16(b)(i) International Employee Plans 3.18(a) Investor 4.10(a) Leased Real Property 3.15(b) Leases 3.15(b) Maryland Department of Assessments and Taxation 2.2 Material Contract Section 4.18(a3.13(a) Material Customer Agreements 3.13(a)(vi) Maximum Annual Premium Section 7.8(c6.11(c) Merger Recitals Merger Sub Preamble MGCL Recitals New Debt Commitment Letter 6.7(b) New Plans 6.12(c) Newco Preamble No-Shop Period Start Date 5.3(a) Old Plans 6.12(c) Option Consideration Section 3.7(a)(i2.7(e)(i) Minimum Condition Section 2.1(a)(iOther Required Company Filing(s) Multiemployer Plan Section 4.11(c)3.27(a) Other Required Newco Filing(s) 4.6(b) Out-Licenses 3.16(b)(ii) Owned Company Shares 2.7(a)(iii) Payment Agent 2.8(a) Per Share Price 2.7(a)(ii) Proxy Statement 3.27(a) Representatives 5.3(a) Requisite Stockholder Approval 3.4 Subleased Real Property 3.15(d) Subleases 3.15(d) Subsidiary Securities 3.8(c) Surviving Corporation 2.1 Tax Returns 3.17(a) Termination Date 8.1(c) Uncertificated Shares 2.8(c) Voting Agreement Recitals

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto given to them in the respective sections Sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii5.3(a) Antiboycott Rules Section 4.22(aAssumed Company Option 2.8(c)(i) Board Recommendation Section 2.2(bAssumed Company Stock-Based Award 2.8(c)(ii) Base Indenture 1.1(ppp) Book-Entry Shares 2.9(b) Burdensome Condition 6.2(b) Bylaws 3.1 Cancelled Owned Company Shares Section 3.7(a)(ii2.7(a)(ii) Capitalization Date 3.7(a) Certificate of Merger Section 3.2 2.2 Certificates Section 3.8(c2.9(b) Changes Section 1.1 Charter 3.1 Closing Section 3.3 2.3 Closing Date Section 3.3 COBRA Section 4.11(d2.3 Collective Bargaining Agreement 3.19(a) Company Preamble Company Common Stock Recitals Board Recommendation 3.3(a) Company Board Recommendation Change 5.3(c)(i) Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(g1.4(a) Company License-Out Agreements Section 4.16(hEmployee 3.18(i) Company Financial Advisor Section 4.10 Plans 6.9(b) Company Recent SEC Reports Article III Company SEC Reports Section 4.7(a3.9 Company Securities 3.7(d) Company Securities Section 4.2(aStockholder Meeting 6.4(a) Company Shares Recitals Termination Fee 8.3(b)(i) Comparable Plans 6.9(b) Confidentiality Agreement Section 10.4 Current Company 9.4 Consent 3.6 D&O Insurance Section 7.8(c) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a6.8(c) DGCL Recitals Term Section Reference Dissenting Company Shares Section 3.7(c)(i2.7(b)(i) EAR Section 4.22(aEffect 1.1(o) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b2.2 Electronic Delivery 9.12 Employee Plans 3.18(a) ERISA Affiliate 3.18(a) Exchange Fund Section 3.8(b2.9(a) Expiration Time Section 2.1(d)(iFinCEN 3.21(d) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bFirst Supplemental Indenture 1.1(ooo) Recitals Recitals Indemnified Persons Section 7.8(a6.8(a) Inventions Section 1.1 Material Contract Section 4.18(aIndenture 1.1(ppp) Initial Termination Date 8.1(c) Injunction 8.1(b) International Employee Plan 3.18(a) Lease 3.14(b) Leased Real Property 3.14(b) Maximum Annual Premium Section 7.8(c6.8(c) Merger Recitals Merger Consideration Section 3.7(a)(iSub Preamble New Plans 6.9(c) Minimum Condition Section 2.1(a)(iNotice Period 5.3(d)(ii)(3) Multiemployer OFAC 3.21(c) Old Plans 6.9(c) Owned Real Property 3.14(a) Parent Preamble Parent Disclosure Letter 1.4(b) Parent Qualified Plan Section 4.11(c6.9(d) Parent Recent SEC Reports Article IV Parent Termination Fee 8.3(c)(i) Party Preamble Paying Agent 2.9(a) Payoff Letter 6.16(d) Permits 3.20 Proxy Statement 6.3(a) Representatives 5.3(a) Repurchase Transaction 6.16(c) Repurchase Transaction Notice 6.16(c) Requisite Stockholder Approval 3.4 Revolving Credit Facility Termination 6.16(d) Sanctioned Countries 3.21(c) Sanctioned Person 3.21(c) Sanctions 3.21(c) Second Supplemental Indenture 1.1(ppp) ▇▇▇▇ ▇▇▇▇▇▇▇ Reference Sublease 3.14(c) Surrendered Company Stock-Based Award 2.8(a) Surviving Corporation 2.1 Tax Returns 3.17(a)(i) Termination Date 8.1(c)

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Agreement Preamble Anti-Corruption Laws Section Reference Acceptable 3.19(b) Articles of Merger Section 1.1 ▇▇▇▇▇ Option Section 4.5(a)(iv) Book-Entry Shares Section 2.3(c) Canaccord Section 4.2(b) Certificates Section 2.3(c) Closing Date Section 2.1 Code Recitals Common Stock Consideration Section 1.4(b)(i) Confidentiality Agreement Section 6.2(e)(iii7.5(h) Acquisition Proposal Continuing Employee Section 6.2(e)(i7.7(a) Acquisition Sub Preamble Adverse Recommendation Change Continuing Employees Section 6.2(c)(i7.7(a) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(ii) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 Closing Section 3.3 Closing Date Section 3.3 COBRA Section 4.11(d) Company Preamble Company Common Stock Recitals Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(g) Company License-Out Agreements Section 4.16(h) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a) Company Securities Section 4.2(a) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company D&O Insurance Policy Section 7.8(c) Customs Laws DGCL Section 4.22(a) Debt Financing Dispute Section 10.9(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) 3.23 EAR Section 4.22(a3.19(c)(i) ECCNs Section 3.19(c)(ii) Effective Time Section 3.2 Enforceability Exceptions 1.1 Employment Agreements Recitals Exchange Agent Section 4.4 Environmental Permits Section 4.15(b2.3(a) Exchange Fund Section 3.8(b2.3(b)(i) Expiration Time Exchange Ratio Section 2.1(d)(i1.4(b)(i) Financial Statements Incipio Incipio Merger Agreement Export Controls Section 4.7(b3.19(c)(i) Recitals Recitals FCPA Section 3.19(b) Import Restrictions Section 3.19(c)(i) Indemnified Persons Parties Section 7.8(a) Inventions ITAR Section 1.1 Material Contract 3.19(c)(i) Joint Proxy Statement/Prospectus Section 4.18(a7.3(a) Malicious Code Section 3.13(m) Maximum Annual Premium Section 7.8(c) MBCA Recitals Merger Recitals Merger Consideration Shareholder Meetings Section 3.7(a)(i7.4(a) Minimum Condition Merger Sub Preamble OFAC Section 2.1(a)(i3.19(c)(i) Multiemployer Plan Qumu Preamble Qumu Board Section 4.11(c3.2(b) Qumu Board Recommendation Section 7.4(e) Qumu Board Recommendation Change Section 7.4(f) Qumu Capitalization Representations Section 2.2(b)(ii)(B) Qumu Designee Section 8.1(a) Qumu Disclosure Letter Article III Qumu Fundamental Representations Section 2.2(b)(ii)(A)

Additional Definitions. The In addition to those terms defined in Section 1.01, the following capitalized terms shall have the respective meanings ascribed thereto meaning set forth in the respective sections of this Agreement Sections set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iAcceptance Period 3.06(c) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(iiAntitrust Division 7.05(b) Antiboycott Rules Section 4.22(aArbitrator 3.06(d) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(ii) Balance Sheet Date 4.07 Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 2.03 Closing Section 3.3 2.02 Closing Date Section 3.3 COBRA Section 4.11(d2.02 Closing Indebtedness 3.06(a) Closing Net Working Capital 3.06(a) Closing Payments 3.03 Company Preamble Company Common Stock 401(k) Plan 7.08 Company Benefit Plans 4.18(b) Company Closing Deliverables 3.04(b) Company Shareholder Agreement Recitals Company Disclosure Letter Article IV Shareholder Consent Recitals Company License-In Agreements Section 4.16(gStock Option 3.01(c) Company License-Out Agreements Section 4.16(hTransaction Expense Direction Notice 6.03 Continuing Employees 6.04(a) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a) Company Securities Section 4.2(a) Company Shares Recitals Confidentiality Agreement Section 10.4 Copyrights 1.01 Current Company D&O Insurance Section 7.8(c) Customs Laws Section Representation 10.14 Customer 4.22(a) Debt Financing Dispute Section 10.9(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(aDisputed Items 3.06(d) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 2.03 Environmental Laws 4.19(a) Environmental Permits Section 4.15(b4.19(c) Exchange Fund Section 3.8(bERISA Affiliate 4.18(g) Expiration Time Section 2.1(d)(iEstimated Closing Cash Amount 3.02 Estimated Closing Indebtedness 3.02 Estimated Closing Net Working Capital 3.02 Estimated Company Transaction Expenses 3.02 FTC 7.05(b) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bHazardous Material 4.19(a) Recitals Recitals Indemnified Persons Section 7.8(aHSR Act 4.05(a) Inventions Section 1.1 Insurance Policies 4.21 Law 4.05(b) Leased Real Property 4.10 Table of Contents Leases 4.10 Licensed Intellectual Property 4.11(b) Marks 1.01 Material Contract Section 4.18(a) Maximum Annual Premium Section 7.8(c4.12(a) Merger Recitals Merger Consideration Sub Preamble Notice of Objection 3.06(c) Outside Date 9.01(c) Owned Intellectual Property 4.11(a) Parent Preamble Continuing Employees 6.04(b) Parent Closing Deliverables 3.04(a) Parent DC Plan 7.08 Patents 1.01 Post-Closing Representation 10.14 Post-Closing Statement 3.06(a) Pre-Closing Statement 3.02 Registered Intellectual Property 4.11(a) Section 3.7(a)(i280G Waived Payments 6.05(a) Minimum Condition Section 2.1(a)(iShareholder Group 10.14 Shareholders’ Representative Preamble Surviving Corporation 2.01 Transfer Taxes 7.02(a) Multiemployer Plan Section 4.11(c)Waiving Parties 10.14

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto given to them in the respective sections Sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(ii5.4(a) Antiboycott Rules Section 4.22(aAnti-Bribery Laws 3.22(c) Board Recommendation Section 2.2(bCertificates 2.10(c)(i) Cancelled Company Shares Section 3.7(a)(iiCFIUS Mitigation 6.2(b) Certificate of Merger Section 3.2 Certificates Section 3.8(cCFIUS Notice 6.2(a) Changes Section 1.1 Closing Section 3.3 2.3 Closing Date Section 3.3 COBRA Section 4.11(d) 2.3 Company Preamble Company Common Stock Recitals Board Recommendation 3.3(a) Company Board Recommendation Change 5.4(c)(i) Company Disclosure Letter Article IV 1.4 Company License-In Agreements Section 4.16(gOption Consideration 2.8(c) Company License-Out Agreements Section 4.16(hPlans 6.10(b) Company Financial Advisor Section 4.10 Relevant Persons 3.22(b) Company RSU Consideration 2.8(b) Company SEC Reports Section 4.7(a3.9 Company Securities 3.7(b) Company Securities Section 4.2(aStockholder Meeting 6.5(a) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company D&O Insurance Section 7.8(cWarrant Consideration 2.9 Comparable Plans 6.10(b) Customs Laws Section 4.22(aCopyrights 1.1(lll) Debt Financing Dispute Section 10.9(aCovenant Exceptions 5.1(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i2.7(c)(i) EAR Section 4.22(aDTC Payment 2.10(d) Effect 1.1(aa) Effective Time Section 2.2 Electronic Delivery 9.14 Enforceability Limitations 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(bEnforcement Expenses 8.3(e) Exchange Fund Section 3.8(b2.10(b) Expiration Time Section 2.1(d)(iExcluded Compensation and Benefits 6.10(b) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bFormer Government Employee 3.13(c)(v) Recitals Recitals Guaranteed Obligations 9.17(a) Guarantor Preamble Indemnified Persons Section 7.8(a6.9(a) Inventions Section 1.1 International Employee Plans 3.19(a) IP Contracts 3.16(d) Labor Agreements 3.20(a) Labor Entities 3.20(a) Lease 3.14(b) Leased Real Property 3.14(b) Marks 1.1(lll) Material Contract Section 4.18(aCustomers 1.1(sss)(x) Material Vendors 1.1(sss)(x) Maximum Annual Premium Section 7.8(c6.9(c) Merger Recitals Merger Sub Preamble New Plans 6.10(c) Notice Period 5.4(d)(ii)(3) OFAC 1.1(eeee) Old Plans 6.10(c) Other Required Company Filing 6.4(e) Other Required Parent Filing 6.4(f) Owned Company Shares 2.7(a)(ii) Parent Preamble Party Preamble Patents 1.1(lll) Payment Agent 2.10(a) Per Share Price 2.7(a)(iii) Personal Information 3.17(a) Privacy and Data Security Requirements 3.17(a) Proxy Statement 6.4(a) Required Permits 3.21 Requisite Stockholder Approval 3.4 Restraint 7.1(c) RSU Acceleration 2.8(a) Security Breach 3.17(b) Surviving Corporation 2.1 Tail Policy 6.9(c) Termination Date 8.1(c) Termination Payment 8.3(e) Trade Controls 3.22(b) Trade Secrets 1.1(lll) Uncertificated Shares 2.10(c)(ii) Unvested Company RSU Consideration Section 3.7(a)(i2.8(a)(ii) Minimum Condition Section 2.1(a)(iUS Continuing Employee 2.8(a)(ii) Multiemployer Plan Section 4.11(c)Vested Cash Portion 2.8(a)(iv) Vested Company RSU 2.8(b) Vested Company RSU Consideration 2.8(b) Voting Agreement Recitals

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(iiAppointment Time 2.3(a) Antiboycott Rules Section 4.22(aArrangements 4.17(n) Board Recommendation Section 2.2(bAssets 4.14(a) Cancelled Company Shares Section 3.7(a)(iiCapitalization Date 4.6(a) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 Closing Section 3.3 Closing Date Section 3.3 COBRA Section 4.11(dCollective Bargaining Agreement 4.18(a) Company Preamble Company Board Recommendation 7.5(a) Company Board Recommendation Change 7.5(b) Company Common Stock Recitals Company Compensation Committee 4.17(n) Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(gPlan 7.11(c) Company License-Out Agreements Section 4.16(h) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a) 4.8 Company Securities Section 4.2(a4.6(c) Company Shares Recitals Company Stockholder Meeting 7.4(a) Competing Acquisition Transaction 9.4(b)(i) Confidentiality Agreement Section 10.4 Current Company Consent 4.5 Continuing Directors 2.3(a) Covered Securityholders 4.17(n) D&O Insurance Section 7.8(c) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a7.10(c) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(bEmployee Plans 4.17(a) Employment Compensation Arrangement 4.17(n) ERISA Affiliate 4.17(a) Exchange Fund Section 3.8(b) Expiration Time Section 2.1(d)(iFunded International Employee Plan 4.17(i) Financial Statements Incipio Incipio Merger Agreement Section 4.7(b) Recitals Recitals Indemnified Persons Section 7.8(a7.10(a) Inventions Section 1.1 International Employee Plans 4.17(a) Leased Real Property 4.13(b) Leases 4.13(b) Material Contract Section 4.18(a4.12(a) Maximum Annual Premium Section 7.8(c7.10(c) Merger Recitals Merger Consideration Section 3.7(a)(i) Minimum Condition Section 2.1(a)(i2.1(b)(i) Multiemployer Plan Section 4.11(cNew Plans 7.11(d)

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto given to them in the respective sections Sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) Agreement Preamble Alternate Debt Financing 6.5(d) Alternative Acquisition Agreement Section 6.2(c)(ii5.3(a) Antiboycott Rules Section 4.22(aCertificates 2.9(c)(i) Board Recommendation Section 2.2(bClearance Date 6.3(a) Cancelled Company Shares Section 3.7(a)(ii) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 Closing Section 3.3 2.3 Closing Date Section 3.3 COBRA Section 4.11(d) 2.3 Company Preamble Company Common Stock Recitals Board Recommendation 3.3(a) Company Board Recommendation Change 5.3(d)(i) Company Disclosure Letter Article IV 1.4 Company LicenseEquity-In Agreements Section 4.16(gBased Award Consideration 2.8(a) Company License-Out Agreements Section 4.16(hLiability Limitation 8.3(f)(ii) Company Financial Advisor Section 4.10 Performance Awards Company Plans 2.8(a)(ii) 6.11(b) Company Privacy Policy 3.16(g) Company SEC Reports Section 4.7(a3.9 Company Securities 3.7(c) Company Securities Section 4.2(aStockholder Meeting 6.4(a) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company D&O Insurance Section 7.8(cComparable Plans 6.11(b) Customs Laws Section 4.22(aCopyrights 1.1(mmm) Debt Commitment Letters 4.10(a) Debt Financing Dispute Section 10.9(a4.10(a) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i2.7(c)(i) EAR Section 4.22(aDTC Payment 2.9(d) Effect 1.1(aa) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b2.2 Electronic Delivery 9.14 Enforcement Expenses 8.3(e) Equity Commitment Letter 4.10(a) Equity Financing 4.10(a) Event Notice Period 5.3(e)(i)(1) Exchange Fund Section 3.8(b2.9(b) Expiration Time Section 2.1(d)(iExisting Confidentiality Agreement 5.3(a) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bFee Letters 4.10(a) Financing 4.10(a) Financing Letters 4.10(a) Guaranty Recitals Guarantor Recitals Indemnified Persons Section 7.8(a6.10(a) Inventions Section 1.1 International Employee Plans 3.18(a) IP Contracts 3.16(d) Labor Agreements 3.19(a) Labor Entities 3.19(a) Lease 3.14(b) Leased Real Property 3.14(b) Lookback Date Article III Marks 1.1(mmm) Material Contract Section 4.18(aCustomers 1.1(sss)(ix) Material Suppliers 1.1(sss)(ix) Maximum Annual Premium Section 7.8(c6.10(c) Merger Recitals Merger Sub Preamble New Debt Commitment Letters 6.5(d) New Plans 6.11(c) No-Shop Period Start Date 5.3(a) Non-Cooperation Notice 6.6(b) Notice Period 5.3(e)(ii)(3) October Closing Event 2.3 Old Plans 6.11(c) Option Consideration Section 3.7(a)(i2.8(a) Minimum Condition Section 2.1(a)(iOther Required Company Filing 6.3(e) Multiemployer Plan Section 4.11(cOther Required Parent Filing 6.3(f) Owned Company Shares 2.7(a)(ii) Parent Preamble Parent Liability Limitation 8.3(f)(i) Party Preamble Patents 1.1(mmm) (a) Per Share Price 2.7(a)(iii) Proxy Statement 6.3(a) Reimbursement Obligations 6.6(f) Required Financing Information 6.6(a)(iv) Requisite Stockholder Approval 3.4 SEC Reports Article III Surviving Corporation 2.1 Tail Policy 6.10(c)

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto given to them in the respective sections Sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(iAdvisor 3.3(b) Agreement Preamble Agreement Date Preamble Alternate Debt Financing 6.5(c) Alternative Acquisition Agreement Section 6.2(c)(ii5.3(b) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(iiCapitalization Date 3.7(a) Certificate of Merger Section 3.2 2.2 Certificates Section 3.8(c2.9(c) Changes Section 1.1 Chosen Courts 9.10(a) Closing Section 3.3 2.3 Closing Date Section 3.3 COBRA Section 4.11(d2.3 Closing Payments 4.12(a) Collective Bargaining Agreement 3.19(a) Company Preamble Company Common Stock Recitals Board Recommendation 3.3(a) Company Board Recommendation Change 5.3(d)(i) Company Breach Notice Period 8.1(e) Company Disclosure Letter Article IV III Company License-In Agreements Section 4.16(gEquity Awards 1.1 Company Liability Limitation 8.3(f)(ii) Company License-Out Agreements Section 4.16(hRelated Parties 8.3(f)(i) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a3.9 Company Securities 3.7(c) Company Securities Section 4.2(aStockholder Meeting 6.4(a) Company Shares Recitals Termination Fee 8.3(b)(i) Confidentiality Agreement Section 10.4 Current Company 0 Consent 3.6 Copyrights 1.1 D&O Insurance Section 7.8(c6.10(c) Customs Laws Section 4.22(aDebt Commitment Letter Recitals Debt Documents 6.6(a)(xii) Debt Financing Dispute Section 10.9(a4.12(b) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i2.7(c)(i) EAR Section 4.22(aDTC 2.9(d) DTC Payment 2.9(d) Effect 1.1 Effective Time Section 2.2 Electronic Delivery 9.13 Employee Plans 3.18(a) Enforceability Limitations 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(bEnforcement Expenses 8.3(e) Equity Commitment Letter Recitals Equity Financing 4.12(a) ERISA Affiliate 3.18(a) ESPP 2.8(e) Event Notice Period 5.3(e)(i)(1) Exchange Fund Section 3.8(b2.9(b) Expiration Time Section 2.1(d)(iFee Letter Recitals Financing 4.12(b) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bFinancing Letters Recitals Go-Shop Period 5.3(a) Guarantor Recitals Guaranty Recitals Indemnified Persons Section 7.8(a6.10(a) Inventions Section Interim Period 5.1 International Employee Plans 3.18(a) Lease 3.14(b) Leased Real Property 3.14(b) Marks 1.1 Material Contract Section 4.18(aRevision 5.3(e)(ii)(3) Maximum Annual Premium Section 7.8(c6.10(c) Merger Recitals Recitals (a) Merger Sub Preamble New Debt Commitment Letters 6.5(c) New Plans 6.11(d) No-Shop Period Start Date 5.3(a) Old Plans 6.11(d) Option Consideration Section 3.7(a)(i2.8(b)(i) Minimum Condition Section 2.1(a)(iOther Required Company Filing 6.3(b) Multiemployer Plan Section 4.11(cOther Required Parent Filing 6.3(c) Owned Company Shares 2.7(a)(iii) Owned Real Property 3.14(a) Parent Preamble Parent Breach Notice Period 8.1(g) Parent Disclosure Letter Article IV Parent Liability Limitation 8.3(f)(i) Parent Reimbursement Obligations 6.6(f) Parent Related Parties 8.3(f)(i) Parent Termination Fee 8.3(c)

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble 90% Top-Up Option 1.4 90% Top-Up Option Shares 1.4 90% Top-Up Exercise Notice 1.4 90% Top-Up Notice Date 1.4 90% Top-Up Closing 1.4 90% Top-Up Notice Receipt 1.4 Adverse Recommendation Change Section 6.2(c)(i) Regulatory Condition Annex A Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(iiAppointment Time 1.3(a) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Cancelled Company Shares Section 3.7(a)(iiAssets 3.20 Capitalization Representation Annex A Certificates 2.8(c) Certificate of Merger Section 3.2 Certificates Section 3.8(c2.2 Change in Control Agreement 6.13(d) Changes Section 1.1 Closing Section 3.3 2.3 Closing Date Section 3.3 COBRA Section 4.11(d2.3 Collective Bargaining Agreements 3.18(a) Company Preamble Company Common Stock Board Recommendation 6.2(a) Company Board Recommendation Change 6.2(b) Company Disclosure Schedule Article III Preamble Company IP Agreements 3.21(f) Company Representative 6.1(b) Company Rights Recitals Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(g) Company License-Out Agreements Section 4.16(h) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a) Rights Plan Recitals Company Securities Section 4.2(a3.4(c) Company Shares Recitals Company Stockholders 1.1(f) Company Stockholders’ Meeting 6.3(a) Compensation Committee 3.3(d) Computershare Recitals Confidentiality Agreement Section 10.4 Current Company 6.9 Consent 3.5(b) Continuing Directors 1.3(a) Covered Securityholders 4.9 D&O Insurance Section 7.8(c6.14(b) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a) DGCL Recitals Delaware Secretary of State 2.2 Dissenting Company Shares Section 3.7(c)(i2.7(c) EAR Section 4.22(aDistribution Date 3.3(c) Effective Time Section 3.2 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b2.2 Employee Plans 3.17(a) ERISA Affiliate 3.17(a) Exchange Fund Section 3.8(b2.8(b) Expiration Time Section 2.1(d)(iExclusivity Agreement 6.10 Export Controls 3.22 FIN 48 3.15(o) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bFunded International Employee Plan 3.17(b) Recitals Recitals Import Restrictions 3.22 Indemnified Persons Section 7.8(aParties 6.14(a) Inventions Section 1.1 International Employee Plans 3.17(a) Leased Real Property 3.19(b) Leases 3.19(b) Material Contract Section 4.18(a3.11(a) Maximum Annual Premium Section 7.8(c6.14(b) Merger Recitals 2.1 Merger Consideration Section 3.7(a)(i2.7(a) Merger Sub Preamble Minimum Condition Section 2.1(a)(i) Multiemployer Plan Section 4.11(c1.1(a)(i)

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto given to them in the respective sections Sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality 280G Analysis 6.21 Accounting Firm 5.4(b) Advisor 3.26 Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) Agreement Date Preamble Alternative Acquisition Agreement Section 6.2(c)(ii5.3(a) Antiboycott Rules Section 4.22(aAlternative Debt Financing 6.5(e) Board Recommendation Section 2.2(bApplicable Termination 8.3(b)(i) Cancelled Company Shares Section 3.7(a)(iiBylaws 3.3(a) Capitalization Date 3.5(a) Certificate of Merger Section 3.2 2.2 Certificates Section 3.8(c2.10(c) Changes Section 1.1 Charter 2.5(a) Chosen Courts 9.10(a) claim 4.13 Closing Section 3.3 2.3 Closing Date Section 3.3 COBRA Section 4.11(d) 2.3 Company Preamble Company Common Stock Recitals Board Recommendation 3.2(b) Company Board Recommendation Change 5.3(c)(i) Company Breach Notice Period 8.1(e) Company Disclosure Letter Article IV III Company License-In Agreements Section 4.16(gLicenses 3.13(e) Company License-Out Agreements Section 4.16(hIP License 3.13(f) Company Financial Advisor Section 4.10 Out Licenses 3.13(f) Company Real Property Lease 3.11(b) Company Related Parties 8.3(f)(ii) Company SEC Reports Section 4.7(a3.7 Company Subsidiary Documents 3.4 Company Termination Fee 8.3(b)(i) Company Securities Section 4.2(aCovered Persons 6.10(a) Company Shares Recitals Confidentiality Agreement Section 10.4 Current Company D&O Insurance Section 7.8(cCOVID-19 1.1(x)(vi) Customs Laws Section 4.22(aCOVID-19 Measures 1.1(x)(xi) debt 4.13 Debt Commitment Letter 4.11(b) Debt Financing Dispute Section 10.9(a4.11(b) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i2.7(c)(i) EAR Section 4.22(aDTC 2.10(d) DTC Payment 2.10(d) Effect 1.1(x) Effective Time Section 3.2 2.2 Electronic Delivery 9.13 Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(bLimitations 3.2(d) Enforcement Expenses 8.3(e) Equity Commitment Letter 4.11(a) Equity Financing 4.11(a) Equity Financing Source 4.11(a) ESPP 2.9 Event Notice Period 5.3(d)(i)(1) Exchange Fund Section 3.8(b2.10(b) Expiration Time Section 2.1(d)(iExcluded Benefits 6.11(a) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bFairness Opinion 3.26 Financing 4.11(c) Financing Conditions 4.11(d) Financing Letters 4.11(c) Guarantee Recitals Guarantor(s) Recitals Recitals Indemnified Persons Section 7.8(aInterim Period 5.1 Labor Agreement 3.14(a)(vii) Inventions Section 1.1 Legacy ERP System 3.13(l) Major Customer 3.14(a)(ix) Major Supplier 3.14(a)(x) Material Contract Section 4.18(a3.14(a) Maximum Annual Premium Section 7.8(c6.10(c) Merger Recitals Merger Sub Preamble Option Consideration Section 3.7(a)(i2.8(a) Minimum Condition Section 2.1(a)(iOther Required Company Filing 6.3(b) Multiemployer Other Required Parent Filing 6.3(c) Owned Company Shares 2.7(a)(iii) Owned Real Property 3.11(a)(i) Parent Preamble Parent Breach Notice Period 8.1(g) Parent Damages 8.3(f)(i)(A)(y) Parent Expense Reimbursement 8.3(b)(iv) Parent Related Parties 8.3(f)(ii) Party Preamble Payment Agent 2.10(a) Per Share Price 2.7(a)(ii) Permits 3.20 Prohibited Financing Modifications 6.5(b)(iii) Proposal Notice Period 5.3(d)(ii)(3) Prospective Purchaser 5.3(b) Proxy Statement 6.3(a) PSU Consideration 2.8(c) Qualified Plan Section 3.16(d) Related Parties 3.27 Required Amounts 4.11(f) Requisite Stockholder Approval 3.2(c) Restricted Stock Consideration 2.8(d) RSU Consideration 2.8(b) Sale/Leaseback Financing 4.11(c) Sale/Leaseback Purchase Agreement 4.11(c) Sale/Leaseback Transaction 6.24 SAP ERP System 3.13(l) Scheduled Amended Tax Return 5.4 Solvent 4.13 Surviving Corporation 2.1 Takeover Statute 3.24 Termination Date 8.1(c) Third Party Purchaser 6.24 Transaction Legal Proceedings 9.10(a) Uncertificated Shares 2.10(c)

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto in the respective sections of this Agreement set forth opposite each of the capitalized terms below: Term Section Reference Acceptable Confidentiality Agreement Section 6.2(e)(iii) Acquisition Proposal Section 6.2(e)(i) Acquisition Sub Preamble Adverse Recommendation Change Section 6.2(c)(i) Agreement Preamble Alternative Acquisition Agreement Section 6.2(c)(iiArrangements 4.17(m) Antiboycott Rules Section 4.22(a) Board Recommendation Section 2.2(b) Assets 4.14 Cancelled Company Shares Section 3.7(a)(ii) Capitalization Date 4.6(a) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 Change of Recommendation Notice 7.5(b)(ii) Closing Section 3.3 Closing Date Section 3.3 COBRA Section 4.11(dCollective Bargaining Agreement 4.18(a) Company Preamble Company Board Recommendation 7.5(a) Company Board Recommendation Change 7.5(b) Company Common Stock Recitals Company Compensation Committee 4.17(l) Company Disclosure Letter Article IV Company License-In Agreements Section 4.16(gIP Contract 4.15(b) Company License-Out Agreements Section 4.16(hPlans 7.11(c) Company Financial Advisor Section 4.10 Company SEC Reports Section 4.7(a) Company Securities Section 4.2(a) 4.8 Company Shares Recitals Competing Acquisition Transaction 9.4(b)(i) Confidentiality Agreement Section 10.4 Consent 4.5 Copyleft Licenses 4.15(i) Current Company D&O Insurance Section 7.8(c) Customs Laws Section 4.22(a) Debt Financing Dispute Section 10.9(a7.10(c) DGCL Recitals Dissenting Company Shares Section 3.7(c)(i) EAR Section 4.22(a) Effective Time Section 3.2 Employee Plan 4.17(a) Employee Plans 4.17(a) Employment Compensation Arrangement 4.17(l) Enforceability Exceptions Section 4.4 Environmental Permits Section 4.15(b) Limitations 4.2 Exchange Fund Section 3.8(b) Expiration Time Section 2.1(d)(iGrant Date 4.6(e) Financial Statements Incipio Incipio Merger Agreement Section 4.7(bHealthcare Laws 4.20(a) Recitals Recitals Healthcare Permits 4.20(d) Indemnified Persons Section 7.8(a7.10(a) Inventions Section 1.1 Institutions 4.15(h) Leased Real Property 4.13(b) Leases 4.13(b) Material Contract Section 4.18(a4.12(a) Maximum Annual Premium Section 7.8(c7.10(c) Merger Recitals Merger Consideration Section 3.7(a)(i) Minimum Condition Section 2.1(a)(i) Multiemployer Plan Section 4.11(cModified Terms 7.5(b) New Plans 7.11(c) Offer Recitals Offer Documents 2.1(g)(i) Offer Price Recitals Offer to Purchase 2.1(a) Old Plans 7.11(c) Open Source Licenses 4.15(i) Option Consideration 3.7(d) Parent Preamble Payment Agent 3.8(a) Permits 4.19 Personal Information 4.15(j) Privacy Policies 4.15(j) Representatives 6.2(b) Restraint 8.1(b) RSU Consideration 3.7(e) Schedule 14D-9 2.2(b) Schedule TO 2.1(g)(i) Subsidiary Securities 4.7(c) Surviving Corporation 3.1 Tax Returns 4.16(a) Termination Date 9.1(b) Termination Fee 9.4(b)(i) Uncertificated Shares 3.8(c) Union 4.18(a)

Additional Definitions. The following capitalized terms shall have the respective meanings ascribed thereto given to them in the respective sections Sections of this Agreement set forth opposite each of the capitalized terms below: Term 2020 Indenture Section Reference Acceptable Confidentiality Agreement 6.12(a) 2020 Notes Section 6.2(e)(iii6.12(a) Acquisition Proposal 2021 Indenture Section 6.2(e)(i6.12(a) Acquisition Sub Preamble 2021 Notes Section 6.12(a) Adverse Recommendation Change Section 6.2(c)(i5.03(d)(i) Agreement Preamble Alternative Acquisition Agreement Anti-Bribery and Anti-Corruption Laws Section 6.2(c)(ii4.26 Available Cash Amount Section 2.02(k) Antiboycott Rules Bankruptcy and Equity Exception Section 4.22(a3.02 Book-Entry Shares Section 2.01(c) Board Recommendation Section 2.2(b) Cancelled BR Guarantor Recitals Canceled Company Shares Section 3.7(a)(ii2.01(b) Capital Stock Section 4.03(a) Capitalization Date Section 4.03(a) Certificate Section 2.01(c) Certificate of Merger Section 3.2 Certificates Section 3.8(c) Changes Section 1.1 1.02 Closing Section 3.3 1.03 Closing Date Section 3.3 COBRA Section 4.11(d) 1.03 Company Preamble Company Common Stock Recitals Benefit Plan Section 4.10(a) Company Board Recommendation Section 4.04 Company Disclosure Documents Section 4.07 Company Disclosure Letter Article ARTICLE IV Company License-In Agreements Financial Advisors Section 4.16(g4.23 Company Owned Property Section 4.17(a) Company License-Out Agreements Related Parties Section 4.16(h8.03(f) Company Financial Advisor SEC Documents Section 4.10 Company SEC Reports Section 4.7(a4.06(a) Company Securities Section 4.2(a4.03(a) Company Shares Recitals Stockholder Approval Section 4.04 Company Stockholder Meeting Section 4.04 Company Termination Fee Section 8.03(b) Confidentiality Agreement Agreements Section 10.4 Current Company D&O Insurance 6.02 Copyrights Section 7.8(c) Customs Laws 10.01 Debt Commitment Letters Section 4.22(a3.09(a) Debt Financing Dispute Section 10.9(a3.09(a) DGCL Recitals Discharge Section 6.12(c) Dissenting Company Shares Section 3.7(c)(i2.03(a) EAR DTC Section 4.22(a2.02(j) DTC Payment Section 2.02(j) Effective Time Section 3.2 Enforceability Exceptions 1.02 End Date Section 4.4 8.01(b)(i) Environmental Permits Law Section 4.15(b4.13 Equity Commitment Letter Section 3.09(a) Equity Financing Section 3.09(a) Exchange Fund Section 3.8(b2.02(b) Expiration Time Excluded Contract Section 2.1(d)(i4.14(b) Financial Statements Incipio Incipio Merger Agreement Filed Company Contract Section 4.7(b4.14(a) Filed Company SEC Documents ARTICLE IV Financing Section 3.09(a) Financing Commitments Section 3.09(a) GAAP Section 4.06(c) Governmental Approvals Section 6.18(a) Grant Date Section 4.03(c) Guarantee Recitals Guarantor Recitals Indemnified Persons Guarantors Recitals Indentures Section 7.8(a6.12(a) Inventions Inquiry Section 1.1 5.03(a)(i) International Benefit Plan Section 4.10(a) Investors Recitals IRS Section 4.10(b) Key Vendor Contracts Section 4.16(a) Key Vendors Section 4.16(a) Lease Section 4.17(a) Leased Real Property Section 4.17(a) Legal Restraints Section 7.01(c) Letter of Transmittal Section 2.02(c) Material Contract Section 4.18(a4.14(b) Maximum Annual Premium Amount Section 7.8(c6.05(c) Merger Recitals Merger Consideration Section 3.7(a)(i2.01(c) Minimum Condition Merger Sub Preamble Merger Sub Common Stock Section 2.1(a)(i2.01(a) Multiemployer Plan Non-Recourse Company Party Section 4.11(c9.10 Notes Section 6.12(a) Notice Period Section 5.03(d)(ii) Optional Redemption Section 6.12(b) Optional Redemption Notices Section 6.12(b) Parent Preamble Parent Disclosure Letter Article III Parent Related Parties Section 8.03(f) Parent Termination Fee Section 8.03(c) Patents Section 10.01 Paying Agent Section 2.02(a) Personal Information Section 4.20(a) Preferred Stock Section 4.03(a) Primary Debt Commitment Letter Section 3.09(a) Privacy Obligations Section 4.20(a) Proxy Statement Section 6.01(a) Real Property Section 4.17(a) Registered Intellectual Property Rights Section 4.18(a) Rental Contract Section 4.15(a) Representatives Section 5.03(a) Secondary Debt Commitment Letter Section 3.09(a) Solvent Section 3.10 Surviving Company Section 1.01 Systems Section 4.21(b) Trademarks Section 10.01 VRTO Guarantor Recitals WARN Act Section 4.19(d)